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NOTATION 
The notation for each residue is to give the chain letter (A or B) first, followed by its 
number in the sequence, followed by the number 1 or 2 representing molecule 1 or 2, 
followed by the residue name; eg. B25.1 Phe represents B25 phenylalanine of molecule 1. 
Mutant insulins are described in turn by the native residue name, the chain letter and 
number in the sequence, the name of the substituted residue and the species name and 
insulin. Residue names are given in one letter codes. For example HBIO D platypus 
insulin, where the His (native) is substituted by Asp (mutant). 
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ABSTRACT 
Platypus Insulin: Indications from the Amino-acid Sequence of Significant 
Differences in Structure from Porcine Insulin. 
Insulin from a monotreme, the platypus (Ornithorhynchus anatinus), was isolated and 
the amino-acid sequence detennined. It differs from pig insulin at eleven amino-acid 
sites, mainly on the surface of the monomer. Substitutions relative to pig insulin occur 
in the monomer-monomer interface, the dimer-dimer interface and the receptor 
binding region. The residues A5 Glu, A8 Lys and Al3 Met have not been reported 
before in any insulin. Multiple sequence comparison studies reveal a relatively close 
relationship with the nearest group of relatives to the platypus, the mammals. The 
relationship of the platypus sequence to reptilian insulin sequences (and amphibian 
and avian insulin sequences in this case) is sufficiently close to support the 
observation that platypus has retained some ancient reptilian characteristics over the 
course of evolution. Model building the platypus insulin sequence on the structure of 
porcine insulin indicates that there may be some interesting differences. 
Total Chemical Synthesis of Native and Mutant HBJ OD Platypus Insulins 
To investigate the biological and physico-chemical properties of platypus insulin, it 
was synthesised by totally chemical means. The A- and B-chains were synthesised 
separately by an automatic solid phase peptide synthesiser using Fmoc chemistry and 
acetamidomethyl (Acm) protection of Cys A6, Cys Al 1, Cys A20 and Cys Bl 9. The 
method of synthesis used was largely based on the stepwise semi-regioselective 
fonnation of firstly the CysA 7-CysB7 disulfide bond followed by the removal of 
S-Acm groups and concomitant fonnation of the other two disulfide bonds by means 
of iodine oxidation. The synthesis products were identified by mass spectrometric 
analysis. The method of total chemically synthesis employed was very successful. 
Also preliminary investigations into the self-association of synthetic platypus insulin 
by sedimentation analysis pointed to some reduction in the self-association at the 
dimer-dimer interface compared to bovine insulin. Furthennore, predicted differences 
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in the spatial arrangement of residues in this interface of the molecular model also 
suggested that the self-associating properties in this region may be affected, seemingly 
lowered. 
This prompted an investigation of the properties of the dimer-dimer interface with 
platypus insulin analogues designed to probe that region. One of these, 
HB 1 OD platypus insulin, was also chemically synthesised to investigate its 
self-association pattern. Both this analogue and the synthetic native platypus insulin 
were obtained in a pure form. A comparison of their circular dichroism spectra showed 
them to be similar to that of porcine insulin. In vitro measurement of the biological 
activity showed that of platypus insulin was identical to and HB 1 OD platypus insulin 
double that of porcine insulin. 
The Self-Association of Zinc-Free Native and Mutant HBJ OD Platypus Insulins 
An extensive study of the self-association patterns of zinc-free synthetic native platypus 
and mutant (HB 1 OD) platypus insulins in solution (pH = 7 .0; I= 0. l M; 25 °C) has 
been undertaken. Sedimentation equilibrium was chosen as the method of study as 
precise information could be obtained on the dependence of both weight-average 
molecular weight and of concentration of the monomer (m1) on total protein 
concentration. Experimental data were fitted to a model, called indefinite duoisodesmic 
_ (IDI) of self-association, to obtain the relevant association constants. 
The method of analysis of the sedimentation equilibrium data was as follows: 
The sedimentation equilibrium data were analysed by the omega-method to obtain the 
thermodynamic parameter a1 (the activity of the monomer in equilibrium with a series of 
polymeric species) as a function of total protein concentration. In the omega analysis, 
omega (Q) function versus total protein concentration curves were extrapolated to yield 
the infinite dilution value, no , whereby the thermodynamic activity of the self-
associating monomer was determined at a reference point in the centrifuge cell. The 
activity of the monomer at this reference point was used to 
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calculate the activity of the monomer as a function of the total solute concentration. 
The concentration of the monomer m1 was then calculated from the activity a1 and 
known molecular weight of the monomer. 
Once the sedimentation equilibrium data was analysed and transformed to 
concentration of the monomer m1 as a function of total protein concentration it was 
fitted to a mathematical equation (Mark and Jeffrey, 1990) describing the Indefinite 
Duoisodesmic (IDI) model of self-association. From this the relevant association 
constants describing polymerising systems were calculated. 
(IDI describes the indefinite self-association of a bivalent insulin monomer along the 
monomer-monomer (a-a) and dimer-dimer(~-~) interfaces governed by two 
association constants KA and K8 respectively. The two initial pathways of 
dimerization are then followed by the indefinite addition of monomer under the 
control of the same two association constants. The above mathematical equation 
describes the composition of a solution consisting of an infinite array of odd and even 
numbered polymeric species). 
The weight-fraction of each species was also calculated as a function of total insulin 
concentration using an expression in terms of the weight-fraction of species as a 
function of total concentration for the IDI model with known KA and K8 values. The 
expression describes the complex distribution of species within the insulin system in 
solution. A distinction can be made between the weight-fraction of the two types of 
dimer a and ~ and tetramer a and~- It stresses the importance of the odd-numbered 
species, the dominant species by weight in bovine insulin under these particular 
conditions. The possible presence of odd-numbered species other than monomer have 
been taken into account. 
In the studies on the self-association of the synthetic native and mutant platypus 
insulins each was compared with bovine insulin. It has been concluded that there is 
some reduction in the extent of the self-association of platypus insulin compared to 
bovine insulin. A reduction in specifically the dimer-dimer interaction is indicated by 
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the higher KA and lower KB values. HBlOD platypus insulin shows a dramatic 
reduction in self-association compared to bovine insulin. (Similar results have 
been obtained with a HB 10D human insulin). Analysis of the self-association 
pattern suggests that a KB value of effectively zero virtually abolishes its 
dimer-dimer interaction. 
Thus platypus insulin has essentially the same biological activity as porcine but 
somewhat lower self-association, while the introduction of one amino-acid in a 
critical region increases the activity two-fold while abolishing self-association 
beyond dimer. 
xv 
~ 
TABLE OF CONTENTS PAGES 
Title • I 
Statement ... Ill 
Acknowlegments • IV 
List of Abbreviations V 
Glossary of Symbols • IX 
i; 
Notation • XI 
Abstract •• XII 
' Chapter 1 
I 
I 
I 
I 
Introduction 
) 
I[ 
1.1 Aim of this project 1 
1.2 Problems of insulin therapy in the treatment of diabetes 3 
mellitus 
1.2.1 The aggregation of insulin 3 
1.2.2 Reproduction of the endogenous insulin-secretion-pattern 4 
1.3 Therapeutic insulins to counteract insulin therapy problems 5 
1.3.1 Therapeutic insulins that are active and monomeric 6 
1.3.2 Therapeutic insulins with altered physico-chemical, 7 
phannacokinetic and biological properties 
1.4 Pursuing a fully active monomeric insulin 8 
1.4.1 Design of an active monomeric insulin 8 
1, 
The three dimensional structure of insulin and its 9 
relationship to function 
. 
XVl 
I 
·•1 
I 
I 
' I 
;[ 
Iii 
II, 
1.5 
1.5.1 
The three interaction surfaces of insulin as independent 
targets for design 
The incorporation of reduced self-association properties 
of naturally occurring insulins, insulin-like molecules and 
insulin analogues 
Evaluation of monomeric status of insulin analogues 
in solution 
Exploring another avenue for identifying an insulin with 
desirable properties 
Using the platypus insulin sequence to explore and identify 
desirable properties 
Structural analysis of platypus insulin 
Total chemical synthesis of native platypus and a mutant 
platypus insulin 
Sedimentation analysis of the self-association pattern 
of chemically synthesised insulins 
Chapter 2 
Literature Review: The Structure-Function Relationship of 
Insulin 
2.1 Introduction 
2.2 The structure of insulin 
2.2.1 The crystal structure of 2 Zn pig insulin 
The conformation of A-chain in the crystal structure 
The conformation of the B-chain in the crystal structure 
The disulfide bonds 
The conformation of the monomer in the crystal 
XVll 
10 
10 
11 
12 
12 
13 
14 
14 
16 
18 
19 
20 
21 
21 
22 
;[ 
~: 
j,, 
The formation of the dimer in the crystal 
The formation of the hexamer in the crystal 
2.2.2 Conformational states of insulin hexamers in crystals 
2.2.3 The structure of HB 1 OD insulin in the crystal 
2.3 The solution structure of insulin: Relationship to crystal 
structure 
Solution structure of insulin monomer 
Structure of a mutant insulin that is predominantly 
monomeric in solution 
Solution structure of dimers 
Zn insulin hexamer and its structure in solution 
2.4 Properties of the insulin molecule 
2.4.1 Residues involved in the self-association of insulin 
The monomer-monomer inteiface 
The dimer-dimer inteiface 
2.4.3 Residues involved in the biological activity of insulin 
Receptor binding region 
Growth promoting activity 
2.5 Invariant amino-acids 
2.6 Stability of the insulin monomer fold with application to 
structure-activity relationship 
2.7 The structure and function of the insulin receptor 
Chapter 3 
Platypus Insulin: Structural Analysis 
3.1 
3.2 
Introduction 
Materials and Methods 
XVlll 
22 
23 
24 
26 
27 
28 
29 
30 
31 
32 
32 
32 
34 
35 
35 
39 
40 
40 
41 
45 
47 
3.2.1 Isolation and purification of native platypus insulin 47 
3.2.2 Determination of the amino-acid sequence of platypus insulin 48 
3.2.3 Amino-acid sequence analysis of platypus insulin 49 
3.2.4 Molecular modelling of the three dimensional structure of 50 
platypus insulin 
3.3 Results 51 
3.3.1 Isolation and purification of native platypus insulin 51 
3.3.2 The amino-acid sequence of platypus insulin 51 
Structural integrity of platypus insulin structure 55 
Self-association interfaces (monomer-monomer and dimer-dimer) 55 
Receptor binding region and biological activity 56 
I 
(metabolic and growth) I I 
I 
' 
3.3.4 Multiple sequence alignment of platypus insulin with that of all 53 
Iii known insulin sequences 
3.3.5 Molecular modelling the three dimensional structure of platypus 54 
Iii 
insulin 
3.4 Discussion 55 
3.4.1 Amino-acid sequence of platypus insulin 55 
3.4.2 Pairwise amino-acid sequence comparisons of platypus insulin 57 
with that of all known insulin sequences 
3.4.3 Multiple sequence alignment of platypus insulin with that of all 58 
known insulin sequences 
3.4.4 A comparison of the computer molecular model of the three 59 
dimensional structure platypus insulin with the crystal structure 
of porcine insulin 
3.4.5 Conclusion 60 
I,, 
X1X 
' ~•1-
I 
''I 
) 
I 
) 
I 
II! 
Chapter 4 
Total Chemical Synthesis and Characterisation of Platypus 
and HBlOD Platypus Insulins 
4.1 Introduction 
4.2 Materials and Methods 
4.2.1 The total chemical syntheses of platypus and 
HB 1 OD Platypus Insulin. 
4.2.1.1 Materials 
4.2.1.2 Analytical procedures 
Preparative HPLC 
Analytical HPLC 
4.2.1.3 Total chemical synthesis of platypus and 
HB 1 OD platypus insulin 
4.2.1.3.1 Strategy of semi-regioselective disulfide 
bond formation 
4.2.1.3.2 Solid-phase synthesis of the peptide chains 
4.2.1.3.3 Cleavage of peptides from the resin 
Collection and purification of 
[C (A )A6, All, A20} A h . ys cm -c azn 
Collection and purification of 
B19 [Cys(Acm) J and 
[Cys(Acm)819J[HBJODJ B-chains 
4.2.1.3.4 S-2-Pyridinesulfenylation of both native 
and mutant [Cys(Acm)819]B-chains at 
Cys B 7 to form their 
[Cys(Acm)819, Cys(S-Pyr)87] 
B-chain derivatives 
xx 
62 
64 
64 
64 
65 
65 
65 
66 
66 
66 
67 
68 
68 
69 
4.2.1.3.5 The combination of 70 
[Cys(Acm)A6, Al 1' A20]A-chain with 
B1 9 B7 . [Cys(Acm) , Cys(S-Pyr) ] B-chain of 
native or mutant to give their respective 
[c (A )A6, Al 1. A20. B19r lin ys cm msu s 
j, 4.2.1.3.6 Iodine oxidation of both native and 71 
mutant [Cys(Acm)A6, Al I, A2o, 819] platypus 
l I insulin to give native and mutant 
1' 
~) platypus insulins. 
4.2.2 Characterisation of the synthetic products 72 
4.2.2.1 Mass analysis of peptides 72 
i 
I 
·•1 4.2.2.2 Biological characterisation of synthetic insulins 73 
Isolation of Adipocytes 73 
;1, 
[3-3HJD-glucose incorporation into cellular lipids 73 
4.2.2.3 Biophysical characterisation of synthetic insulins 74 
Circular dichroism spectra of synthetic insulins 74 
4.3 Results 75 
I 4.3.1 Total chemical synthesis of platypus and HB 1 OD platypus insulin 75 
1: 4.3.1.1 Solid-phase synthesis of the peptide chains 75 
4.3.1.2 S-2-pyridinesulfenylation of the B-chains 76 ·1 
4.3.1.3 Fonnation of the disulphide linked CysA7-CysB7 dimer 77 
4.3.1.4 Subsequent disulfide bond fonnation between 77 
Cys A2O-Cys B19 and Cys A6-Cys All 
4.3.1.5 Purification of synthesised native and mutant insulins 78 
4.3.1.6 Desalting of the native and mutant platypus insulin 78 
4.3.1. 7 Purity of the synthetic insulin samples 78 
4.3.1.8 Yields of the products of synthesis. 79 
4.3.1.9 Mass analysis of peptides 80 
XX1 
l1 
Iii 
4.3.2 Biological activity of synthetic native and mutant platypus 
insulins 
4.3.3 Biophysical characterisation of synthetic native and 
mutant platypus insulins 
Circular dichroism spectra of synthetic native and 
mutant platypus insulin 
4.4 Discussion 
Combination of the A- and B-chains 
Iodine oxidation 
Relative yields of native and mutant platypus insulin 
Characterisation of synthetic insulins CD spectra and 
biological activity 
Conclusion: Verification, yields and homogeneity 
Chapter 5 
The Self-Association Pattern of Zinc-Free Bovine, Synthetic 
Platypus and HBlOD Platypus Insulin: 
A Sedimentation Equilibrium Study 
5.1 Sedimentation analysis 
5.1.1 Sedimentation equilibrium 
Sedimentation equilibrium of a single solute species 
Sedimentation equilibrium of a single solute species which 
self-associates to form an equilibrium mixture of states of 
different molecular weights 
5.1.2 The omega analysis 
Extrapolation of the omega function 
.. 
XX11 
80 
81 
81 
82 
82 
83 
83 
84 
85 
86 
87 
89 
91 
92 
95 
5.1.3 Associating systems at low total solute concentrations c 96 
5.1.4 Associating systems at high values of total solute concentrations 98 
c non-ideality effects 
5.2 Review of the self-association of zinc-free insulin 99 
5.2.1 The indefinite duoisodesmic (IDI) model of self-association 99 
5.2.2 Weight-fractions of species 102 
5.2.3 Comparison of ID I with other proposed models 103 
I 5.3 Materials and methods 110 
5.3.1 Bovine insulin preparation 110 
5.3.2 Sedimentation equilibrium studies 111 
5.3.3 Analysis of sedimentation equilibrium data 111 
5.4 Results 112 
5.4.1 The dependence of "reduced" weight-average molecular weight 112 
on total bovine, platypus and HB 1 OD platypus insulin 
concentration 
lj! 
5.4.2 Omega Analysis. 113 
5.4.3 Evaluation of the weight-fractions of all species up to and 117 I\ ,  
I 
including hexamer of bovine, platypus, and HB 1 OD platypus i D I 
insulin as a function of total concentration. 
5.4.4 Comparison of the weight-fractions of monomers and oligomers 118 
of the three insulins. 
5.5 Discussion 119 
5.5.1 Omega Analysis 119 
The coincidence of the omega plots 120 
The extrapolation of the omega function 120 
The choice of the reference concentration 121 
Thermodynamic non-ideality effects 121 
5.5.2 The fitting of the m1 versus c data to the IDI model 122 
The association constants KA and K8 122 
XXll1 
' I 
·- ---
JI, 
i~ 
I 
i: 
I 
''1 
I 
' ,., 
5.5.3 The dependence of "reduced" weight-average molecular weight 123 
on total insulin concentration. The overall extent of the self-
association of zinc-free insulin 
Comparison of the self-association pattern of bovine and 124 
platypus insulin 
Comparison of the self-association pattern of bovine and 126 
HBJOD platypus insulin 
Comparison with published results of state of association 129 
5.5.4 Weight-fractions as a function of total concentration. 129 
5.6 Future work 132 
Bibliography 136 
XXIV 
11: 
iji 
Chapter 1 
Introduction 
1.1 Aim of this project 
Since the discovery of insulin by Banting and Best in the 1920's its use in the 
treatment of human insulin-dependent diabetes mellitus has been one of the 
spectacular successes of pharmaceutical science. The problems in conventional insulin 
therapy are that none of the presently available commercial preparations, in any 
combination, adequately reproduce the endogenous insulin-secretion-pattern resulting 
in poor blood-sugar control. Poor blood-sugar control can lead to microvascular 
complications; one such example is retinopathy in the eye suffered by many diabetics 
(Bristow, 1993). Many problems associated with its exogenous administration, 
namely nasal delivery, intravenous and in particular subcutaneous injection, are 
caused by the aggregation of insulin (Renard et al., 1995; Olsen et al., 1995; 
Lougheed et al., 1980; Bristow, 1993) and this is an ongoing problem in insulin 
therapy (Galloway and Chance, 1994; Renard et al., 1995; Olsen et al., 1995). 
The aggregation phenomenon may also lead to the formation of insoluble fibrils, 
amorphous precipitates and aggregates in therapeutic insulin formulations used in 
delivery systems. Aggregated forms of insulin also present numerous problems on 
application; for instance the generation of a significant percentage of immune 
reactions seen in diabetic patients (Robbins et al., 1987), their implication in the 
formation of the amyloid growths at injection sites (Dische et al., 1988), difficulties in 
controlling dosage and the likelihood that they may impair the activity of monomeric 
insulin by competing for receptor binding sites. 
The problems of concern in this study are associated with the self-association of 
soluble insulin. The significance of these problems have been discussed by Galloway 
and Chance (Galloway and Chance, 1994 ). The approach used was to explore 
properties of an insulin with natural variations in its amino-acid sequence. Platypus is 
1 
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such an exotic species with natural variation. The idea being that the amino-acid 
sequence of platypus insulin could hopefully show characteristics which would be of 
value in the design of insulin analogue(s) that were more user friendly in insulin 
therapy. By far the most advantageous property that can be built into a designed 
insulin molecule is that it does not self-associate while retaining full activity. 
In order to investigate the structure and properties of platypus insulin it was 
necessary to have sufficient material but for ethical and moral reasons it was not 
contemplated that this could be obtained from platypus pancreases since it is an 
unique and protected animal of Australia. For the study, however, it was imperative 
that the amino-acid sequence of platypus insulin be known and fortunately sufficient 
material could be purified for its determination from platypus which had died of 
natural causes. To obtain sufficient material for further investigations other means of 
obtaining this was necessary and to do this chemical synthesis was thus chosen. 
Also researched was the method for the total chemical synthesis of insulins by the 
strategy of the stepwise semi-regioselective formation of the disulfide bonds for the 
purpose of producing designed insulin analogues of a specific sequence for 
evaluation. The insulin molecule consists of two chains, namely the A- (21 amino-
acids) and B- (30 amino-acids) chains, linked by two inter-chain disulfide bridges and 
one intra-chain disulfide bridge on the A-chain (Blundell et al., 1972; Balcer et al., 
1988). To synthesise this complex protein by total chemical means has to date been a 
difficult and laborious task (Brandenburg, 1990). Thus in this study considerable 
effort was put into optimising and modifying existing methods of chemical synthesis 
of insulin (and insulin-like molecules) to produce insulins in a pure form in a relatively 
short period of time. Although higher quantities of insulin can be produced by DNA 
recombinant technology it is not possible to produce insulins with some substitutions 
by this method, as for instance NA21P human insulin (Markussen et al., 1988). An 
added advantage of chemical synthesis is that non-natural amino-acids as well as 
chemical side chains with known chemical properties can be built into the insulin 
molecule at specific sites for evaluation of their effect(s). 
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Since reducing or abolishing the self-association of therapeutic insulin is pivotal to 
improving insulin therapy, it is important to be able to analyse critically the self-
association pattern of insulin analogues for potential use in solution. In this thesis 
sedimentation analysis has been used for evaluating chemically synthesised insulins in 
detail. Association constants, characteristic of the self-association pattern of a specific 
insulin, are derived using this analysis allowing quantitative assessment of the effects 
of sequence changes. 
1.2 Problems of insulin therapy in the treatment of diabetes mellitus 
1.2.1 The aggregation of insulin 
Insulin self-associates reversibly in solution characteristically forming an array of 
polymeric species in equilibrium, of which the hexamer is most prominent. The zinc 
hexamer is the form in which insulin molecules are stored as inactive crystals in the 
f pancreas. Hexamers in solution are evident at quite low concentrations even in the 
absence of zinc (Jeffrey, 1990). Many of the problems associated with the exogenous 
administration of insulin originate as a result of this aggregate formation at the high 
application concentrations that are used. These aggregates engage the potent 
monomers in interactions to form biologically inactive polymers. 
Insulin can also form irreversible aggregates in solution resulting in precipitation 
(fibril or gel formation). This irreversible aggregation is a nucleation-driven process 
initiated by partial denaturated states of insulin (Sluzky et al., 1991) and results in 
insulin fibrils that contains a perturbed native structure with increased ~-structure (Yu 
et al., 1974; Burke and Rougvie, 1972). This nucleation process is thought to take 
place in any of the following; the solution, the gas-liquid interface and the solid-liquid 
interface (Dathe et al., 1990). Insulin adsorbs to various materials such as a variety of 
plastics and glass (Sefton and Antonacci, 1984; Cuatrecasas and Hollenberg, 197 5). It 
is thought that the basic element for the nucleation process at solid-liquid interfaces is 
the monomer or dimer and are assumed to be adsorbed to the interface via their 
hydrophobic regions (Dathe et al., 1990). Upon adsorption, insulin may alter its 
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conformation and subsequent molecules might bind to the adsorbed layer which 
progressively grows (Grau et al., 1982). 
The aggregation of insulin has limited development of insulin infusion devices for 
intravenous administration of insulin (Lougheed et al., 1980). Changes of 
temperature, agitation and dissimilar metal pump components can also trigger 
precipitation in insulin solutions and limit the reproducibility of the dosages 
(Lougheed et al., 1980). 
1.2.2 Reproduction of the endogenous insulin-secretion-pattern 
The endogenous insulin-secretion-pattern in humans consists of two components; 
namely the secretion of insulin at a continuous basal level and supplementation by 
rapid postprandial increases in response to elevated blood-sugar levels (Eaton et al., 
1980). Both components of insulin secretion are essential, the former to maintain 
normal blood-sugar levels (euglycaemia), particularly at night and in the morning, and 
..• ! the latter to regulate blood-sugar levels following meals. 
j., 
Obviously the intended application of insulin therapy is to match or reproduce this 
secretion-pattern as closely as possible; namely the secretion at a continuous basal 
level in conjunction with a response to elevated blood glucose levels after a meal. 
Physiologically, insulin secretion peaks within one hour of an intake of an oral 
glucose load and returns to basal levels within approximately three hours (Brange et 
al., 1990). The normal serum concentration of insulin is in the 1 nM range but to 
effect a lowering of post-prandial blood glucose levels in diabetics the insulin 
concentrations used in soluble formulations for injections are in the 4 mM range 
(Jeffrey, 1990; Bristow, 1993). This is about a million times more concentrated than 
that in circulation in normal individuals although incidentally the quantity applied per 
application is similar in quantity to the level in total blood volume. The exogenous 
administration of insulin results in the peaking of plasma levels only 1.5-2 hours after 
injection which remain elevated for 3-5 hours. As a consequence diabetics who 
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administer insulin at the time of a meal tend to experience hyperglycaemia within the 
first hour and hypoglycaemia somewhat later (Kang et al., 1991 b ). 
At the normal serum concentration of insulin ( 1 nM range) it exists for all practical 
purposes as a monomeric molecule, the form which is considered to be active. At the 
concentrations used in soluble formulations for injections (about 4 mM) it consists 
mostly as dimers and higher order polymers. Calculations from the studies of insulin 
self-association show that at 1 nM only one insulin molecule in ten thousand is not a 
monomer while at 4 mM only one insulin in about 50 is a monomer (Jeffrey, 1990). 
These are all problems which emphasise the need of research to produce more user 
friendly insulin preparations and in particular those associated with the aggregation of 
insulin. 
1.3 Therapeutic insulins to counteract insulin therapy problems 
II! In the treatment of diabetics attempts have been made to counteract some of these 
problems of aggregation of insulin and also of improving post-prandial control of 
peripheral glucose metabolism (Bristow, 1993) by producing insulin analogues with 
desirable properties such as: 
• fully potent insulins that do not self-associate 
• insulins with altered physico-chemical, pharmacokinetic and biological 
properties 
that can be used in formulations to mimic the normal insulin-secretion-pattern. 
These insulin analogues can be produced by three different means: 
• recombinant DNA technology, 
• total chemical synthesis and 
• enzymatic modification reactions. 
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1.3.1 Therapeutic insulins that are active and monomeric 
It is generally thought that insulin aggregates have to dissociate to monomers in order 
to be absorbed from the subcutaneous injection site (Kang et al., 1991b). The benefits 
of altering the insulin molecule to prevent self-association are an increase in the rate 
of absorption; quickening of the onset of effect and shortening the duration of effect 
(Kang et al., 1991 a; Kang et al., 1991 b ). This would suggest that formulations which 
contain predominantly monomers would be advantageous. These would be 
considered quick-acting insulins and their use would also eliminate other problems 
arising from aggregation. 
11 Since the indications are that monomeric insulin formulations would have the 
advantages of limited aggregation and rapid absorption, attempts have been made to 
keep native human insulin in this highly desirable state in solution (Brange et al., 
~ 1988). Some of these were by addition (Bringer et al., 1981) or removal of (Jeffrey, 
1986) substances associated with therapeutic insulin solutions. Attempts have been 
made to produce insulin analogues with the desired properties. Molecules where the 
amino-acids in the insulins from human, pig and cow are strategically replaced or 
modified have been synthesised (Brange et al., 1988; Weiss et al., 1991; Brems et al., 
1992). The strategies that were employed to achieve this to date were to substitute or 
modify residues in the interfaces between molecules in dimers and higher polymers, 
the so-called monomer-monomer interface and the dimer-dimer interface, so as to 
reduce aggregation without adversely affecting the activity of the insulin. 
At present several insulin analogues that are thought to be predominantly monomeric 
have and are being investigated for potential therapeutic use. With some of the 
JI, analogues tested it has been claimed that they display clinically similar 
pharmacokinetics on injection (subcutaneously) at meal times to the endogenous 
insulin secretion seen in response to a meal (Kang et al., 1991 b ). The methods used to 
assess the association states of these insulin analogues are not very sensitive and their 
true monomeric status in solution would still seem to be uncertain (Jeffrey, 1990). To 
date none of these "monomeric" insulins have been implemented in insulin therapy. 
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1.3.2 Therapeutic insulins with altered physico-chemical, phannacokinetic and 
biological properties 
Many insulin analogues with altered physico-chemical, phannacokinetic and 
biological properties have been produced which show considerable potential as 
I, therapeutic agents in the management of diabetes (Bristow, 1993). These include 
production of 
Iii 
• superpotent analogues by increasing receptor affinity and alterations of the 
physiological actions of insulin 
• insulin formulations which are quick-acting (in solution) and which contain 
monomeric insulin analogues or 
• long-acting insulin (crystalline) which crystallises at the injection site or 
• mixtures of both. 
The production of superpotent analogues with a higher affinity for the insulin receptor 
have also received attention due to the efficacy of smaller therapeutic doses. B 10 Asp 
(HB 1 OD) human in~ulin is one such candidate that is superpotent in vitro but 
preliminary clinical evaluation, whilst clearly indicating the advantages due to the 
analogue's rapid absorption, failed to demonstrate an overall increased potency in man 
(Kang et al., 199 la). It is possible that analogues with different receptor affinities 
might prove to be useful clinically on account of their differing specificities for the 
various insulin-responsive tissues. At present, however, clinical studies have not 
indicated any significant advantages in the use of the superpotent insulin analogues. 
One example of a long-acting-insulin is an analogue that crystallises at physiological 
pH when injected thus delaying onset of action while increasing its duration. Such 
preparations have considerable clinical potential since a single daily injection could be 
prepared which closely matches the physiological basal rate of insulin secretion. 
Another that has been tried is proinsulin which displays about 10% of the activity of 
insulin and which is normally present in humans in small amounts and also has a 
prolonged plasma half-life. It also exhibits reduced self-association compared with 
native human insulin (Pekar and Frank, 1972). Evaluation of proinsulin as a 
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potentially clinically useful therapeutic agent in the treatment of diabetes led it to be 
discontinued due to an apparent increase in cardiovascular morbidity and mortality in 
patients when compared with those receiving insulin (Galloway et al., 1992). 
It is safe to say that despite many decades of experience and improvements in the 
quality of therapeutic insulin as well as the delivery devices and formulations 
available, serious problems to conventional insulin therapy remain (Galloway and 
Chance, 1994; Bristow, 1993). 
1.4 Pursuing a fully active monomeric insulin 
The production of a fully active monomeric insulin is still being pursued. Apart from 
the therapeutic advantages summarised above, monomeric insulins provide an 
important new tool for biochemical and 1H-NMR (nuclear magnetic resonance) 
studies of insulin structure and dynamics in solution. Such studies are limited by 
aggregation, a phenomenon which leads to line-broadening in the physiological pH 
range. To analyse the solution structure of insulin NMR studies of insulin analogues 
that are mainly monomeric under physiological conditions have been undertaken 
(Shoelson et al., 1992; Weiss et al., 1991). 
1.4.1 Design of an active monomeric insulin 
For the design of an active monomeric insulin the following need to be considered: 
• The three dimensional structure of insulin and its relationship to function 
• The three interaction surfaces of insulin as independent targets for design 
• The incorporation of reduced self-association properties of naturally 
occurring insulins, insulin-like molecules and insulin analogues 
• The method of evaluation of the monomeric status of insulin analogues in 
solution 
8 
'•1 
The three dimensional structure of insulin and its relationship to function 
To study the structure-function relationship of insulin detailed knowledge of the three 
dimensional structure and an understanding of how it relates to function and 
molecular interactions is needed. This knowledge may also be used in the design of 
insulins with desired characteristics of which the active monomeric insulin would be 
most beneficial in the treatment of diabetes. A database of the three dimensional 
structures of many insulins and analogues have been compiled. Three dimensional 
structures can be obtained by two means, namely X-ray crystallography and in 
solution using multi and two dimensional nuclear magnetic resonance (2D NMR). 
The crystal structures of insulins are subjected to crystal packing forces which 
probably do not reflect the conformation that it acquires in solution as a monomer at 
physiological concentrations. On the other hand in NMR experiments, aggregation of 
insulin at concentrations where these studies need to be undertaken impairs the 
acquisition of detailed information. Improvements in the detail of the structures have 
been obtained with designed insulin analogues (Chapter 2) that are predominantly 
monomeric in the buffers used. 
What is apparent from this large database of three dimensional structures is that 
insulin is conformationally flexible and exists in different conformations. The flexible 
segments of the molecule could easily be displaced upon insulin receptor binding 
(Badger, 1992) and it is believed that a conformational change takes place upon 
binding of insulin to its receptor and that the receptor induces or assists in this 
change. How insulin works in detail as a hormone at the level of molecular 
interactions is still not clearly understood. This may become clear when the co-crystal 
structure of insulin bound to its receptor or the ectodomain of the receptor is solved. 
In the meantime any information bearing on the conformation assumed by the 
monomer as it binds to its receptor would be helpful. 
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The three interaction suifaces of insulin as independent targets for design 
It seems that the properties of biological competence and aggregation are so deeply 
embedded in the insulin structure that it is a formidable challenge to alter the one 
without the other. Despite this there have been analogues developed, based on the 
I, sequence of human insulin, where substitutions in discrete positions on the surface of 
insulin have seemingly independent effects on its three dimensional structure and 
function. The functions of concern are the two self-association surfaces and the 
receptor recognition surface (Shoelson et al., 1992). An example is the DKP-human 
insulin (B 10 Asp; B28 Lys; B29 Pro) with substitutions in both the interaction 
surfaces (B 10 Asp in the dimer-dimer interface and B28 Lys and B29 Pro in the 
monomer-monomer interface). This insulin analogue has reduced tendencies to 
aggregate but has an enhanced affinity for the insulin receptor (Weiss et al., 1991). A 
comparison of a family of DKP analogues having potency-altering substitutions at the 
B24 and B25 positions with similar analogues of human native insulin which exhibit 
parallel trends in receptor binding potency irrespective of which insulin template was 
studied (Shoelson et al., 1992). 
The incorporation of reduced self-association properties of naturally occurring 
insulins, insulin-like molecules and insulin analogues 
Attempts have been made to prepare insulin analogues for potential therapeutic use 
with amino-acid substitutions at positions in the two self-association interfaces which 
exhibit reduced or lack of ability to fonn polymers. Examples of approaches that have 
been followed in these attempts are: 
• Charge repulsion, for example by insertion of opposing negative charges 
at the interface, and steric hindrance, by insertion of bulky amino-acid side 
chains (Brange et al., 1988; Brange et al., 1990). In general, charge 
repulsion has proven to be the more successful of these two approaches. 
• Deleting the hydrophobic B26-B30 region (Kubiak and Cowbum, 1986) 
(C-terminal of the B-chain). A des-(B26-B30)-human insulin shows 
reduced self-association properties (Jeffrey, 1986). 
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• Using the reduced self-association properties of insulins from animals like 
the hagfish (Schwartz et al., 1987; Peterson et al., 1975; Peterson et al., 
197 4 ). Hagfish insulin has an Asp in the B 10 position and does not form 
hexamers and only exists as dimers in solution and also crystallises as a 
dimer. (His in that position is essential for hexemerisation.) A synthesised 
HB 1 OD human insulin with Asp instead of His in this position did in fact 
show these reduced self-association properties (Weiss et al., 1991). 
• Using the reduced self-association properties of an insulin-like molecule, 
namely the insulin-like growth factor-I (IGF-1). IGF-1 (with about 50 % 
structural homology with insulin) has at the carboxy-terminus of its B-
chain, lysine at position 28 and proline at position 29 (Rinderknecht and 
Humbel, 1978). It does not self-associate as strongly as native human 
insulin. Using computational chemistry it was possible to ascertain that 
this modification of insulin would self-associate poorly (Shields, 1993 ). 
The KP (B28 Lys; B29 Pro) human insulin that has been produced and 
shown to have reduced self-association properties (Weiss et al., 1991) is 
fast acting (Galloway and Chance, 1994). 
Evaluation of monomeric status of insulin analogues in solution 
It is crucial that a reliable and reproducible method for measuring self-association 
behaviour be used to monitor molecular changes designed to modify this behaviour. It 
is argued here that sedimentation analysis in the analytical ultracentrifuge is still the 
best technique for characterising protein interactions (Jeffrey, 1990). The self-
association pattern of insulin analogues can be quantitatively compared by using a 
model of self-association that best describes the system and by calculating association 
constants that describe the relative strengths of interaction at the two association 
I interfaces. In this study the self-association pattern of synthesised platypus insulin and 
a mutant has been analysed by making use of a well established background of theory 
for analysing self-associating systems and of experimental studies of insulin with the 
analytical ultracentrifuge. 
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There are cases where methods used to assess the changes in self-association of 
insulin analogues have been relatively insensitive and this is illustrated where 
osmometry by the NOVO group was used (Brange et al., 1988). Closer examination 
of this work led to the conclusion that although good progress has been made in 
increasing the amount of monomeric species at concentrations used for insulin 
ll. fonnulations, the monomer was not the major molecular species at the chosen 
l,1 
concentration (Mark and Jeffrey, 1990; Jeffrey, 1990). This emphasises the need for 
critical quantitative study of changes to self-association as well as to potency. 
1.5 Exploring another avenue for identifying an insulin with desirable 
properties 
The purpose of the present undertaking was to explore another avenue for identifying 
an insulin with desirable properties as a template, namely to exploit natural variation 
as exhibited in an exotic species like the platypus. Modifications of self-association 
ji behaviour without loss of activity may succeed in one of the more exotic insulins 
because its different_ composition and properties offer a different baseline for 
modification from the common mammalian insulins. 
1.5.1 Using the platypus insulin sequence to explore and identify desirable 
properties 
The platypus (Omithorhynchus anatinus) is the only extant species of the family 
Omithorhynchidae belonging to the order Monotremata. It is an ancient, highly 
specialised animal well adapted to its amphibious existence in the waterways of 
eastern Australia (Grant, 1989). It, like mammals, has mammary glands but lays eggs. 
The monotreme eggs are very similar in appearance to reptile eggs, with a soft and 
rubbery shell (Griffiths, 1988). Its biological features indicate that it is more closely 
related to marsupial and placental mammals than to any group of reptiles, despite 
retaining several ancestral reptilian characteristics over the course of evolution 
(Grant, 1989; Griffiths, 1988). 
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The availability of a small quantity of platypus pancreatic tissue and the subsequent 
purification of enough native insulin (ng) to determine its amino-acid sequence gave 
us the opportunity to investigate the composition, structure, biological activity and 
self-association of insulin from this unique animal. This study consists predominantly 
of three parts; namely: 
• the structural analysis of platypus insulin, 
• the total chemical synthesis of the active native platypus and a mutant 
platypus insulin and the determination of their biological activities and 
• finally the sedimentation analysis of the self-association pattern of these 
synthesised insulins. 
Structural analysis of platypus insulin 
The primary amino-acid sequence of platypus insulin differs from that of human at 
eleven amino-acid sites; of which three residues have not been observed previously in 
( other organisms. It also differs from pig and human insulin in two other significant 
I aspects. The one being at its self-associating surfaces (monomer-monomer and dimer-
I,, 
dimer interfaces) where it differs by 4 residues; offering the possibility of a change in 
association properties. The other amino-acid substitutions were at its receptor binding 
surface where platypus insulin differs from human by 2 residues; here offering the 
possibility of a change in biological activity. 
In chapter 3 the primary sequence of platypus insulin is compared with all insulin 
sequences in the database. Comparative studies include pairwise sequence analysis as 
well as multiple sequence analysis. A three dimensional model of platypus insulin 
based on the sequence was built with computer programmes. Predictions of the 
physico-chemical and biological properties of platypus insulin, namely its self-
association, receptor binding and activity, were tentatively made on the basis of the 
sequence as well as the model of the three dimensional structure. 
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Total chemical synthesis of native platypus and a mutant platypus insulin 
To test predictions about the structure-function relationship of platypus insulin, it was 
necessary to obtain adequate material by producing the insulin by either DNA 
technology or by total chemical synthesis. The latter was chosen because of the 
( expertise available in the laboratory and because this route had the added advantage 
of being able to produce insulins with non-proteinogenic residues. Chapter 4 
describes the strategy for the chemical synthesis of platypus insulin. 
1,1' 
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The total chemical synthesis was successful and preliminary investigations into the 
self-association of synthetic platypus insulin pointed to some reduction in the self-
association at the dimer-dimer interface compared to bovine insulin (Chapter 5). 
Furthermore predicted differences in the spatial arrangement of residues in the dimer-
dimer interface of the three-dimensional molecular model (Chapter 3) also suggested 
that the self-associating properties in this region may be affected, seemingly lowered. 
It was also decided to synthesise a platypus insulin mutant (B 10 His replaced by an 
Asp) with a substitution in the hexamer forming region (dimer-dimer interface) and 
analyse its self-association pattern. The reason was to obtain an insulin with reduced 
self-association properties and increased biological activity as was found with a 
similar HBIOD human insulin (Schwartz et al., 1987). The effect of this mutation on 
the self-association pattern of platypus insulin was analysed and investigated in detail. 
Both synthetic insulins were obtained in a pure form and biological activity and the 
circular dichroism spectra were determined. 
Sedimentation analysis of the self-association pattern of chemically synthesised 
insulins 
An extensive study of the self-association patterns of zinc-free synthetic native 
platypus and mutant (HB 1 OD) platypus insulins in solution, at room temperature and 
neutral pH, has been undertaken and is described in Chapter 5. The sedimentation 
equilibrium method was chosen because of the accuracy of the data that could be 
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obtained. The omega-method of analysis was used to obtain the thermodynamic 
parameter a1 ( the activity of the insulin monomer in equilibrium with a series of 
polymeric species) as a function of total insulin concentration. 
Once the sedimentation equilibrium data was analysed and transformed to 
i1: concentration of the monomer m1 as a function of total protein concentration it was 
fitted to a mathematical equation (Mark and Jeffrey, 1990) describing a model of self-
association previously shown to be the best description of the complex insulin system. 
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From this the relevant association constants describing the two pathways of formation 
of insulin dimers and higher polymeric species were derived. This detailed analysis of 
changes to self-association brought about by specific residue changes allows 
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comparison of self-association in different insulins in quantitative terms and the 
quantitative linkage of self-association changes to changes in specific structural loci. 
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Literature Review: The Structure-Function Relationship of Insulin 
j., 
2.1 Introduction 
11 The importance of the hormone, insulin, has made it the most intensively investigated I 
I 
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protein in human biology and medicine. It was also the first protein to be sequenced 
in full (Sanger et al., 1959 ). One aspect on which attention has been focused is its 
structure, with the ultimate goal being defining the role of its conformation in relation 
to its function. An important step toward this goal was the determination of the 
three-dimensional crystal structure of native 2 Zn porcine insulin (Blundell et 
al., 1972; Baker et al., 1988). Subsequently, several other crystal structures of insulin 
have been reported, as for example 4 Zn insulin, hagfish and des-(B26-B30) insulins 
(Bentley et al., 1976; Cutfield et al., 1979a; Cutfield et al., 1979b; Baker et al. , 1988; 
Derewenda et al., 1989) and conformation variations have been observed especially in 
the so-called flexible regions. The flexibility, combined with the rigid structure of the 
rest of the molecule, is most likely to be of importance for the expression of insulin 
activity (Baker et al., 1988 and Blundell 1972). 
A detailed understanding of the many facets of insulin structure and flexibility in 
solution is of fundamental importance to the understanding of its activity. Binding 
affinities and conformations in solution are among the most important properties of 
peptides that determine activity and ultimately, potency (Smith et al., 1991). An 
understanding of these properties at a fundamental molecular level will ultimately 
enhance future ability to design therapeutic insulins with desirable properties. 
The biological activity of insulin arises from the ligand-receptor complex and is in 
equilibrium with free insulin. This equilibrium occurs at low insulin concentrations 
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(Schaffer, 1994; Sonne, 1986). Consequently, an understanding of the biological activity 
of insulin may best be achieved by 
• determining its physico-chemical properties in solution and 
• knowledge of the three-dimensional conformation of insulin in solution as it binds 
to the receptor 
Also knowledge of the multiple conformations in dynamic exchange in solution at higher 
concentrations (as needed in insulin therapy) may lead to an understanding of its self-
association properties. 
The crystal structure has been used as a basis to predict the tertiary fold of insulin in 
solution. This has been carried out in a number of ways namely, the analysis of the crystal 
packing of insulin (Chothia et al., 1983), by energy minimisation calculation (W odak et 
al., 1985), and by molecular dynamic computer simulations (Kruger et al. , 1987; Mark et 
al., 1991). An experimental determination of the three-dimensional solution structure of 
proteins became possible with the new developments in the field of nuclear magnetic 
resonance (NMR) (Wtithrich, 1986). 
Since knowledge of the crystal structure of 2 Zn insulin has been of paramount 
importance in understanding the relationship between the structure and function of insulin 
as well as to the work to be described here, an outline of this structure is presented. This 
may be used as a basis for the study of the structure of insulin in solution and how that 
relates to its biological action as well as its self-association properties. 
The properties of the residues that contribute to the physico-chemical characteristics and 
biological activity have the following indications. Firstly is the significance of the 
contribution of specific amino-acid residues to the properties of the three interfaces of the 
insulin molecule. These interfaces are the regions of self-interaction (monomer-monomer-
interface and dimer-dimer interface) and the insulin region of receptor interaction. Some 
amino-acid residues are common to both the monomer-monomer interface and the 
receptor binding region (Shoelson et al. , 1992). Another indication is the self-association 
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behaviour of insulin at the concentrations used in both the therapeutic management of 
diabetes and in physico-chemical studies where in each case it is difficult to mimic the 
concentrations applicable in the physiological action of insulin (Mark et al., 1990). 
Also presented in this literature review is a description of the crystal and related solution 
structures of the mutant HB 1 OD human insulin. This information is of importance since in 
the work presented here (Chapter 4) a similar mutant, HB 1 OD platypus insulin, was 
chemically synthesised and the structure-function relationship investigated. Special 
attention has been given to its self-association properties. 
Also knowledge of the, as yet unknown, three-dimensional structure of the insulin 
11
l receptor and insulin-bound receptor are fundamental to an understanding of the 
11! 
biological action of insulin. The most recent information in respect to the structure of the 
insulin receptor as well as the most recent model of binding to and activation of receptor 
are discussed briefly. 
2.2 The structure of insulin 
The primary amino-acid sequence of insulin (porcine), with the residues at specific 
positions responsible for the characteristics and properties of insulin, is presented in 
Figure 2.1. The insulin molecule consists of two chains (A and B) connected by two inter 
disulphide bridges (A7Cys-B7Cys and A20Cys-B19Cys). There is also an intra disulphide 
bridge (A6Cys-Al lCys). The current image of the three-dimensional structure of insulin 
is primarily based on X-ray crystallographic data. Flexible regions based on relatively 
high thermal parameters have been observed in the N-terminal of the A-chain (Al-A6), 
the N-terminal (Bl-B4) and the C-terminal of the B-chain (B27-B30). (The thermal 
parameter is a quantitative estimate of the mean square displacement of each atom from 
its mean position (Baker et al., 1988).) Less is known of the structure of insulin in 
solution. This is primarily because native insulin, close to its physiological pH and at 
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Figure 2.1 
The amino-acid sequence of porcine insulin. (Human insulin differ at B30 Thr.) 
The insulin molecule consists of two chains, called A and B connected by two 
inter disulphide bridges (A7Cys-B7Cys and A20Cys-B 19Cys). There is also an 
intra disulphide bridge (A6Cys-Al lCys). Residues (speckled) that are found in 
the inner core of the molecule; residues (cross-hatched) that contribute to the 
monomer-monomer interface; residues (diagonal line shading) that contribute to 
the dimer-dimer interface; the residues indicated by arrows contribute to the 
receptor binding region (many residues share properties with the monomer-
monomer interface) and B 14 Ala (black dot) that are found in the inner core and 
contribute to the dimer-dimer interface. 
Figure 2.1 
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concentrations normally required for physico-chemical studies, strongly self-associates in 
solution to forrn a complex mixture of polymeric species (Mark et al., 1987). 
2.2.1 The crystal structure of 2 Zn pig insulin 
ll, The crystal structure of insulin described in this section will be that of the rhombohedral 
crystals of 2 Zn pig insulin as seen in electron density maps calculated from X-ray data 
extending to 1.5 A at room temperature and a pH of 6.2 (Baker et al., 1988 and 
references therein). The structures of the hexamer, dimer and monomer are depicted in 
Figures 2.2, 2.3 and 2.4 respectively. The view of the hexamer is down the three-fold 
axis and the view of the dimer is down the two-fold axis. The view of the monomer is 
perpendicular to the three-fold axis, similar to that of the monomer in the dimer in Figure 
2.3. 
In the unit cell of the crystal six monomers pack into three compact dimers that further 
111 aggregate to form a hexamer around two zinc ions (Figure 2.2). The three compact 
dimers each consist of two monomers (designated 1 and 2) with identical amino-acid 
sequences but different spatial arrangements of their residues. These conformational 
variations of the monomers in the dimer are thought to have been the result of crystal 
packing forces. The molecule 1 in the dimer differs from molecule 2 mainly at B25 Phe 
where in molecule 1 the Phe is turned back towards the body of the molecule to make 
contact with the aromatic A19 Tyr and in molecule 2 the Phe is pointed away from the 
molecule towards the solution (Figure 2.2). In the dimer the B25 Phe of both monomers 
make contact in the monomer-monomer interface. 
The hexamer is assembled from three dimers related by an exact three-fold axis of 
symmetry, the local two-fold axis within each dimer is perpendicular or approximately so 
to the three-fold axis. Two Zn2+ ions are located on the three-fold axis, and each is 
coordinated by three symmetry-related B 10 His residues from separate monomeric units. 
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Figure 2.2 
Hexarner: A view down the three-fold axis of the 2 Zn crystal structure of 
porcine insulin. The three dimers in yellow, orange and green are assembled in a 
way that brings the B 10 His residues (pink) together to coordinate 2 Zn2+ ions 
(not shown) in the centre of this column. The model of the hexarner was based 
on the coordinates of X-ray crystal structure of rhombohedral 2 Zn porcine 
insulin, entry 3 ins (Wlodawer et al., 1989) of the Brookhaven Protein 
Databank. 

Figure 2.3 
Dimer: A view down the two-fold axis of the 2 Zn crystal structure of 
porcine insulin depicting the monomer-monomer interface. Molecule 1 has 
an A-chain in pink and B-chain in white; molecule 2 has an A-chain in 
yellow and a B-chain in blue. The orientation of the B25 .1 and B25 .2 Phe are 
depicted in orange. The disulphide bonds are in red. The aromatic residues 
that line the monomer-monomer interface are illustrated. The model of the 
dimer was based on the coordinates of X-ray crystal structure of 
rhombohedral 2 Zn porcine insulin, entry 3 ins (Wlodawer et al., 1989) of 
the Brookhaven Protein Databank. 

Figure 2.4 
Monomer: A view perpendicular to the three-fold axis of the 2 Zn crystal 
structure of porcine insulin. Depicted is molecule 2 with B25 Phe in an outward 
orientation. The A-chain is in yellow and the B-chain in blue. The model of the 
monomer was based on the coordinates of X-ray crystal structure of 
rhombohedral 2 Zn porcine insulin, entry 3 ins (Wlodawer et al., 1989) of the 
Brookhaven Protein Databank. 
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The three-fold axis of symmetry of the hexamer (Figure 2.2) is a view of the hexamer 
down the Zn coordinated cavity ( column) lined by the B 10 and B5 histidines. 
Non-crystallographic lines of approximately two-fold axes of symmetry can be traced 
between the monomers. The two-fold axes are labelled OP (along the monomer-
monomer interface) and OQ (along the dimer-dimer interface) (Blundell et al., 1972). In 
the crystal each monomer is in direct contact with five monomers of the alternative 
variety, i.e. 1 is closely surrounded by molecules of type 2 and vice versa. 
The conformation of A-chain in the crystal structure 
The A-chain consists of two irregular a-helical regions, namely the A2-A8 and the 
Al2-Al 9 regions that run very nearly antiparallel and are joined by a stretch of extended 
polypeptide chain from A9 to A 12. The view in Figure 2.4 of the monomer shows that 
the A-chain is folded into a plane in which the N- and C-terminal residues are brought 
together, Thus the A19 Tyr side chain and the A2 Ile side chain are at van der Waal's 
contact. The A2-A8, a-helical region, contains the A 7 Cys that forms a disulphide bridge 
with the B7 Cys contained in a a-helical region on the B-chain that runs antiparallel with 
the A2-A8 a-helix. There is a marked difference between the A-chain projections in 
molecules 1 and 2. This difference is largely because of a rotation of 32° about ( ~) of 
residue A6 Cys in molecule 2 and this in turn forces the rotation of A 19 Tyr and the 
displacement of B25 Phe relative to molecule 1. This rotation in molecule 1 is largely 
responsible for destroying the exact two-fold symmetry. In both molecules residues 
A2-A8 follow somewhat distorted helical conformations. Also the N-terminal (Al-A6) 
region is considered to be mobile based on its relatively high thermal parameters (Baker 
et al., 1988). 
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The conformation of the B-chain in the crystal structure 
The structure of the B-chain consists of three segments, an N-terminal extended ~-chain 
(B 1-B8), a central a-helix and a C-tenninal extended P-chain (B21-B30) (Figure 2.4). 
The initial B-chain residues are free of interchain links and can move away from the body 
of the molecule. Different conformations are apparent in different insulin crystal 
structures (Cutfield et al., 1981). The central a-helix (B9-B 19) packs in a concave 
fashion towards the rest of the molecule. At each end of the helix (at B7 and B 19) there 
is a cystine linking it to the A-chain. The C-terminal-chain extends back in the reverse 
direction at B20 Gly to B21 Glu . This sharp turn is made possible by the conformation 
of the B20 Gly which is that of the D-amino-acid (Baker et al, 1988). Multiple 
intramolecular bonds maintain the insulin fold in this region. Examples of these bonds are 
H-bonds between the peptide carbonyl and NH groups of B20 Gly and B23 Gly; B23 Gly 
and A21 Asn and A19 Tyr and B25 Phe as well as the ionic interaction between B22 Arg 
and the A21 C-terminal (Baker et al., 1988). There are also intramolecular contacts 
(H-bonds) that allow insulin to dimerise and some are between B24 Tyr and B26 Tyr 
where the chain is involved in an antiparallel H-bond with its two-fold related equivalents 
in the dimer (Figure 2.3). The C-terminal-chain (residues B27-B30) is mobile in the 
monomer as can be seen by the latter's relatively high thermal parameters in the crystal. 
Also relatively high thermal parameters have been observed for the N-terminal-chain 
(residues B l-B4), indicating their mobility (Baker et al., 1988). 
The disulfide bonds 
The insulin monomer is a hetero dimer consisting of an A-chain and a B-chain coupled 
covalently by two inter chain disulfides bridges (A20-B 19 and A 7-B7) and one intra 
disulfide bridge (A6-Al 1) (Figure 2.4). Of the three disulfide bonds in each molecule, 
A6-Al 1 is completely buried, A20-B19 is largely buried, whereas A7-B7 is exposed; 
both sulfur atoms are in contact, rather differently, with water molecules (Baker 
et al., 1988). 
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At each end of the central a-helix (B9-B 19) at B7 and B 19 there is a cystine linking it to 
the A-chain. The positions of all the other cystine residues (A6, A7, Al 1 and A20) are 
also close to the ends of the a-helices (A2-A8 and Al2-Al9 in the A-chain). The 
disulfide bridges probably contribute to the rigidity and stability of the core of the 
molecule. The precise relative positions of the A-and B-chains are strengthened at a 
number of points by hydrogen bonds and ionised contacts (Baker et al., 1988). 
The conformation of the monomer in the crystal 
The inner core of the insulin molecule is predominantly comprised of wholly buried non-
polar residues that form a sphere with a radius of 6 A. These residues include the 
invariant leucine residues A16, B6, B 11 and B 15, the invariant cystine A6-Al 1, the 
A 19 Tyr ring, also A2 Ile and B 14 Ala. The atoms of this inner core make contact with 
other non-polar residues, A3 Val, Al3 Leu, B 12 and B 18 Val, B24 Phe and B 19 Cys, 
which in turn are in contact with most of the remaining non-polar residues (See 
Figures 2.1 and 2.4).. Since members of the last two groups are all partly on the outside 
of the molecule and make contact with other non-polar residues in the monomer-
monomer and dimer-dimer interfaces, there is in fact an irregular belt of continuous non-
polar character around the three-fold axis within the hexamer. It is notable that none of 
these buried residues are aromatic; in marked contrast with the situation in the 
aggregated surfaces (Baker et al., 1988). 
The formation of the dimer in the crystal 
The C-tenninal end of the B-chain is mainly involved in the dimer formation (monomer-
monomer interface). The buried surface of the monomers in the dimer is flat, studded 
with aromatic and aliphatic residues. In the dimer, as found in the crystal, the dissimilar 
monomers l and 2, are rotated relative to the two-fold axis (monomer-monomer 
interface) (Figure 2.3). The respective extended ~-chains (N-terminal B-chains) of the 
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monomers are packed face to face. The relative positions of the extended ~-chains in the 
dimer surface are secured by an antiparallel ~-sheet of hydrogen bonds involving the 
B24 Phe and B26 Tyr residues. The forces leading to aggregation are predominantly non-
polar (Jeffrey and Coates, 1966a), reinforced and given direction by hydrogen bonds. All 
but one of the contacts involve B-chain residues. The packing of the aromatic rings in 
this interface is of interest. The six residues, two B 16 Tyr's, two B24 Phe's and two 
B26 Tyr's are linked together in a network of loose contacts 4-4.5 A long. A second 
smaller group of three aromatic residues is formed by the two B25 Phe of which B25. l 
(see notation, p ix, this thesis) is in contact with Al 9.1 Tyr. The B25.2 Phe side chain lies 
across the two-fold axis in contact with B25. l (Figure 2.2 and 2.3). The B 12.2 Val 
residue fills in the cavity formed at the centre of the aromatic cluster. 
The formation of the hexame r in the crystal 
In the 2 Zn crystals three dimers are assembled around two central zinc ions on the three-
fold-axis each octahedrally coordinated to three symmetry-related N3-atoms of B 10 His's 
in molecules 1 and 2 (Figure 2.2). The two zincs are related by the same two-fold 
symmetry that relates the dimers. The centre of the hexamer is surrounded by six 
glutamic acid B 13 residues brought together in a circle. They are arranged in pairs, the 
two within each dimer in direct contact. Both pairs of carboxylic oxygen ions are 
hydrogen bonded to well-defined water molecules in the central cavity, two of which are 
linked to B 10 His. There is a polar channel at the centre of the hexamer made up of 
coordinating B-chain histidines, B9 Ser and B 13 Glu. Associated with these groups is a 
well defined, but complex water structure which links the hydrogen bonding atoms in a 
elaborate chain of the structure. The structure of the six central glutamic acids is 
arranged as three hydrogen bonded pairs and suggests that the charge repulsion that 
would be normally operating is avoided by protonation (Baker et al., 1988; Blundell 
et al., 1972). 
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When the hexamer is assembled through the zinc coordination, both polar and non-polar 
residues are buried between the dimers. The packing in the dimer-dimer interface is 
correspondingly much looser than in the molecular interface within each dimer 
(monomer-monomer interface). The initial residue of each B-chain, B 1 Phe, from each 
monomer is buried in a non-polar environment (A13 Leu, Al4 Tyr) in the adjacent dimer. 
This crossover lends extra stability to the dimer. Between the B-chain N-terminal 
extended ~-chains are buried non-polar residues whose contacts complete a hydrophobic 
circle which connects up the non-polar cores of the monomers already in touch within the 
dimer (Baker et al., 1988). In addition, the association is also strengthened by ionic 
attraction between the N-terminal B 1 amino group and the Al 7 Glu carboxyl ion (Baker 
et al., 1988). 
2.2.2 Conf onnational states of insulin hexamers in crystals 
The zinc-insulin hexamer is the storage fonn of insulin in the pancreas. There are three 
distinct confonnational states observed in crystals, designated T 6, (TR)3 and R6• These 
are based on their ligand binding properties, allosteric behaviour and pseudo point 
symmetries (Wollmer et al., 1987; Kaarsholm et al., 1989; Choi et al., 1993). The T6 state 
is associated with the 2 Zn insulins; the (TR)3 with the 4 Zn insulins and R6 with the 
phenol hexamers. In the T-state, residues 1-9 of the B-chain are in an extended 
~-confonnation (as in the 2 Zn porcine insulin crystals) and in the R-state in an a-helix, 
with the B-chain a-helix now encompassing residues 1-19. The T- to R-state 
conformational transition comes about in the presence of phenol, phenol analogues and 
lyotropic anions. The (TR)3 hexamer is composed of asymmetric dimers wherein each 
dimer contains one insulin molecule in the T-conformation with the other in the 
R-conformation (Brzovic et al., 1994). It is also called the 4 Zn insulin, which is grown 
from high chloride ion concentrations (Smith et al., 1984). 
Clearly the contacts between the dimers in these three hexamer types are very different. 
The T 6 hexamer binds 2 zincs and is that of the 2 Zn insulin crystal structure where the 
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hexamer constitutes the rhombohedral unit cell and the dimer the asymmetric unit as 
discussed in the previous section (Derewenda et al., 1990). 
The (TR)3 hexamer binds 4 zincs at high chloride ion concentrations. A rearrangement of 
contacts in the hexamer are generated to accommodate the binding of these ions and thus 
stabilising the structure. New compensating dimer-dimer contacts in the hexamer are 
generated by the extended P-conformation-a-helix transition that takes place only in 
monomer 2 at the N-terminal Bl-B8 which now form a continued helix Bl-Bl9. Extra 
zinc sites are created as a result in molecule 2 by the B5 His positioned on the helix and 
the B 10 His in the adjacent dimer which swivel away from the central three-fold hexamer 
axis thus creating a tetrahedral binding site. The tetrahedral binding site consists of the 
two histidyl N atoms (B5 and B 10), a chloride ion and a water molecule. Also the 
packing of the leucines in the R-molecule buries the zinc site, thus significantly increasing 
the stability of the hexamer. In this hexamer (TR)3 there are three tetrahedral sites and 
one octahedral axial site that coordinates the 4 zincs com pared to T 6 that has two 
octahedral axilla sites binding 2 zincs. The zinc binding site in monomer 1 is unchanged 
(Derewenda et al., 1990). 
The R6 hexamer structure binds two zincs and in the presence of phenol to form 
monoclinic crystals. The presence of phenol causes an extension of the helical structure in 
the N-terminal B-chain to the B 1-B 19 a-helix in all the monomers. These phenol 
molecules bind in a non-polar cavity created by the packing of the B l-B8 helix against 
the A-chain of the three-folded related other dimer. The R6 hexamer is also stabilised by 
these contacts that are made by these six phenol molecules that are specifically bound 
between the dimers (Derewenda et al., 1990). The phenol makes two hydrogen bonds to 
the main-chain groups (one to the A6 carbonyl oxygen, the other to the peptide nitrogen 
of Al 1) and has displaced water molecules while some close non-polar contacts are 
enhanced (Derewenda et al., 1989). The aromatic ring of the phenol packs at van der 
Waal's distance against the B5 His imidazole group. Since all the monomers are helical at 
B 1-B8 the contacts between the dimers are equivalent. It has the same organisation of its 
25 
'1' 
' I 
i i 
' 
symmetry elements as the rhombohedral 2 Zn insulin hexamer. The contact between the 
B 1-B 19 helices that are made by B6 Leu along the axis are strengthened and both zinc 
sites are buried (Dodson et al., 1993). All the monomers show increased separation at 
B25-A19 and show variations in the conformation of the B25 Phe (Derewenda 
et al., 1990). 
2.2.3 The structure of HB 1 OD insulin in the crystal 
This mutant crystallised into dimers in the absence of zinc. Analysis shows that the 
B 10 Asp and B 13 Glu carboxylate groups, both negatively charged, are directed away 
from each other (Dodson et al., 1993). The mutation HB 1 OD in insulin abolishes the 
capacity of the molecule to hexamerise in the presence of zinc. Zinc ions are important 
for hexamer formation by native insulin and in this mutant the zinc-binding residue His 
B 10 is substituted for an Asp, therefore altering hexamer assembly. In the presence of 
zinc, however, this mutant forms a dodecamer in which two sets of three dimers are 
coordinated to two zinc ions on the central three-fold axis (Dodson et al., 1993). The zinc 
coordination is through the B5 His imidazole ring and is reminiscent of the tetrahedral 
coordination that is seen in the R6 insulin hexamer. The monomers in the structure have 
the T-confonnation and the dimer-dimer contacts include many of the same residues that 
are used in the T6 insulin hexamer. The contacts are, however, very different. In 
particular, a critical salt bridge is made by the mutated B 10 Asp to the B-chain a-NH2 
group. Residues B 10 Asp and B 13 Glu, due to their negative charge, repel each other 
and do not form the polar channel at the centre of hexamer as does B 10 His and B 13 Glu 
in native insulin. The B 13 Glu side chains are not packed together, in contrast with the 
native insulin hexamers, but are hydrogen bonded to the A9 Ser in one dimer interaction 
and to the A 16 Tyr in the other. Another essential interaction is between the two B4 Gln 
residues, which fonn three pairs of the complementary hydrogen bonds about the three-
fold axis (Dodson et al., 1993). 
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2.3 The solution structure of insulin: Relationship to crystal structure 
The current image of the structure of insulin is one primarily based on X-ray 
crystallographic data and little is known in regard to the solution structure of the most 
probable active form of the hormone. (Mark et al., 1991). There are several well defined 
crystal structures of insulin in different conformations available, and some may be 
interconvertible (Hua et al., 1991 and references therein). The information provided by 
these can give clues as to the structure of insulin in solution and from these a picture of 
the active conformation may emerge. [The structure of insulin in solution is that of 
multiple of structures in dynamic exchange. The structure that is determined in solution is 
that of a population of conformations averaged over a specific time period (Smith 
et al., 1991)]. There is some indication that further changes from the crystalline structure 
may be necessary for insulin's biological action because it is thought that the biologically 
active structure(s) is not represented in the series of known structures (See later section) 
Also it is thought that the monomer is the biologically active species in solution (Balcer 
et al., 1988; Blundell et al., 1972). Thus in trying to understand the biological action and 
self-association of insulin it is necessary to have knowledge of its conformational 
variations in solution. This may shed light in structural terms on the sequence of events 
that lead to optimal binding of insulin to its receptor and in its concomitant action, as well 
as the nature of its self-association behaviour in solution. This will enable manipulation 
and modification of the function and behaviour of insulin in a more effective way. 
Unfortunately no detailed structure of monomeric insulin under physiological solution 
conditions is as yet available. The reason for this is primarily because native insulin, close 
to physiological pH and at concentrations normally required for physico-chemical studies, 
strongly self-associates in solution to form a complex mixture of polymeric species (Mark 
et al., 1987). In particular this has thus far prevented detailed structural analysis using 
high-resolution NMR, although changes in the NMR spectrum and circular dichroism 
spectrum of native insulin at high dilution indicates that there are conformational 
differences between the monomeric and aggregated forms (Packer and Biswas 1980; Roy 
et al., 1990). Some progress has, however, been made using native insulin under extreme 
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solvent conditions (Roy et al., 1990) and using mutant insulins with altered association 
properties (Weiss et al., 1991). This will be discussed below. The 2 Zn insulin crystal 
structure acts as a starting point to an understanding of the action of insulin in solution 
(see previous section) 
Solution structure of insulin monomer 
For the study of the structure of insulin in solution two dimensional nuclear magnetic 
resonance (2D NMR) methods have predominantly been employed. Unfortunately, it is 
only possible to study the insulin structure at concentrations where insulin aggregates 
(near its phannacological concentrations). Also broad NMR signals are obtained with 
insulin aggregates in contrast to monomers (Weiss et al., 1989). In order to overcome 
these problems several approaches have been followed: 
• Mutant insulins have been designed that are thought to be 
predominantly monomeric at the desired concentrations (Weiss et 
al., 1991 ) . 
• 
• 
Solvents (among others 20% acetic acid in water) have been used that 
are known to render insulins predominantly monomeric at the desired 
concentrations (Weiss et al., 1989; Hua and Weiss, 1991a; Hua and 
Weiss, 1991b) 
Simulation of the structure in solution by molecular dynamics (Mark et 
al., 1991) using known crystal structure coordinates. 
Available solution structures of native insulin are not well defined (Hua and Weiss, 
1991b) but distinct features of the solution structure of native insulin has been identified 
with the following indications: 
• it is globally flexible, 
• the N-terminal B-chain residue B 1 Phe has a flexible configuration (Kruger 
et al., 1987; Hua et al., 1991; Hua and Weiss, 1991b; Weiss et al., 1989), 
• the B25 Phe has an outward configuration (molecule 2) and 
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• A14 Tyr is exposed to solvent (Weiss et al., 1991). 
Structure of a mutant insulin that is predominantly monomeric in solution 
To obtain a more detailed NMR structure of insulin in solution a mutant DKP (B 10 His, 
B28 Lys and B29 Pro are replaced with Asp, Pro and Lys respectively) human insulin, 
that was shown to be predominantly monomeric in solution, was used (Weiss et 
al., 1991). This reduced self-association was according to sedimentation equilibrium 
studies as well as from indications of 2D NMR spectrum line-widths that were 
appropriate for monomers (Weiss et al., 1991). This mutant retains native receptor-
binding potency. The spectra of DKP-insulin provides a model for the solution structure 
of insulin monomer and it most closely resembles the hexameric 2 Zn crystal form of 
porcine insulin with flexibility in the N- and C-terminus of the B-chain. 
The 2D NMR study of DKP-insulin shows that the C-terminal region of the B-chain 
(residues B23-30) remains closely associated with the remainder of the protein (Weiss et 
al., 1991) and is an indication that B24 and B26 Tyr each pack against the hydrophobic 
core, as observed in their crystal structures (Blundell et al. , 1972; Baker et al. , 1988). 
There is also an indication of flexibility in the B23-30 region. There is no evidence for the 
existence of the monomer 1. An outward orientation for B25 Phe (molecule 2 of the 2 Zn 
crystal structure) is suggested that would enable this side chain to interact directly with 
the insulin receptor. The absence of the B23 Gly-A21 Asn interaction (Baker et al., 1988, 
see previous section) suggests that the proximity of these two conserved residues, as 
observed in the crystal structures, is not stably maintained in solution. Fluctuations in the 
B23-A21 distance have been modelled by molecular dynamics simulations (Kruger 
et al., 1987; Mark et al., 1991) and reflect both local motions of the A21 side chain and 
the global changes in the orientation of the C-terminal a-helix of the A-chain relative to 
the B-chain. 
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Despite the ingenious experimental approaches outlined above, the structure of the 
monomeric insulin molecule as it interacts with the receptor is still not defined. 
Solution structure of dimers 
Detailed knowledge of the contacts between the monomer is essential for the proper 
understanding of this interaction in solution. The solution structure of the dimer is thus of 
interest not only for its comparison with the monomer but also because of the continuing 
interest in the nature of the self-interaction itself. Based on the crystal structure of insulin 
it is highly likely that the 1nonomer-monomer interaction region designated OP is the site 
of aggregation of insulin molecules into dimers in solution (Dodson et al., 1983). Also 
this area of the monomer surf ace excluded from contact with water by dimer formation is 
sufficient to provide the favourable entropic increase necessary to drive the assembly 
process (Chothia and Janin, 1975; Balcer et al., 1988). To determine the solution structure 
of dimers in solution the mutant SB9D human insulin was used as a model. This mutant 
fonns dimers in solution at low pH and its detailed structure was determined by 2D NMR 
(J0rgensen et al., 1992) and is discussed below. (SB9D insulin had been synthesised by 
Brange et al. (Brange et al., 1988) for the purpose of producing a monomeric insulin at 
pharmacological concentrations and neutral pH). 
The SB9D human insulin dimer was well defined and no detectable differences between 
the monomers were found. The conformation of both the monomers was that of molecule 
1. The association of the two monomers in the solution dimer is relatively loose as 
compared with that in the crystal dimer (J0rgensen et al., 1992). This was also found in a 
molecular dynamics simulation study of the insulin dimer in water (Mark et al., 1991), 
with the contacts in most cases identical to those found by J0rgensen et al. (J0rgensen 
et al., 1992). The overall secondary and tertiary structures of the monomers were similar 
to the monomers in the 2 Zn porcine insulin crystal. Minor but significant deviations from 
this structure, as well as from the structure of monomeric insulin in solution, were shown 
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and ascribed to the absence of the hexamer and crystal packing forces as well as to the 
presence of monomer-monomer interactions. 
Compared with the monomer in the 2 Zn crystal structure these deviations show the 
following: 
• a destabilisation of the A-chain a-helix (A2-A8), 
• an extension of the B-chain a-helix (B9-B19) to include B8 Gly, 
• a less well defined P-tum in the B-chain (B21-B22) that might indicate a 
relatively high flexibility of this structural element, 
• a bending of the N-terminal end of the B-chain (B l-B4) towards the 
A-chain loop (Millican and Brems, 1994). 
All of these deviations are located at or close to the monomer-monomer interface and are 
consistent with structural constraints imposed by dimerisation. 
Zn insulin hexamer and its structure in solution 
The existence of the different conformations of hexamers in the T 6, (TR)3 and R6 
conformation in crystals suggests that insulin is capable of undergoing transitions 
between the three conformational states. It has been suggested that the three 
conformational states observed in crystals are indicative of the sequential conformational 
transitions involved in the T to R conformational change in solution (Brzovic et al., 1994) 
and that the inter-conversion of T 6 and R6 occurs via a third species assigned as (TR)3 . 
The transition from the T-state to the R-state involves a coil-to-helix transition in 
residues Bl-B8 producing a continuous a-helix from Bl-B19. This conformational 
transition is also accompanied by small changes in the positions of A-chain residues and 
other B-chain residues. Anions act as heterotropic effectors that shift the distribution of 
hexamer conformations in favour of the R-state (Brzovic et al., 1994). These three 
conformational states in solution have also been suggested by circular dichroism studies 
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and detailed analysis were perfonned of the changes in secondary structure associated 
with the hexamer-to-monomer dissociation (Melberg and Johnson, Jr. 1990). 
2.4 Properties of the insulin molecule 
There are three identifiable regions that are associated with the physico-chemical 
characteristics and biological activity on the surf ace of the insulin molecule (Baker 
et al., 19888; Blundell et al., 1972). These regions are the interfaces of self-association 
(monomer-monomer-interface and dimer-dimer interface) and the receptor binding 
region. The residues that are thought to contribute to these properties (Shoelson et 
al., 1992) are shown in Table 2.1 and Figure 2.1. There are residues in the monomer-
monomer interaction region (in bold) and also in the dimer-dimer interaction region 
(underlined) that are shared by the residues in the receptor binding region. 
2.4.1 Residues involved in the self-association of insulin 
The monomer-monomer inte,face 
The interaction between the residues that are thought to contribute to the properties of 
the monomer-monomer interaction region (shown in Table 2.1 and Figure 2.1) (Shoelson 
et al., 1992) on the surface of the monomers leads to the formation of the dimer. Many of 
the side-chain residues that participate in this interaction are situated on the central 
a-helix (B9-19) (B9 Ser, B12 Val, B16 Tyr) and the C-terminal end of the B-chain 
(B23-B28). Also the C-tenninal residue A21 Asn is included in this group and lies on the 
monomer surface adjacent to the B23 Gly, the first residue in the extended P-chain of the 
C-tenninal B-chain. (Baker et al., 1988). Upon dimerisation the extended P-chains 
(B24 Phe, B25 Phe and B26 Tyr) of each monomer form an antiparallel P-sheet that is 
notable for an extensive set of van der Waal's interactions between adjoining hydrophobic 
surfaces (Baker et al., 1988). 
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Table 2.1 Amino-acid residues that contribute to the three interaction regions in the 
insulin molecule. 
Monomer-monomer interface 
A21 Asn B8 Gly 
B23 Gly B24 Phe 
Dimer-dimer interface 
Al3 Leu A14 Tyr 
B13Glu B14A1a 
Receptor binding region 
Al Gly A5Gln 
B 17*Leu B23 Gly 
B9 Ser 
B25 Phe 
B12 Val 
B26 Tyr 
A17 Glu Bl Phe 
B 17 Leu B 18 Val 
B16 Tyr 
B27 Thr 
B20 Gly 
B28 Pro 
B2 Val B4Gln 
B19 Cys B20 Gly 
A13*Leu A19 Tyr A21 Asn B12 Val 
B24 Phe B25 Phe 
B21 Glu 
BlO His 
B16 Tyr 
Residues (bold) in the monomer-monomer interlace and the receptor binding region 
Residues (underlined) in the dimer-dimer interlace and the receptor binding region 
* Residues that contribute to the second receptor binding site (Schaffer et al., 1994). 
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The removal of B26-B30 in the despentapeptide insulin abolishes self-association totally 
(Jeffrey, 1986) and by implication dimerisation. This is because B26 Tyr is essential for 
hydrogen bonding and the despentapeptide contains approximately a third of the 
dimerising surface (Baker et al., 1988; Spoden et al. , 1995). Both hydrogen bonding and 
the non-polar contacts are obviously important in stabilising the dimer. The removal of 
B26-B30 does not significantly alter the folding of the rest of the molecule in neither the 
crystal (Bi et al., 1984) nor that in solution (Hua et al., 1992), nor does it affect the 
biological activity provided the new C-tenninus is amidated (Fisher et al., 1985). 
Reduced dimerisation was observed in IGF-1 with residues B28 Lys and B29 Pro. This 
led to the production of the DK human insulin where the residues B28 and B29 are 
reversed (i.e. B28 Pro to Lys; B29 Lys to Pro) which also displays marked reduction in 
dimerisation (Weiss et al., 1991). In the native insulin B28 Pro is on the monomer surface 
and is largely buried by dimer formation. The extended ~-chain structure also packs the 
prolyl sidechain against the B26 tyrosil side chain. The Pro in the B29 position most 
likely introduces a steric property that interferes with this packing and thus reducing the 
interaction with the other monomer. The structural basis of this effect however is 
presently not understood (Weiss et al., 1991). 
The dimer-dimer inteiface 
The interaction between the residues that are thought to contribute to the properties of 
the dimer-dimer interaction region (shown in Table 2.1 and Figure 2.1) (Shoelson 
et al., 1992) on the surface of the dimers leads to the formation of mainly hexamers in the 
presence of zinc (Baker et al., 1988) at neutral pH and dimers at low pH (Badger, 1992) 
(Badger 1992). (In a zinc -free solution depending on the total protein concentration, 
insulin may form an indefinite array of polymeric species interacting along both the 
monomer-monomer interface and the dimer-dimer interface at neutral pH (Mark et 
al., 1987 and Chapter 5)). These residues are situated on the surface on the opposite side 
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of the monomer and are mainly found in the central B-chain a-helix (B9-B 19) (namely 
BIO His, B13 Glu, B14 Ala, B17Leu, B18 Val and B19 Cys), the N-terminal B-chain 
(Bl Phe, B2 Val and B4 Gln) and the C terminal a-helix (Al2-Al9) in the A-chain 
(A 13 Leu, A 14 Tyr and Al 7 Glu). It is noted that the dimer-dimer interaction region 
shares no residues with the monomer-monomer interaction region. Also the B 10 His is, 
in this group, essential for the coordination of Zn2+ in the hexamer (See previous 
sections). 
Modification of B 1 Phe with large groups may interfere with the formation of hexamers, 
whereas deletion of B 1 Phe and B2 Val may weaken hexamer formation but would not 
prevent it (Brandenburg, 1969; Blundell et al., 1972). Neither Bl and B2 is involved in 
stabilising interactions that might be important to the tertiary structure (Blundell 
et al., 1972). Specific mutation of residues involved in the dimer-dimer interface can 
disrupt association properties without affecting the activity. This was shown with the 
mutant HB 10D human insulin where self-association (especially hexamerisation) was 
reduced as shown by sedimentation equilibrium (Weiss et al., 1991) without effecting the 
activity of the molecule in vivo (Vora et al., 1988; Bristow, 1993). This is an aspect 
investigated in this work. 
2.4.3 Residues involved in the biological activity of insulin 
Receptor binding region 
The residues that are thought to contribute to the properties of the receptor binding 
region (Shoelson et al., 1992) and binding of insulin to its receptor are shown in Table 2.1 
and Figure 2.1. Most of these residues are found on the surface of the monomer situated 
on the N-terminal A-chain (Al Gly and A5 Gln), the central a-helix of the B-chain 
(B12 Val, B16 Tyr and B17 Leu), the C-terminal B-chain (B23-B25) and also the 
C-terminal A-chain (Al 9 Tyr and A21 Asn). There is a large overlap in the residues 
involved in the monomer-monomer interaction (previous section) as well as those 
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participating in receptor binding. These overlapping residues are mainly situated on the 
central a-helix B-chain (B 12, B 16, B 17), the C-terminal B-chain (B23-B25) and also the 
C-terminal A-chain residue Asn. Residues A13 Leu and B 17 Leu are also thought to be 
implicated in this binding and are also notably overlapping residues with the dimer-dimer 
in terrace that is thought to constitute the second receptor binding site (Schaffer, 1994 ). It 
is thus highly unlikely that this monomer-monomer interaction mode of dimerisation can 
be eliminated without adversely affecting the activity of the insulin. By implication it may 
be more beneficial to target the dimer-dimer intenace. 
Additional residues A2 Ile and A3 Val not found on the sunace in the receptor binding 
region may also contribute to the binding of insulin to its receptor (Nakagawa and Tager, 
1992). The reason for this is that it has been suggested that the C-terminal B-chain of 
insulin moves away from the rest from the N-terminal A-chain exposing the underlining 
hydrophobic core containing A2, A3, and possibly B 15 (Baker et al., 1988) upon binding 
to the receptor. This separation includes B25 Phe and possible B24 Phe. This 
confonnational change that has been suggested is based on observations that several 
insulins and insulin analogues with native-like structures , especially at the active 
sunaces, show reduced potency One of these is the (des B30) insulin in which Al a-
amino is peptide bonded to B29, now the COOH terminal residue (Markussen 1985). 
This cross-linked insulin is inactive but the residues in the identified active sunaces have 
an identical structure to that seen in active insulins. Although it crystallised in the 4 Zn 
structure, where B 1-B8 changes into the helical conformation (see previous section) 
under the appropriate solution conditions, the C-terminal B-chain is unable to move away 
to expose the underlying A-chain residues. This suggests that this inability to move is the 
reason for loss of activity. Supporting the notion that a conformational change is 
necessary for activity is the insulin covalently crosslinked between B26 and B 16 with a 
80 % loss in activity (Derewenda et al., 1990). Another observation relevant to insulin's 
active surfaces is that despite the removal of B26-B30 this despenta insulin (DPI) is fully 
active provided the B25 carboxylate group is amidated. This indicates that the DPI 
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contains all the active surfaces necessary for the expression of biological activity 
(Derewenda et al., 1990). 
In the above mentioned cross-linked insulins the C-terminal B-chain is unable to move 
away from the A-chain to expose the underlining residues necessary for binding to the 
receptor explaining the loss of activity. In the DPI insulin those underlining residues are 
already exposed with the removal of the B26-B30 B-chain explaining the retention of full 
biological activity. Thus residues A2 Ile and A3 Val may also be added to the list of 
residues necessary for binding to the receptor (Derewenda et al., 1990). 
In a study where the steric requirements of the position B 12 for high biological activity in 
insulin were investigated it was found that Val, a invariant residue (see following section) 
in the B 12 position fulfills special side-chain packing requirements involved in the 
stability of the structure of insulin (Hu et al., 1993). 
Positions B24 Phe and B25 Phe are very important for biological activity and mutations 
at these positions are associated with diabetes in man (Tager et al., 1979; Shoelson et 
al., 1983a; Shoelson et al., 1983b; Haneda et al., 1984; Hua et al., 1993). Various studies 
designed to elucidate the role of these aromatic groups (Mirmira and Tager, 1989; 
Mirmira and Tager, 1991; Mirmira et al., 1991) have suggested that whereas none of 
these residues seem to directly influence the affinity in insulin-receptor interactions, they 
both play important roles in determining the three-dimensional structure of the insulin 
peptide backbone in the C-terminal region; a region which is critical for the receptor 
binding of the hormone (Minnira et al., 1991). This was indicated by replacement of 
B24 Phe by any variety of amino-acids with D-configuration or by Gly without major loss 
in receptor-binding potency (Mirmira and Tager, 1989). One of these, the mutant FB24G 
insulin where Phe is substituted by Gly in the same position, still displayed nearly full 
biological activity. Its solution structure indicates that the C-terminus of the B-chain is 
displaced from the native conformation exposing part of the underlying hydrophobic core 
(Hua et al., 1991). Also B25 Phe can be replaced by other residues as long as the 
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C-tenninal pentapeptide of the insulin B-chain is removed (Nakagawa and Tager, 1986; 
Nakagawa and Tager, 1987; Casaretto et al., 1987; Schwartz et al., 1989). Taking the 
above information into account and from a study where the peptide bonds in the 
C-terminal B-chain domain of insulin were replaced by a 'tf(CH2-NH) linker, it seems 
though that sequential peptide bonds between insulin residues B23-B26 each play an 
important role in determining an acceptable insulin structure(s) as well as the potential for 
high-affinity insulin-receptor interactions (Nakagawa et al., 1993), although the specific 
structural requirements of most of these positions are still unclear (Svoboda et al., 1994). 
Currently suggestions regarding the structural requirements for position B25 have, 
however, been proposed . These are that the B25 imino group has a direct role in the 
fonnation of a hydrogen bond with the receptor (Wollmer et al., 1994) and that the 
characteristics necessary for high affinity binding of this position are: the distance of side-
chain branching and amide bond in B25, the planarity (sp2-hybridization) at the Cy atom 
in B25 and the potential for hydrogen bond formation, but not necessarily the aromatic 
structure (Spoden et al., 1995). 
The role of the B26 Tyr in receptor recognition is not clear because despite the fact that 
it is absent in des-(B26-B30) insulin amide the insulin still exhibits native bioactivity 
(Fischer et al., 1985). Thus by implication the C-terminal pentapeptide of the B-chain is 
unnecessary for activity. 
The insulin receptor binding region shares residues with the monomer-monomer 
interaction region (A21 Asn, B 12 Val, B 16 Tyr, B23 Gly, B24 Phe and B25 Phe) 
(Shoelson et al., 1992). Schaffer (Schaffer, 1994) proposed a second binding domain on 
the opposite side of the molecule from the classical binding site. Residues A13 Leu and 
B 17 Leu, located in the dimer-dimer interaction region (hexamer-forming surface), 
seemed to be involved in this second binding site. A model for receptor binding has been 
proposed where each of the two a-subunits of the insulin receptor (see later) contributes 
with a different binding region to the formation of the high-affinity binding site. 
Subsequently, a second molecule of insulin is able to bind to a low-affinity site involving 
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one of the a-subunits, thus accounting for the curvilinear Schatchard plot (Schaffer, 
1994). 
Growth promoting activity 
An important point that should be raised in this chapter is that insulin has both metabolic 
and growth-promoting activities. One of these growth-promotion activities includes rapid 
effects on gene transcription (Messina, 1990). Which residues participate in growth 
promoting activities has been tentatively postulated; a postulation. The suggestions are 
based on a comparison of the residues in insulins as well as insulin-like growth factors 
(both of which show enhanced growth promoting effects) with mammalian insulins that 
show high potency for metabolic effects, but low potency for growth. Some of these 
insulins with growth promoting effects also show enhanced metabolic effects (turkey 
insulin) while others show low potency for metabolic effects (hystricomorph (guinea pig, 
porcupine, coypu and casiragua insulins) and the insulin-like growth factors (IGF)). The 
residues identified are A8 His in turkey insulin (Ala or Tor in mammals), B 10 Asn, Gln or 
Glu in some hystricomorphs and IGF's (His in mammals); B 13 Asp in some 
hystricomorphs and IGF's (Glu in mammals), A4 Asp in some hystricomorphs and IFG's 
(Glu in mammals) and B25 Tyr in some hystricomorphs and IGF's (Phe in mammals) 
(Horuk et al., 1979; King and Kahn, 1981). Another feature of some of the . 
hystricomorph insulins is that they have a substitute residue at B 10 (Gln in coypu and 
Asn in guinea pig). Without a His in that position insulin is unable to coordinate around 
zinc ions to form a hexamer structure as found in pig insulin (Blundell, 1972). 
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2.5.1 Invariant amino-acids 
The invaiiant residues and the residues in the receptor binding region that are important 
for biological activity are shown in Figure 2.5. The residues in insulin that are conserved 
may give insight into the structural properties required for the biological action of insulin. 
These invariant amino-acids can be divided into two groups 
I A6 Cys, A7 Cys, Al 1 Cys, A20 Cys, B7 Cys and B19 Cys; A16 Leu, B6 
Leu, Bll Leu, B15 Leu; B12 Val; B8 Gly and B23 Gly. 
II Al Gly, A19 Tyr and A21 Asn. 
The first group (I), one which includes all the cysteines that form the disulphide bridges, 
are thought to be essential to the construction of the molecule. The second contains 
surface residues that may be extended to include certain others conserved in most 
insulins, A2 Ile, A3 Val, AS Glu, B22 Arg, B24 Phe, B25 Phe and B26 Tyr. They lie on 
two continuous surfaces, the B-chain monomer-monomer interface (B24 -B26) and a 
polar surface containing the A-chain residues (A2, A3, AS) and B22. Some of these are 
in the flexible regions (N-terminal A-chain and C-terminal B-chain) where changes of the 
molecular arrangement in different crystals affect their conformation (Balcer et al., 1988). 
2.6 Stability of the insulin monomer fold with bearing to 
structure-activity relationship 
For diabetic patients that use therapeutic insulin daily it is important that insulin should be 
stable. Considerable enhancement of folding stability is engineered by mutations in the N-
terminal capping boxes of helices (Harper and Rose, 1993). Helices that may be 
considered for this stability engineering of the insulin molecule are the central a-helix of 
the B-chain (B9-B19) and the a-helix of the A-chain (A2-A8) (Kaarsholm et al., 1993). 
In fact mutations that have been produced to confer increased stability in these regions 
40 
Figure 2.5 
The amino-acid sequence of porcine insulin. Residues that are invariant in group 
I (text) are marked with horizontal line shading, residues that are invariant in 
group II are marked with vertical line shading and the residues indicated by 
arrows contribute to the receptor binding region. 
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are identical to those that lead to enhanced biological activity. Mutations in two regions 
were examined, namely A8 (the A2-A8 a-helix) where the threonine was substituted for 
a His or an Arg, and B 10 (the B9-B 19 a-helix) where the His was substituted for a Glu 
or an Asp. It was found that the substitutions affect stability in a nearly independent 
fashion. These stabilising mutations were generally found to enhance the cooperativity of 
the unfolding transition. It was concluded from this study that these highly potent insulin 
mutants elicit enhanced activity because these mutations stabilise structural motifs of 
critical importance for receptor recognition (Kaarsholm et al., 1993). 
2. 7 The structure and function of the insulin receptor 
Although the binding of insulin to its receptor was not investigated in the work presented 
in this thesis it is of interest to discuss this because the changes introduced in a desirable 
therapeutic insulin are relevant to receptor binding. 
Historically, there has been a great interest in the details of how insulin binds to its 
receptor. The exact regions of the receptor that directly contact hormone remain 
incompletely defined and are still the object of much scrutiny. It is still unclear how many 
insulin monomers bind to one holoreceptor, as some workers hold that only one molecule 
of insulin binds to its receptor (Lee and Pilch 1994), while others postulate that two 
monomers bind (Schaffer, 1994 ). 
The three-dimensional structure of insulin shows that regions widely separated in the 
primary structure, for example A 1 Gly, A2 Ile, B25 Phe, are brought together in the 
tertiary structure to provide a region that might recognise the receptor (Blundell et al., 
1972). In fact the large surface of the molecule implicated in receptor binding suggests 
that insulin is almost surrounded by its receptor. This is consistent with the finding that 
no insulin mimetic small molecule can compete as a full agonist at the receptor and no 
insulin modified at a single amino-acid residue is a full agonist (Balcer et al., 1988). Also 
Nalcagawa and Tager (Nalcagawa and Tager, 1993) suggested that the insulin receptor 
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shows considerable capacity to participate in the conformational adjustment of the ligand 
molecules and that receptor mediated movements in native insulin lead to important 
structural adjustments without the need for major changes in the usual insulin fold . 
The insulin receptor is a large glyco-protein molecule of molecular mass of about 
300 000 daltons and a member of the tyrosine kinases family; a group of enzymes that 
play a clitical role in cell division, metabolism and development (McDonald et al. , 1995). 
It consists of two alpha and two beta chains organised in a generally similar way to that 
in immunoglobulin molecules. A model of a ligand-free, inactive form of the structure of 
the receptor is shown in Figure 2.6. 
Cloning and sequencing the cDNA of the insulin receptor revealed similar features to 
those of other tyrosine receptor kinases (Ebina et al., 1985; Ulllich et al. , 1985). These 
include an extracellular cystine-lich domain followed by a single transmembrane region 
which is probably helical, and then an intracellular tyrosine kinase. The insulin receptor is 
proteolytically processed into a and p subunits that remain covalently associated by 
disulphide bond(s). These ap units are further disulphide linked to give the mature (aP)2 
heterotetrameric receptor (McDonald et al., 1995). 
Some progress has been made in identifying receptor residues involved in binding of 
insulin and the residues implicated are in the LI, S and L2 domains (Figure 2.6) (Lee and 
Pilch, 1994). Studies with pulified insulin receptor indicate that there are two classes of 
binding sites. One binding a single monomer of insulin which occurs at low concentration 
of the hormone. The other which occurs at higher concentrations of insulin where at least 
one further insulin monomer binds, but with a lower affinity. These bindings, together 
with the accelerated dissociation rate as measured using labelled insulin from the receptor 
in the presence of unlabelled insulin, is characteristic of the phenomenon of "negative 
cooperativity". Negative cooperativity has been interpreted either in terms of competition 
for binding sites on the receptor or in terms of insulin dimer formation competing with 
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Figure 2.6 
A schematic representation of the model of the insulin receptor. The receptor 
comprises the a and ~-units which are linked by disulphide bonds. There is a 
further disulphide bond which joins the two a-subunits of the tetramer. Ll and 
L2 are the duplicated large domains each comprising four or five copies of a 
helix-tum-strand motif, S is the cystine-rich domain, which contains three 
repeats. The first fibronectin domain F 1 is interrupted by an insert which spans 
the a/~ junction followed by the second fibronectin domain F2. Tis the 
transmem brane helix and K the kinase domain. The circles on the kinase domain 
represent the three regulatory tyrosines of the kinase domain that are subjected 
to phosphorylation/dephosphorylation. 
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insulin receptor complexes. Most recently it has been explained in terms of a model in 
which bound insulin cross-links the subunits of the receptor (DeMeyts, 1994). 
Two insulin molecules bind to the a-subunits of the (a~)2 heterotetrameric receptor 
complex (Schaffer, 1994). The most current model for the binding of insulin to its 
receptor (to account for the negative cooperativity phenomenon) and activation of the 
receptor is that proposed by McDonald et al. (McDonald et al., 1995) where they 
propose that: insulin may bind to the Ll and L2 domains in two possible ways. This is 
either to the L 1 and L2 of the same a-chain or the two a-chains of the complex. 
Negative cooperativity exhibited upon binding insulin may be either through an 
unspecified conformational change within the second a-chain to make binding of the 
second molecule more difficult or a rotation of the respective half receptors so that the 
Ll and L2 sites are too far apart to form a site equivalent to the occupied binding site. 
For activation it may be necessary for an insulin-induced conformational change effecting 
the kinase domain in order to bring them into close enough juxtaposition for trans-
activation. This confonnational change could be achieved by either a scissors motion of 
the two kinase domains or a relative rotation of the two halves of the receptor. 
The mechanism of activation of the tyrosine kinase is still unclear and one possibility is 
that a confonnational change within the a-subunit on binding insulin is followed by a 
change of relative orientations of the two tyrosine kinases in the dimer (McDonald et al., 
1995). After insulin binds to its receptor the intrinsic tyrosine kinase activity of the 
receptors is rapidly stimulated through autophosphorylation. Three closely spaced 
tyrosine residues shown in the diagram (Figure 2.6) within an activation loop of the 
kinase domain are believed to be responsible for this activation. An important 
consequence of the activation is the recruitment of IRS-1 (insulin receptor substrate-I) 
and other effector and adaptor molecules. Each of these effector and adaptor molecules 
contain SH2 (Src homology 2) domains that bind phosphotyrosines with high affinity. 
IRS-1 is the main target for these SH2-containing proteins rather than the insulin 
receptor itself (White and Kahn, 1994), although recent evidence indicates parallel 
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pathways, independent of IRS-1 for activating kinases, also exist (Araki et al., 1994). 
Eventually these transient complexes formed with IRS-1 activate a number of pathways 
involving kinases which can ultimately lead to the initiation of protein synthesis (Lin and 
Lawrence, 1994) and the translocation of an insulin-sensitive glucose transporter to the 
cell surf ace for glycolysis and lipogenesis. 
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Chapter 3 
Platypus Insulin: Structural Analysis 
3.1 Introduction 
Investigations of the composition, structure, biological activity and self-association of 
insulin from more exotic species increases the possibility of identifying an insulin with 
desirable properties by exploiting natural variation. The platypus ( Ornithorhynchus 
anatinus ) is one such exotic animal. It is the only extant species of the family 
Omithorhynchidae belonging to the order Monotremata, the egg laying mammals. Thus a 
detailed understanding of the many facets of the platypus insulin structure, primary, 
secondary and tertiary are of fundamental importance to the understanding of its activity 
and physico-chemical properties. These include properties of amino-acids in the sequence 
that contribute to: 
• the structural integrity of the overall three-dimensional structure (invariant residues), 
• the self-association interfaces (monomer-monomer and dimer-dimer) 
• the receptor binding region 
• the metabolic potency and 
• the growth promotion effects of platypus insulin. 
Also an understanding of these above face ts at a fundamental molecular level will 
ultimately enhance future ability to design therapeutic insulins with desirable properties. 
The physico-chemical properties, namely the self-association behaviour in solution at 
physiological pH, of platypus insulin are of particular interest. This self-association only 
becomes of significance in those instances where the insulin is present in high 
concentrations, as is the case in diabetes therapy and in the determination of the three-
dimensional structure of insulin in solution by the method of 2D NMR where aggregation 
of insulin produces broad NMR signals which reduce the ability to determine structures 
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in detail. (See Chapter 2). There are two regions implicated in self-association, namely, 
the monomer-monomer interaction region (OP) and on the opposite side of the molecule, 
the weaker dimer-dimer interaction region (OQ) (Chapter 2). These two interaction 
regions as well as the receptor binding surface can be regarded as independent design 
features when engineering mutants with altered functional properties (Shoelson et al., 
1992). There is, however, a large overlap of residues involved in the monomer-monomer 
interface and those participating in receptor binding (Chapter 2). Residues targeted for 
mutation in the monomer-monomer interface to bring about the reduction in self-
association must be chosen carefully so as not to disrupt the hormone's receptor binding 
capability and thus its activity. As the monomer-monomer interaction is the stronger 
interaction (compared with the dimer-dimer interaction) this area has been the main 
target for producing mutations that will reduce the strength of this interaction and thus 
the overall self-association of insulin. Mutations in this area are also used to probe the 
binding characteristics of the hormone to its receptor without taking into account its self-
association properties. (Binding of insulin to its receptor occurs at concentrations (ng) at 
which insulin does not aggregate). It might, however, be of an advantage to produce 
mutations in the dimer-dimer interaction region to reduce self-association since this 
region is on the opposite side of the molecule and independent of the receptor binding 
region. 
In the first part of this chapter the sequence of platypus insulin is compared by the 
method of pairwise sequence comparison as well as multiple sequence alignment to the 
sequence of all the insulins of different animals. This was done in order to identify the 
degree of similarity at the amino-acid sequence level of structural elements as well as the 
regions in the insulin molecule that contribute to its the physico-chemical and biological 
properties. In this sequence comparison analysis by computer the amino-acids are 
described with a set of physico-chemical properties. In the construction of a multiple 
sequence alignment qualitative descriptions of the residues found at each position are 
used (Gracy et al., 1993). To do this the Genetics Computer Group sequence analysis 
software package was used (Devereux et al., 1984 ). This sequence comparison analysis 
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may also give information in respect to the evolutionary relationship of platypus insulin 
with other insulins from different organisms. The method of multiple sequence alignment 
is well suited to the latter. It was also of interest to determine the relationship of the 
platypus insulin sequence with that of the hystricomorph insulins (guinea pig, porcupine, 
coypu and casiragua) as some of the latter insulins have distinct physico-chemical and 
biological properties (Chapter 2). For example some of these hystricomorph insulins do 
not self-associate to the extent that mammalian insulins do. This is because B 10 His, 
essential for coordinating zinc in hexamer formation in some of these insulins is 
substituted by Asn or Gln (Blundell, et al., 1972). Also its growth promoting activity 
(relatively high) and metabolic potency (relatively low) are more comparable with insulin-
like growth factors than with mammalian insulins (Chapter 2 and King and Kahn, 1981). 
The full function of each amino-acid in a protein sequence is manifest only in its context 
in the tertiary structure. Therefore to make meaningful alterations to the sequence 
requires a three-dimensional model (Taylor, 1988). Thus in order to analyse the structure 
of platypus insulin in a meaningful way, information about its three-dimensional structure 
is necessary. Only ~e amino-acid sequence of platypus insulin was available so in order 
to obtain some information about its three-dimensional structure platypus insulin was 
modelled on the basis of its complete sequence using the coordinates of the X-ray crystal 
structure of porcine insulin. These studies form part of a program with the aim of 
evaluating insulins and insulin derivatives, both new and previously reported, with the 
desired characteristics. 
3.2 Materials and Methods 
3.2.1 Isolation and purification of native platypus insulin 
Platypus insulin was isolated by G. Barbara Treacy (Nourse et al., 1996). The procedure 
is outlined below in detail. 
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Platypus pancreatic tissue was obtained from 9 animals which had been deep frozen at 
death. For the preparation the bodies were kept in a refrigerator overnight and the tissue 
dissected out before defrosting was complete. 
The extraction of the pancreases was carried out in the cold by a modification of the 
method of Treacy et al. (Treacy et al., 1989). This consisted of homogenisation in cold 
acidic ethanol, centrifugation, adjustment of the pH of the supernatant to 8 and removal 
of the resulting precipitate by centrifugation. The supernatant was adjusted to pH 5.3, 2 
M ammonium acetate solution at pH 5.3 added and the crude insulin and pancreatic 
polypeptide precipitated by the addition of cold absolute ethanol and cold diethyl ether. 
After being left overnight in the cold the precipitate was collected by decantation and 
centrifugation. 
At this point it was observed that the precipitate did not separate cleanly from the liquid 
but rather as a dark coloured oily-looking liquid between the yellow precipitate and the 
other layer. This is not normally seen when preparing insulins from other organisms. 
Platypus insulin was obtained from this "oily supernatant". Reversed phase (RP)-HPLC 
was employed to purify the insulin by applying successive 25µ1 aliquots, diluted to 250µ1 
with starting solution, to a HPLC RP300C8 column, 4.6 mm i.d., and collecting the 
appropriate peak in each case. Elution was in 0.09% aqueous trifluoroacetic acid using a 
linear gradient from 8% to 50% acetonitrile in 20 min. The insulin was purified further by 
combining the material from several runs and reapplying them to the RP300C8 column. 
3.2.2 Determination of the amino-acid sequence of platypus insulin 
The amino-acid sequence of insulin from platypus Ornithorhynchus anatinus was 
determined using the Applied Biosystems Model 477, a pulsed liquid phase sequencer 
with on-line Model 120A PTH-Analyser (Applied Biosystems Inc., Foster City, CA, 
U.S.A.) modified for picomole sensitivity. Methods used were as described by Treacy et 
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al. (Treacy et al., 1989). The molecular mass of platypus insulin, calculated as 5865 
daltons, has been confirmed with a matrix-assisted laser desorption ionisation (MALDI) 
time-of-flight mass spectrometer by the author. For a more detailed description of the 
mass analysis see chapter 4 section 4.2.2. 
3.2.3 Comparative phylogenetic analysis of the amino-acid sequence of platypus insulin 
For the amino-acid sequence comparison studies the Genetics Computer Group (GCG) 
Sequence Analysis Software Package Version 7.1 (Devereux et al., 1984) that include 
the FAST A, GAP, PILEUP and SEQ ED programs, was used. The computationally fast 
algorithm FAST A, (Pearson and Lipman, 1988) that allows a homology search of one 
sequence against the entire SWISS-PROT amino-acid sequence database was employed 
to search for insulin from different organisms with amino-acid sequences related to the 
amino-acid sequence of platypus insulin. FAST A uses a Ktup value of 2 (the default 
value) and a P AM250 scoring matrix. Scores between platypus insulin amino-acid 
sequence and each of the database entries were calculated and presented in order of 
decreasing- best scores with the highest scores corresponding to the strongest 
relationship. The best 55 scores (all the insulin amino-acid sequences) were subjected to 
analysis by a more sensitive sequence comparison program, GAP (Needleman and 
Wunch, 1970). The GAP program that covers the complete sequence, maximises the 
number of matches and minimises the number of gaps. Data entries, where the amino-
acid sequences included the signal and C chain, had been edited out with SEQED for the 
GAP alignments. 
A dendogram displaying the clustering relationships of the primary sequence of platypus 
insulin with insulins from other organisms was compiled with PILEUP. 
The PILEUP program (GCG) is an extension of the GAP program (GCG) where a 
multiple sequence alignment (algorithm of Feng and Doolittle) (Feng and Doolittle, 
1987) is created from a group of related sequences using progressive pairwise alignment. 
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3.2.4 Molecular modelling of the three-dimensional structure of platypus insulin 
Platypus monomer insulin structure was modelled using the coordinates of the X-ray 
crystal structure of rhombohedral 2 Zn porcine insulin, monomer 2, entry 3 ins 
(Wlodawer et al., 1989) of the Brookhaven Protein Databank. Monomer 1 (Chinese 
nomenclature) differs from monomer 2 mainly at the B25 Phe in the 2 Zn dimeric crystal 
structure. In monomer 1 the B25 Phe side chain turns inward to contact Al 9 Tyr, 
whereas the side chain in monomer 2 points outward from the molecule (Baker et al., 
1988). 
The porcine insulin monomer 2 structure was subjected to 250 iterations of steepest 
decent energy minimisation followed by 5000 iterations of conjugate gradient in vacuo. 
This energy minimised porcine insulin monomer 2 structure has been used for modelling 
the structure of platypus monomer insulin with the appropriate different residues A5, A8, 
A9, Al0, Al 3, B2, B22, B25, B27, B29 and B30. The platypus monomer insulin has 
been subjected to 250 iterations of steepest decent energy minimisation followed by 5000 
iterations of conjugate gradient energy minimisation in vacuo. The maximum derivative 
achieved was 0.0093 kcal/mol-A. 
Molecular dynamics for 100 ps of simulation at 200 K have subsequently been performed 
in vacuo. Analysis was performed using the transient structures written at intervals of 1 
ps. Computations for molecular dynamics were carried out using the Fujitsu VP of the 
Australian National University Supercomputer Facility. During the simulations the 
charges were on and constant pressure off. The number of iterations were 100 000 with a 
time step of 1 fsec. No cross terms energies and no Morse potential for bond energies 
were included. The leapfrog integration algorithm was employed. A history file was 
written every 1000 steps. 
Transient structures written at 15 ps; 55 ps; 81 ps and 97 ps were chosen and each were 
energy minimised by using the conjugate gradient algorithm for 5000 steps in vacuo. In 
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all cases the maximum derivative was below 0.001 kcal/mol-A. Energy minimisation was 
performed with charges on. Cross term energies and Morse potentials for bond energies 
were also included. 
Both the energy minimisations and simulations were carried out using the program 
Discover Version 94.0 (May 1994) on a Silicon Graphics workstation as well as the 
analysis using the program Analysis, all generated by the computer program Insight II 
version 2.3.0 (December 1993). 
3.3 Results 
3.3.1 Isolation and purification of native platypus insulin 
Platypus insulin was obtained from the "oily supernatant" after the precipitation step in 
the isolation process (Section 3.2). The yield of the platypus insulin was just sufficient to 
meet the amount required ( > µg) for the amino-acid sequence determination. No peak of 
platypus insulin was found from the yellow precipitate where it was expected but which 
instead contained a pancreatic polypeptide. This platypus pancreatic polypeptide was 
identified by amino-acid sequence and comparison with the SWISS-PROT database. 
3.3.2 The amino-acid sequence of platypus insulin 
The amino-acid sequence of platypus insulin shown in Figure 3.1, differs from that of 
human and porcine insulin at eleven residues. Most of these, summarised in Table 3.1, 
represent relatively conservative substitutions in regions that have been observed as 
varying from highly conserved to variable. Three, A5 Glu, A8 Lys and Al3 Met have not 
been observed in other organisms (Table 3.2). Most substitutions occur on the surface, or 
at least partial surface, in regions important to receptor binding and aggregation of the 
molecule. Substitutions at all three interactive surfaces include B25 Phe• Tyr and 
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827 Thr• Ile (monomer-monomer interface); A13 Leu• Met and 82 Val• Pro (dimer-
dimer interface) and A5 Gln• Glu and B25 Phe• Tyr (receptor binding region). 
Figure 3.1 
The amino-acid sequence of insulin from platypus 
(Omithorhynchus anatinus). The 11 residues that differ in 
porcine insulin are shown below the platypus sequence. 
A-Chain 
1 5 10 15 20 
GI VEECCKGVCSMYQLENYCN 
Q TS I L 
B-Chain 
1 5 10 15 20 25 30 
FPNQHLCGSHLVEALYLVCGEKGFYYI PRM 
V R F T KA 
3.3.3 Pairwise amino-acid sequence comparisons of platypus insulin with that of all 
known insulin sequence 
The pairwise comparisons of platypus insulin sequences with insulin sequences from 
other organisms using the GAP program is presented in Table 3.3 in order of decreasing 
percent identity with the platypus insulin sequence. The sequence comparison program 
GAP make comparisons between pairs of amino-acids by looking up a value in a symbol 
comparison table, in this case the Dayhoff P AM-250 matrix . The symbol comparison 
table has a real number for the match quality of every possible pair of symbols and the 
52 
Table 3.1: 
Residue 
A5 
A8 
A9 
Al0 
A13 
B2 
B22 
B25 
B27 
B29 
B30 
A phylogenetic comparison of the amino-acid sequence of platypus and porcine insulin. 
Only platypus amino-acid substitutions relative to porcine insulin are presented. 
Amino-acid Side Chain Properties Structural domain (a,b) 
Porcine Platypus Porcine Platypus 
Gin Glu* polar acidic a-helix, receptor binding 
Thr Lys* polar basic a-helix 
Ser Gly polar surf ace residue 
Ile Val non polar non polar extended P-conf ormation 
Leu Met* non polar non polar, S a-helix, dimer-dimer interface 
Val Pro non polar non polar dimer-dimer interface 
Arg Lys basic basic P-bend, ionic pair 
Phe Tyr aromatic aromatic monomer-monomer interface, 
receptor binding region 
Thr Ile polar non polar monomer-monomer interface 
Lys Arg basic basic extended P-chain 
Ala Met polar non polar, S extended P-chain 
Type (a,b) 
conserved 
variable 
variable 
variable 
variable 
variable 
conserved 
conserved 
variable 
variable 
variable 
a) Baker et al., 1988; b) Shoelson et al., 1992; S: sulfur containing residue; *Previously not observed in insulin 
Table 3.2: Comparison of platypus insulin with insulin sequences from other organisms. 
Only platypus insulin residues different from porcine insulin are shown. 
Sequence library used was the SWISS-PROT database. 
Organisms that share residues with platypus insulin. 
None 
None 
None 
Elephant, goat, porcupine, sheep, horse, guinea pig 
Elephant, goat, porcupine, sheep, cat, camel, bovine 
Rattle snake, cantor, electric ray, dogfish, ratfish, elephantfish 
Electric ray, dogfish, salmon, alligator 
Rattle snake, cantor, electric ray, dogfish, degu, copyu, casiragua 
Guinea pig 
Rattle snake, cantor 
Sponge 
Platypus insulin residues 
differing from porcine 
A5 a) Glu 
A8 a) Lys 
A13 a) Met 
A9 c) Gly 
AIO c) Val 
B2 c) Pro 
B22 c) Lys 
B25 b) Tyr 
B27 c) Ile 
B29 c) Arg 
B30 c) Met 
a)Residues not observed in other organisms; b)Residues conserved, but observed in other organisms; 
c)Residues variable and shared with other organisms. 
number is assigned based on chemical similarity or evolutionary distance. Percent identity 
is the percent of the symbols that actually match (Devereux et al., 1984 ). 
The percent identity of platypus insulin with other insulins is not particularly high, the 
highest being only about 82% (Table 3.3). This is the group of mammalian insulins that 
include elephant, goat and sheep. In the percent identity range of 72-82 % are 
represented insulins of mammals, reptiles, birds and amphibians. Mammalian insulins are 
predominantly at the higher end and amphibian insulins at the lower end of this range. 
Outside this range, (54-72% ), are found the insulins of fish and the hystricomorphs 
(guinea pig, porcupine, coypu and casiragua), the latter at the lower end. 
3.3.4 Multiple sequence alignment of platypus insulin with that of all known insulin 
sequences 
The insulin sequences from different organisms were also subjected to multiple sequence 
alignment on the basis of pairwise similarity (PILEUP) and presented as a dendogram 
(Figure 3.2). The vertical branch distance of the dendograms are proportional to the 
similarity between sequences (Devereux et al., 1984 ). 
In the dendogram the insulin sequences cluster into 4 main branches. The first two 
branches consist of the amphibian insulin sequence (cluster 1) and mammalian insulin 
sequence (cluster 2). These two together form cluster 3. The mammalian insulin 
sequences (cluster 2) can be roughly divided into subcluster 2.1, the mouse and rat 
insulin sequences and subcluster 2.2, which contain the very similar sequences of porcine, 
bovine, human, elephant etc. It can be pointed out that the marsupial insulin sequence 
(Didelphis marsupials virginiana identical to kangaroo Macro pus giganteus) (Treacy et 
al., 1989) and the low potency insulins of Aotus trivirgatus (Seino et al., 1987), Hystrix 
cristata (King and Kahn, 1981) and Chinchilla brevicaudata (Horuk et al., 1979) are 
outside subclusters 2.1 and 2.2 which indicate that they are more distantly related. The 
third branch is represented by the single platypus insulin sequence which participates in a 
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Table 3.3: 
SWISS-PROT 
Nomenclature 
plifla) 
Ins_Elema 
Ins_Caphi 
Ins_Sheep 
Ins_Horse 
Ins_Camdr 
Ins_Bovin 
Ins_Balph 
Ins_Macfa 
Ins_Canfa 
Ins_Pig 
Ins_Human 
Ins_Rabit 
Ins_Felca 
Ins_Balbo 
Ins_Anapl 
Ins_Croat 
Ins_Ansan 
Ins_Chick 
Ins_Crilo 
Ins_Hyscr 
Ins_Lepsp 
Ins_Zoadh 
Ins_Acoca 
Ins_Didma 
Ins2_Rat 
Ins2_Mouse 
Ins_Allmi 
Pairwise comparison of platypus insulin with insulin sequences from 
other organisms in order of decreasing percent identity. Amino-acid 
sequence comparisons were performed using the Genetics Computer 
Group programmes GAP which used the PAM 250 scoring matrix. 
The protein sequences and their respective references are stored in the 
SWISS-PROT database. 
Organisms % Identity 
Omithorhynchus anatinus (platypus) 100 
Elephas maximus (Indian elephant) 82.353 
Capra hircus (goat) 82.353 
Ovis arie (sheep) 82.353 
Equus caballus (horse) 80.392 
Camelus dromedarius (Arabian camel) 80.392 
Bos taurus (bovine) 80.392 
Balaenoptera physalus (fin back whale) 78.431 
Macaca fascicularis (monkey) 78.431 
Canis f amiliaris (dog) 78.431 
Sus scrofa (pig) 78.431 
Homo sapiens (man) 78.431 
Oryctolagus cuniculus (rabbit) 78.431 
Felis catus (cat) 78.431 
Balaenoptera borealis (sei whale) 78.431 
Anas plathyrhynchos ( duck) 76.471 
Crotalus atrox (rattlesnake) 76.471 
Ans er ans er ans er (goose) 76.471 
Gallus gallus (chicken) 76.471 
Cricetulus longicaudatus (Chinese hamster) 76.471 
Hystrix cristata (porcupine) 76.471 
Lepisosteus spatula (alligator) 74.510 
7.aocys dhumnades (cantor) 74.510 
Acomys cahirinus (Egyptian spiny mouse) 74.510 
Didelphis marsupials virginiana ( opossum) 74.510 
Rattus norvegicus 2 (rat) 74.510 
Mus musculus 2 (mouse) 74.510 
Alligator mississippiensis 74.000 
Ins_Geocy Geodia cydonium (sponge) 74.000 
Ins2_Xenla Xenopus laevis 2 (African clawed frog) 72.549 
Insl_Mouse Mus musculus I (mouse) 72.549 
Insl_Rat Rattus norvegicus 1 (rat) 72.549 
Ins_Squac Squalus acanthias (spiny dogfish) 72.549 
Insl_Xenla Xenopus laevis I (African clawed frog) 70.588 
Ins_Aottr Aotus trivirgatus (night monkey) 70.588 
Ins_Torma Torpedo marmorata (electric ray) 70.588 
Ins_Chibr Chinchilla brevicaudata ( chinchilla) 68.627 
Ins_Oncgo Onchorhynchus gorbuscha (salmon) 68.000 
Ins_Loppi Lophius piscatorius (goosefish) 67.347 
Ins_Cypca Cyprinus carpio (carp) 67.347 
Ins_Oncke Oncorhynchus keta (salmon) 66.667 
Ins_Myosc Myoxocephalus scorpius (sculpin) 66.000 
Ins_Thuth Thunnus thynnus 2 (bluefin tuna) 66.000 
Ins_Plafe Platichthys flesus (flounder) 66.000 
Ins_Petma Petromyzon marinus (sea lamprey) 66.000 
Ins_Calmi Callorhynchus milii (elephantfish) 64.706 
Ins_Hydco Hydrolagus colliei (spotted ratfish) 64.706 
Insl_Batsp Batrachoididae sp I (toadfish) 64.000 
Ins_Gadca Gadus callarias (Baltic cod) 64.000 
Ins2_Batsp Batrachoididae sp (toadfish) 63.265 
Ins_Katpe Katsuwonus pelamis (skipjack tuna) 62.000 
Ins_Myxgl Myxine glutinosa (Atlantic hagfish) 60.784 
Ins_Octde Octodon degus (degu) 60.000 
Ins_Cavpo Cavia porcellus (guinea pig) 58.824 
Ins_Myoco Myocastor coypus (coypu) 54.000 
Ins_Progu Proechimys guairae ( casiragua) 54.000 
a) Name assigned for platypus insulin. 
Figure 3.2 
Dendogram displaying the clustering relationships of the primary sequence of 
platypus insulin with insulins from other organisms using the PILEUP 
program. Platypus insulin was given the name plin. Names of insulins from 
different organisms are SWISS-PROT designations and their sequences and 
their respective references are stored in the SWISS-PROT database. Own 
clustering nomenclature was used. 
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clustering relationship with the amphibian and mammalian insulin sequences ( cluster 3) to 
fonn cluster 4. The final branch consists of reptilian and avian insulin sequences ( cluster 
5) that clusters with cluster 4 to fonn cluster 6. (Multiple sequence alignment with fish 
and other hystricomorph rodent insulin sequences are not shown). 
3.3.5 Molecular modelling the three-dimensional structure of platypus insulin 
Upon viewing the animation of the molecular dynamics simulation from 1 to 100 ps it 
was noted that the structures changed very little between 35 ps to 100 ps. Movement of 
the B 1 Phe occurred but the arrangement of B 1 Phe, A13 Met and A14 Tyr (see 
discussion) remained essentially the same. Transient structures minimised at 55 ps; 
81 ps and 97 ps in vacuo superimposed well and remained essentially the same. 
Space-filling diagrams of modelled platypus insulin monomer 2 and crystal structure of 
porcine insulin monomer 2 viewed in the direction of the local two-fold axis are 
presented (Figure 3.3). Also shown are coloured models of the same two insulins viewed 
from the same angle (Figure 3.4 ). Viewing of the two insulins is in the same plane. The 
arrangement of the residues B 1, A13 and A14 in the dimer-dimer interface of the 
platypus insulin model is very different from the porcine insulin crystal structure. The 
orientation of B25 (a shared residue in the monomer-monomer interface as well as the 
receptor binding area) of both insulins is seemingly similar. The arrangement of A5 
(a residue in the receptor binding area) of both insulins does not differ dramatically. 
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Figure 3.3 
Space-filling diagrams of modelled platypus insulin monomer 2 and porcine 
insulin monomer 2 viewed in the direction of the local two-fold axis. 
Receptor binding region (diagonal right to left line shading,), monomer-
monomer interface (diagonal left to right line shading), dimer-dimer interface 
(shaded), Al3 (speckled) ; platypus insulin A5, B25, and B27 (vertical line 
shading). 
Figure 3.3 
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Figure 3.4 
CPK coloured models of platypus and porcine insulin. The monomer-
monomer interface is in pink, the dimer-dimer interface in green and the 
receptor binding area in red. There is considerable overlap of the monomer-
monomer interface and the receptor binding area. Residue B 1 is in orange 
and Al3 in blue. Residues different in platypus insulin B25 and A5 are in 
yellow and B27 in purple. The view is along the two-fold axis. 
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3.4 Discussion 
3.4.1 Amino-acid sequence of platypus insulin 
Structural integrity of platypus insulin structure (invariant residues) 
Most of the eleven residue substitutions of platypus insulin ( compared with porcine 
insulin) occur on the surface, or at least partial surface, in regions important to receptor 
binding and aggregation of the molecule. The amino-acid sequence reveals strict 
conservation of the residues known to be involved in maintaining the three-dimensional 
structure (Baker et al., 1988). These include the thirteen invariant residues (the six half-
cystine residues, A6, A7, Al 1, A20, B7, B19, glycine residues at B8 and B23, leucine 
residues at Al6, B6, Bll, and Bl5 and Bl2 Val) as well as the invariant group of surface 
residues believed to be involved in receptor binding and expression of biological activity 
(A 1 Gly, A 19 Tyr and A2 l Asn) (Baker et al., 1988). Some of the highly conservative 
sites A2 Ile, A3 Val, B24 Phe and B26 Phe to be found on the surface of the molecule 
are present in the platypus insulin structure. A5, B22 and B25, that are grouped with the 
latter, are conservative changes of 
A5 Gln• Glu, B22 Arg• Lys and B25 Phe• Tyr in platypus insulin. 
Self-association interfaces ( monomer-monomer and dimer-dimer) 
There are three distinct surfaces on the insulin molecule, namely, the monomer-monomer 
interface (A21, B8, B9, B 12, Bl 6, B20, B21 and B23-B28), the dimer-dimer interface 
(Al3, A14, Al 7, Bl, B2, B4, BIO, Bl3, B14, and Bl7-20) that constitute the protein-
protein interactive surfaces and the receptor binding surface (Al, A5, A19, A21, B 12, 
B16, B23, B24 and B25) (Baker et al., 1988; Shoelson et al., 1992). Platypus insulin has 
substitutions at all three interactive surfaces namely B25 Phe• Tyr and B27 Thr• Ile 
(monomer-monomer interface); Al3 Leu• Met and B2 Val• Pro (dimer-dimer interface) 
and A5 Gln• Glu and B25 Phe• Tyr (receptor binrling region). 
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Self-associating forces that lead to dimerisation of insulin (Baker et al., 1988; Shoelson 
et al., 1992) are predominantly non-polar, reinforced by hydrogen bonding (Baker et al. , 
1988; Pocker and Biswas, 1981). Thus B25 and B27 Ile, the residues different in 
platypus and part of monomer-monomer interface, considered conservative changes, fulfil 
these criteria. All other residues that form part of this surface, including B28 Pro, the 
latter especially important for high affinity self association (Brems et al., 1992), are 
unchanged in platypus insulin. It can be concluded then that it is highly likely that the 
platypus insulin will fonn dimers and since B5 His and B 10 His are conserved, 
hexamerization can be expected in the presence of zinc (Bentley et al., 197 6; Blundell 
et al., 1972). 
Receptor binding region and biological activity (metabolic and growth) 
A model for insulin binding to the receptor was recently proposed (Schaffer, 1994) where 
the involvement of A 13 and B 17 in a putative second receptor binding site were 
discussed. Platypus insulin has a Met in position A 13 com pared to Leu in porcine, which 
has not been seen in other organisms. B25 Tyr, also part of the receptor binding region 
and different from porcine insulin, is Phe in most mammals. The aromatic ring seems to 
be important for biological activity (Nakagawa and Tager, 1986). It has been shown that 
substitution at A8 Thr for Arg or His (positively charged residues) provide strong 
stabilisation of the A-chain NH2-tenninal helix which leads to enhanced biological activity 
(Kaarsholm et al., 1993). Substitutions at A5 Gln• Glu (receptor binding region and 
charged) and A8 Thr• Lys ( positively charged residue) of platypus insulin introduce 
possible charge interactions in this region. The A5 Glu and B 25 Tyr substitutions are 
known from the IGF-1 molecule (Rinderknecht and Humbel, 1978) and in combination 
with substitutions in A8, A13 and B22, indicate that binding properties to the insulin and 
IGF-1 receptors would be interesting to investigate. Receptor interaction and biological 
activity may be affected by the above substitutions and the structural consequences need 
direct investigation. Also some members of the insulins of the hystricomorphs which 
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show enhanced in vitro growth promoting activity, reduced insulin receptor binding 
affinity and low metabolic potency but enhanced in vitro growth promoting activity, 
share residues with the sequence of platypus insulin (Table 3.2). These residues are 
A9 Gly, B27 Ile and B25 Tyr while only the latter B25 Tyr is postulated to participate in 
this growth-promoting activity (King and Kahn, 1981). 
The consequences of these residue changes of platypus insulin were subsequently 
investigated on a chemically synthesised platypus insulin. The in vitro biological activity 
(metabolic) (Chapter 4 section) and the self-association properties in a Zn free neutral 
pH solution (Chapter 5, section) were investigated. 
3.4.2 Pairwise amino-acid sequence comparisons of platypus insulin with that of all 
known insulin sequences 
The relatively low percentage identity (82%) of platypus insulin with its nearest relatives 
(Table 3.3), a group of mammalian insulins from elephant, goat and sheep, emphasises 
the unique biological features of this monotreme. This low percentage identity is reflected 
in the platypus insulin sequence differing at a great number of residues from its nearest 
relatives (8) and possessing amino-acids (3) that have not been reported before. 
In the relatively small percent identity range of 72-82%, it is expected to find mammalian 
insulin sequences. The fact that reptilian, avian and amphibian insulins are also 
represented in this range, albeit at the lower end, shows their relationship to platypus 
insulin. This relationship on a molecular level fits in with anatomical and biological 
studies of this remarkable egg-laying mammal that has retained several ancestral reptilian 
characteristics over the course of evolution (Grant, 1989; Griffiths, 1988). It is 
interesting to note that the sponge insulin is also to be found in this range and has a 
percentage identity of 7 4% with platypus insulin. It also shares a B30 Met with platypus 
insulin (Table 3.2). Also the relative percent identity of platypus insulin compared with 
that of the hystricomorph insulins was the lowest, namely 54-60% (Table 3.3). The 
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conclusion that could be drawn from this pairwise sequence comparison study is that the 
relationship of the platypus insulin with that of the hystricomorph insulins is relatively 
low. 
3.4.3 Multiple sequence alignment of platypus insulin with that of all known insulin 
sequences 
On taxonomic grounds it is believed that the monotremes are the last survivors of a 
group of early mammals that evolved independently of the creatures that gave rise to 
today's marsupials and other mammals (Grant, 1989; Griffiths, 1988). The PILEUP 
dendogram, displaying interrelationships of insulin sequences from different animals 
(Figure 3.2), reflects this theory. Although the platypus insulin sequence is not part of 
subcluster 2.2 that contains the similar sequences of human, porcine, and elephant etc. 
and from which some rodent and marsupial insulin sequences are excluded, its closest 
relationship appears to be with the mammalian insulin sequence as a single member of a 
more distantly related branch. (cluster 2 of Figure 3.2 and highest percent identity, Table 
3.3). Its relationship with reptilian insulin sequences (and amphibian and avian insulin 
sequences in this case) is sufficiently close to support the observation that platypus has 
retained some ancient reptilian characteristics over the course of evolution (Grant, 1989; 
Griffiths, 1988). The insulin sequence of the other living member of the monotremes the 
echidna, two species Tachyglossus aculeatus and 'Zaglossus bruijnii (Grant, 1989; 
Griffiths, 1988) are still unknown. It would be expected that the sequence is similar ( or 
identical) to that of platypus and thus should subcluster with it. In support of this 
proposal is the similar subclustering of the mouse and rat in subcluster 2.1 as well as the 
snakes in subcluster 5.1 (own nomenclature). The results of the sequence comparison 
studies fits in with known taxonomic data used to classify and compile a hypothesis for 
the evolutionary relationship of platypus with these animals (Grant, 1989; Griffiths, 
1988). 
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3.4.4 A comparison of the computer molecular model of the three-dimensional 
structure platypus insulin with the crystal structure of porcine insulin 
Comparison of the structure of the molecular model (monomer 2) with that of porcine 
insulin reveals it to be different. The A2-8 a-helix seems more distorted and the 
B21-23 ~-tum more irregular. The C-terminal B28-B30 end of the B-chain, which is 
known to be flexible, folds slightly back towards the main body of the monomer. A two-
fold axis view reveals residues Al 3, Al 4, Al 7, Bl and B2 (part of the dimer-dimer 
interface) to be involved in a different spatial arrangement from porcine insulin 
(Figure 3.3). The non polar nature has been preserved in the two amino-acids (Al3 Met 
and B2 Pro) of platypus insulin that differ from porcine insulin in this interface. In the 
porcine insulin crystal there exists an A14 Tyr-B 1 Phe interaction in the dimer-dimer 
interface (Baker et al., 1988; Blundell et al., 1972), although in 2D NMR studies of 
insulin monomers in solution these residues seem to be flexible and the interaction 
unlikely to be maintained in solution (Weiss et al., 1989). In the platypus insulin model 
A 13 Met is sandwiched between A 14 and B 1 and the B 1 Phe is pushed away from the 
body of the monomer (Figure 3.3). Such structural differences should be interpreted with 
caution and thus a postulated altered dimer-dimer interaction as well as altered self-
association properties of platypus insulin needs to be verified experimental! y under 
solution conditions when sufficient material is available. 
Viewing the space filling models of both platypus and porcine insulin, by looking directly 
at the receptor binding region, revealed no marked difference. As viewed from the two-
fold axis porcine insulin is mainly heart shaped while platypus insulin has a squarer 
structure. The invariant amino-acids responsible for the stable core structure of insulin 
(Baker et al., 1988) are identical in both species. 
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3.4.5 Conclusion 
The biological features of platypus insulin indicate that it is more closely related to 
marsupial and placental mammals than to any group of reptiles, despite retaining several 
ancestral reptilian characteristics over the course of evolution (Grant, 1989; Griffiths, 
1988). There is also only a relatively distant relationship with the hystricomorph insulins. 
This study of the amino-acid sequence of platypus insulin showed it to be quite varied, 
one that might possibly lend itself to the study of identifying the desirable properties 
needed to produce an insulin that is monomeric in solution (Chapters 1 and 2). Platypus 
insulin differs from that of the human at eleven amino-acid sites; of which three residues 
have not been observed in other organisms. It also differs from porcine and human insulin 
at its self-associating surfaces (monomer-monomer and dimer-dimer interfaces) by 4 
residues, offering the possibility of a change in association properties, and at its receptor 
binding surface by 2 residues, offering the possibility of a change in biological activity. It 
might be of interest to note that the B25 Tyr has been postulated as participating in 
growth promoting activity (Chapter 2) and this residue is present in platypus insulin. In 
designing an insulin for therapeutic use the possibility of growth promoting activity must 
be taken into account. 
In conclusion, platypus insulin's self-association behaviour under physiological conditions 
needs to be evaluated. The influence of the changes in amino-acid composition on 
biological activity and receptor binding characteristics of platypus insulin also requires an 
experimental study. Platypus insulin possesses a unique evolutionary-designed primary 
structure. The study of the ramifications of this, especially its molecular interactions and 
physico-chemical behaviour in its physiological environment, namely in solution, blood, 
and in contacts with residues of its receptor upon binding to elicit a biological response, 
should contribute to our understanding of the structure-function relationship of insulin in 
general. The combination of knowledge gained from the resources of evolutionary 
designed and protein-engineered insulins will in tum contribute to a more informed 
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insulin design and evaluation strategy in the quest for a monomeric, active, stable and 
immunologically safe insulin for diabetes therapy. 
Platypus insulin and the HB 10D mutant have been chemically synthesised (Chapter 4) 
based on its known sequence. Sufficient material has been obtained for in vitro biological 
activity tests (Chapter 4) and self-association studies in solution (Chapter 5). 
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Chapter 4 
Total Chemical Synthesis and Characterisation of Platypus and 
HBlOD Platypus Insulins 
4.1 Introduction 
Platypus insulin has been isolated to purity by others but the amount obtained was very 
limited; being sufficient only to determine the amino-acid sequence and mass (Nourse et 
al., 1996). 
To investigate the biological and physico-chemical properties of platypus insulin 
relatively large amounts (mg quantities) of insulin were needed. For ethical and moral 
reasons the purification of insulin from its natural source, the pancreases of platypus, was 
not contemplated on this scale since it is a unique and protected animal of Australia and 
pancreas are available only rarely from animals that have died of natural causes. 
Alternative means of obtaining the required amounts of this insulin were contemplated, 
namely by chemical synthesis and DNA recombinant technology. For these studies its 
synthesis by totally chemical means was chosen. This had the potential advantage of 
being able to make mutants of the insulin using non-natural amino-acids. 
The A- and B-chains were synthesised separately by an automatic solid phase peptide 
synthesiser using standard Fmoc chemistry and acetamidomethyl (Acm) protection of 
cysteines Cys A6, Cys Al 1, Cys A20 and Cys B 19. The sulfhydryl groups of the other 
cysteines Cys A 7 and Cys B 7 were not protected. In the synthesis a strategy of the 
stepwise semi-regioselective formation of the disulfide bonds was employed. This 
strategy was based on the chemical synthesis of bombyxin II (an insulin-like molecule) 
(Nagata et al., 1992). The CysA7-CysB7 disulfide bond was formed first, followed by 
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the removal of Acm groups on the other cysteines and concomitant formation of the two 
disulfide bonds by means of iodine oxidation. 
Although the published methods work for synthesising bombyxin it was found that they 
were not suitable for synthesising platypus insulin. With platypus it was necessary to 
introduce numerous critical modifications and optimise other reaction steps. These for 
the AB chain combination reaction were: 
• Addition of acetonitrile to the prescribed buffers to aid solubilization of 
the A- and B-chain derivatives 
• An accurate determination of the A- and B-chain molar ratios. 
Other modifications were: 
• More dilute reaction mixtures for all reaction steps than prescribed by 
Nagata et al. (Nagata et al., 1992) 
• Optimising the reaction time of the oxidation reaction responsible for the 
formation of the other two disulfide bonds. This was found to be longer 
with platypus and even longer for the mutant platypus insulin 
• Modifying the RP-HPLC separation conditions and gradient for 
purification of the final reaction product, namely insulin. 
The method of total chemical synthesis employed yielded mg quantities of purified 
platypus insulin. Preliminary investigations into the self-association of synthetic platypus 
insulin by sedimentation analysis pointed to some reduction in the self-association at the 
dimer-dimer intetface compared to bovine insulin (Chapter 5). Furthermore, observed 
differences in the spatial arrangement of residues in this interface of the molecular model 
(Chapter 3) also suggested that the contribution to the self-associating properties of this 
region may be lowered. This prompted an investigation of the properties of the dimer-
dimer intetface with platypus insulin analogues designed to probe that region. It was 
anticipated that the introduction of different residues, including non-proteinogenic amino-
acids, into this interface would modulate self-association without having an adverse 
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effect on the biological activity. Consequently the total chemical synthesis of HB lOD 
platypus insulin (B 10 His is substituted for an Asp in the dimer-dimer interface) was also 
undertaken to analyse the self-association pattern of this mutant. A similar HB 1 OD 
human insulin (Schwartz et al., 1987) displayed a reduction in self-association properties 
(Weiss et al., 1991) but at the same time had increased biological activity in vitro. 
Both synthetic insulins were obtained in a pure form and biological activity and the 
circular dichroism spectra were determined. 
4.2 Materials and methods 
4.2.1 The total chemical syntheses of platypus and HB 1 OD platypus insulin. 
4.2.1.1 Materials 
Protected amino-acids, Fmoc-Asn-OCH2 phenoxymethyl and Fmoc-Met-OCH2 
phenoxymethyl resin were purchased from Applied Biosystems (Applied Biosystems Inc., 
Foster City, CA, U.S.A.). 2,2'-dithiodipyridine(DTDP) was from Sigma (Sigma Chemical 
Company, Sigma-Aldrich Pty Ltd., Castle Hill, NSW, Australia) and 
a-cyano-4-hydroxycinnamic acid from Aldrich (Aldrich Chemical Company Inc., Castle 
Hill, NSW, Australia). Collagenase A (from C. histolyticum) was from Boehringer 
Mannheim (Boehringer Mannheim Australia Pty Ltd., Castle Hill, NSW, Australia). 
Other reagents and solvents were of the highest quality available and were used without 
further purification. 
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4.2. l .2 Analytical procedures 
Preparative HPLC 
All the preparative reversed phase (RP) HPLC experiments were performed with a 
BIO-RAD Model 700 Chromatography Work Station (Bio-Rad Laboratories, Richmond, 
CA, U.S.A) with 1355T Soft-Start pumps and a Bio-Rad Model 1706 UVNIS Monitor. 
Samples (peptides) were applied to a 5x300 mm C8 83-323-CHO I 0087 Dynamax-300A 
pore column (25x300 mm) from Rainin (Rainin Instrument Co. Inc., Emerville, CA, 
U.S.A), eluted at room temperature at a flow rate of 24 ml/min by gradients of 
acetonitrile (CH3CN) and monitored at 215 nm. Mass spectra of respective peaks were 
obtained and analysed by matrix-assisted laser desorption ionisation time of flight-mass 
spectrometry (MALDI-TOF-MS) using a VG Tofspec Fisons Analytical Instrument 
(Fisons Instruments, Manchester, England). 
The separation conditions (buffers and gradients) of the peptides on the preparative 
RP-HPLC column are shown in Tables 4.1 and 2. The various peaks were collected, 
molecular mass analysis performed to confirm the identities of the appropriate peptides, 
usually in the major peaks, (Table 4.4) and lyophilised. The peaks containing 
[Cys(Acm)A6, All, A20] A-chain, [Cys(Acm)819] and [Cys(Acm)819][HB 10D] B-chains 
were lyophilised in the presence of 0.1 % (v/v) ~-mercaptoethanol to prevent oxidation. 
Analytical HPLC 
Analytical RP-HPLC was performed with a BIO-RAD Model 700 Chromatography 
Work Station with 1350T Soft-Start pumps and a Bio-Rad Model 1706 UV/VIS 
Monitor. Both platypus and HB 1 OD platypus insulin were individually applied to a 
Waters RCM column (8x10 mm, Millipore), eluted at room temperature at a flow rate 
of 1 ml/min in 0.09% TFA with a linear 10-50% CH3CN gradient within 30 minutes 
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and monitored at 214 nm. Ultimate product purity was assessed by analytical RP-HPLC, 
mass analysis and high perfonnance capillary electrophoresis (HPCE). 
4.2.1.3 Total chemical synthesis of platypus and HB 10D platypus insulin 
4.2.1.3.1 Strategy of semi-regioselective disulfide bond formation 
The strategy of the semi-regioselective disulfide bond fonnation of insulin is shown in a 
diagram (Figure 4.1 ). This strategy was followed for both the syntheses of the native and 
mutant platypus insulin. The [Cys(Acm)A6, AI 1' A20] A-chain (S-Acm A-chain) and the 
[Cys(Acm)819] B-chains (S-Acm B-chain) were synthesised separately by an automatic 
solid phase peptide synthesiser. During the synthesis the trityl-function was used as a 
protecting group for the sulfhydryl groups of cysteines Cys A 7 and Cys B7 and the 
acetamidomethyl for Cys A6, Al 1, A20 and Cys B 19. Trityl is TFA labile while 
acetamidomethyl is 12 labile (Nagata et al., 1992). Cleavage of the peptides from the resin 
II: support by standard TF A methods (King et al., 1990; Applied Biosystems, 1988) 
removed all protecting groups except the S-Acm groups and left free the thiol functions 
of the Cys A7 S-Acm A-chain and the Cys B7 of the S-Acm B-chain. The free thiols of 
Cys B7 of the S-Acm B-chain peptides were first subjected to S-2-pyridinesulfenylation 
with 2,2'-dithiodipyridine (DTDP) (Nagata et al., 1992; Maruyama et al., 1990) to give 
[Cys(Acm)819, Cys(S-Pyr)87] B-chain which were then coupled with equivalent amounts 
of [Cys(Acm)A6,A 11 A20] A-chain to yield the disulfide bond CysA7-CysB7 of 
[Cys(Acm)A6, Al 1• A2o, 819] insulin (Ruiz-Gayo et al., 1988). The S-Acm groups were then 
removed and the other disulfide bonds f onned by iodine oxidation in glacial acetic acid 
and HCl (Nagata et al., 1992; Kamber et al., 1980). 
4.2.1.3.2 Solid-phase synthesis of the peptide chains 
The solid phase peptide synthesis of [Cys(Acm)A6, All, A20] A-chain, [Cys(Acm)819] and 
[Cys(Acm)819][HB 10D] B-chains of platypus and HB 10D platypus insulin were carried 
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Figure 4.1 
Strategy of the semi-regioselective disulfide bond formation. 
Figure 4.1 
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out on a Model 430A peptide synthesiser (Applied Biosystems, Foster City, CA, U .S.A) 
using the Fmoc a-amino group protecting strategy (Chang and Meienhofer, 1978; Fields 
and Noble, 1990). The following amino-acid derivatives requiring side chain protection 
were used; Fmoc-L-Cys (Acm) for insulin chain A positions 6, 11, and 20 as well as 
chain B positions 19; Fmoc-L-Glu (OtBu)-OH; Fmoc-L-Cys(Trt)-OH for insulin chain A 
and B position 7 ; Fmoc -L-Lys(Boc)-OH; Fmoc-L-Ser(tBu)-OH; 
Fmoc-L-Tyr(tBu)-OH; Fmoc-L-Asn(Trt); Fmoc-L-Asp(OtBu)-OH; 
Fmoc-L-Arg(PMC)-OH; Fmoc-L-His(Trt)-OH. Activation was with 
N,N-dicyclohexylcarbodiimide (DCC) and hydroxybenzotriazole (HOBt) to form an 
HOBt active ester. 0.1 M Dimethylaminopyridine/N,N-Dimethylformamide acting as a 
catalyst was used for the loading of an amino-acid onto the 
I-IMP-resin (4-hydroxymethylphenoxymethyl polystyrene resin) 
(HMP, 025 mmole, 0.250 g). Coupling was performed in 
N-methyl-2-pyrrolidone (NMP) the major solvent for approximately 61 minutes. A 
capping step with acetic anhydride was included after each cycle to ensure chain-
termination in the event of incomplete coupling, thus reducing the possibility of obtaining 
peptides lacking only a single amino-acid residue (deletion products) which might be 
difficult to resolve from the target peptide. Double couplings were used right through 
and the percentage stepwise coupling was greater than 95%, as ascertained by ninhydrin 
analysis (Sarin et al., 1981). 
4.2.1.3.3 Cleavage of peptides from the resin 
The TFA cleavage procedure was as follows for each peptide: The cleavage mixtures, 
containing 0.75 g crystalline phenol, 0.25 mL ethanedithiol (EDT), 0.5 mL thioanosole, 
0.5 mL D.I. H20 and 10 mL TFA each, were cooled (in ice) to give 10 mL reaction 
volumes per 0.1 - 1.5 g peptide - resins. The cleavage mixtures were added to cooled 
dried peptide-resins under argon and mixtures were allowed to reach room temperature. 
Gentle argon flow over the mixtures was maintained to minimise oxidation and stirred at 
room tern perature for 1.5 hours. The peptides were isolated by filtration. The reaction 
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mixtures were then vacuum filtered through a medium-porosity, fritted glass funnel to 
separate them from the resin supports. The remaining resins were washed with 1 mL 
TFA. The filtrates were concentrated on a rotary evaporator under high vacuum to 
volumes of approximately 1 to 2 mL. The temperature of the water bath was maintained 
below 40 °C to prevent damage of the peptides. 50 mL of cold ethanol was added to 
concentrated reaction mixtures to precipitate the peptides. 
Collection and purification of [Cys(Acm)A6, All, A20 J A-chain 
This A-chain derivative was collected by filtration, dried and redissolved in 10 mL 
3 M Guanidinium/thiocyanate, 100 mM KH2PO4 pH 4.0, and the pH was adjusted to 7 to 
aid dissolution. This represented the aqueous phase. The phenol and other organic 
chemicals were extracted with chloroform and methanol followed by tert-butyl methyl 
ether. The A-chain derivative was dissolved in the aqueous phase and isolated from this 
phase by a preparative RP-HPLC column, purification method I (Table 4.1 and 2). 
~-mercaptoethanol was added to prevent oxidation before lyophilising. Analysis by 
MALDI mass spectrometry confirmed a molecular mass of 2598 daltons. 
Collection and purification of [ Cys( Acm)819] and 
[Cys(Acm)
819
][HBJOD} B-chains 
After filtering and drying, the native and mutant B-chain derivatives were further purified 
separately. The peptides were dissolved separately in about 15 mL glacial acetic acid, the 
solutions diluted to 40% acetic acid, centrifuged (the precipitates contained minimal 
amounts of peptide) and the supematants applied to a 51x16 mm (i.d.) Sephadex 010 
column. The [Cys(Acm)B19][HB10D] B-chain was markedly less soluble under these 
conditions. The peptides were eluted in 40% acetic acid and collected in the void volume 
peak. ~-mercaptoethanol was added to prevent oxidation and the peptides lyophilised. 
Analysis with the MALDI-TOF mass spectrometer confirmed molecular masses of 3557 
and 3535 daltons for [Cys(Acm)B19] and [Cys(Acm)B19] [HB 1 OD] B-chain respectively. 
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The native and mutant B-chain derivatives were further purified on a preparative 
RP-HPLC column as follows. The lyophilisates were dissolved separately, firstly in 
CH3CN plus 0.09% TFA, sonicated and this diluted to 20% CH3CN plus 0.09% aqueous 
TFA, (total volume of 100 mL; approx. 0.75 mg/mL and 260 mL; approx. 0.27 mg/mL 
respectively). The solutions were applied separately to the column in several runs. The 
purification methods II and III (Table 4.1 and 2) for the native and mutant B-chain 
derivatives respectively were used. The identities of the peptides eluted in the major 
peaks of different runs were confirmed by molecular mass analysis (3557 and 
3535 daltons respectively). 
4.2.1.3.4 S-2-Pyridinesulfenylation of both native and mutant 
[Cys(Acm)819]B-chains at Cys B7 to form their 
[Cys(Acm)819, Cys(S-Pyr)87] B-chain derivatives 
The S-2-Pyridinesulfenylation of each of [Cys(Acm)819] native and 
[Cys(Acm)819][HB10D] B-chains was carried out using 50 mg (14 µmole) and 25 mg 
(7 .1 µmole) respectively of each of the peptides by the following procedure: The process 
involved making two solutions. In one the particular peptide was first dissolved in 
0.5 M ammonium acetate buffer (pH 4.0)/acetonitrile (65:35; v/v, 100 mL ). In the other 
2,2'-Dithiodipyridine (DTDP, 330 mg) was dissolved in acetonitrile ( 17.5 ml) to which 
was added 0.5 M ammonium acetate buffer (pH 4.0, 32.5 ml) to give a 30 mM DTDP 
solution. The two solutions were added together and the mixture stirred at room 
temperature for 20 minutes. The [Cys(Acm)819 , Cys(S-Pyr)87] [HB 10D] B-chain was less 
soluble and stirring needed to be continued for another 40 minutes. The resulting peptide 
solutions were first diluted to 20% CH3CN with 0.09% aqueous TF A and then subjected 
to preparative RP-HPLC using purification method II for the native B-chain derivative 
and III for the mutant B-chain derivative. The appropriate peak containing the 
[Cys(Acm)
819
, Cys(S-Pyr)87] B-chain of both the native and the mutant samples was 
collected, lyophilised and their molecular masses confirmed by mass analysis as 3667 and 
69 
Table 4.1: Buffers with gradients used during the synthesis: Method I-IV; starting buffer A for 2 minutes 
Method V-VI; starting buffer A for 8 minutes. 
Method Buffer A 
I 5 % CH1CN in 30 % aqueous TEAA 
II 0.09 % TFA in 20 % aqueous CH1CN 
III 0.09 % TFA in 20 % aqueous CH1CN 
IV 0.09 % TFA in 10 % aqueous CH1CN 
V 20 % CH1CN in 100 mM H3POi 
20 mM TEA/50 mM NaC1O4 pH 3.0 
VI 20 % CH1CN in 100 mM H3POi 
20 mM TEA/50 mM NaC1O4 pH 3.0 
Buffer B 
CH1CN 
0.09 % TFA in CH1CN 
0.09 % TFA in CH1CN 
0.09 % TFA in CH1CN 
40 % CH1CN in 100 mM H3PO4/ 
20 mM TEA/50 mM NaC1O4 pH 3.0 
40 % CH1CN inl00 mM H3PO4/ 
20 mM TEA/50 mM NaC1O4 pH 3.0 
Gradient 
5-40 % CH1CN (30 min) 
20-60 % CH1CN (30 min) 
20-50 % CH1CN (30 min) 
10-60 % CH1CN (30 min) 
20-28 % CH1CN (2 min); 
28-33 % CH1CN (30 min); 
33- 40 % CH1CN (2 min); 
40 % CH1CN (8 min). 
20-29 % CH1CN (2 min); 
29-34 % CH1CN (30 min); 
34- 40 % CH1CN (2 min); 
40 % CH1CN (8 min). 
Table 4.2: Methods used in the preparative RP-HPLC purification of peptides 
Method Peptide/Protein 
I [Cys(Acm)A6, AI I, A2o] A-chain 
II [Cys(Acm)B 19] B chain 
B19 B7 . [Cys(Acm) , Cys(S-Pyr) ] B cham 
A6 All A20 B19 . . [Cys(Acm) ' ' ' ] platypus mulin 
III [Cys(Acm)B 19] [HB 1 OD] B-chain 
[Cys(Acm)B 19, Cys(S-Pyr)B7] [HB 1 OD] B-chain 
A6 All A20 B19 . . [Cys(Acm) ' ' ' ][HBlOD] platypus msulm 
IV Platypus and HB 1 OD platypus insulin ( desalting step) 
V Platypus insulin 02 oxidation step) 
VI HB 1 OD platypus insulin 02 oxidation step) 
3645 daltons respectively. The B-chain mutant derivative was less soluble in these 
solvents. 
4.2.1.3.5 The combination of [Cys(Acm)A6, All, A20]A-chain with 
[Cys(Acm)819, Cys(S-Pyr)87] B-chain of native or mutant to give their 
. [C (A )A6 Al I A20 B19] . 1· respective ys cm ' ' ' insu ins 
Molar ratios are critical to the outcome of this bond formation reaction. Amino-acid 
analysis (performed by the Biomolecular Resource Facility at the John Curtin School of 
Medical Research, Institute of Advanced Studies, Australian National University, 
Australia) was used to measure accurately the concentrations of the solutions containing 
the relevant peptides. From this the molar extinction coefficients of 1.0 M peptide 
solutions at 280 nm in the particular solvent had been calculated; £i80=165OO M-1 cm-1 for 
[Cys(Acm)819, Cys(S-Pyr)87] B-chain in 40% CH3CN, 0.5 M Tris·HCI, pH 8.6 and 
A6 All A20 . · lj· Eiso=43OO M-1 cm-1 for [Cys(Acm) ' ' ] A-chain in 4O% CH3CN, 5 mM HCI. In the 
concentration measurements of the mutant B-chain derivative the Eiso of the native 
B-chain derivative was used. 
The [Cys(Acm)819, Cys(S-Pyr)87] B-chains of each of the native and mutant preparations 
were dissolved in 40% CH3CN plus 0.5 M Tris·HCI, pH 8.6. With the native sample 
· 12 µmole (44 mg) was dissolved in 20 mL while with the mutant 2.7 µmole (10 mg) was 
dissolved in 32 mL. [Cys(Acm)A6, All, A20] A-chain was dissolved in 40% CH3CN plus 
5 mM HCI. For that to be used with the native B-chain derivative sample an equimolar 
amount (31 mg) was dissolved in 30 mL while with the mutant 14 mg was dissolved in 48 
mL giving a B/ A chain molar ratio of 1.4. To combine the chains the solutions of 
[Cys(Acm)A6, All, A20] A-chain were added dropwise to the solutions of 
[Cys(Acm)819, Cys(S-Pyr)87] B-chains of both the native and mutant samples separately 
with continuous mixing for 60 minutes at 45 °C. The resultant reaction mixtures ( total 
volume 50 mL and 80 mL for the native and mutant respectively) were diluted with an 
equal volume of 0.09% aqueous TFA to give a 20% CH3CN solution and subjected to 
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preparative RP-HPLC. The purification method II was used for the native sample and 
method III for the mutant sample (Table 4.1 and 2). The main peaks were collected and 
- A6 All A20 Bl9 confirmed to be [Cys(Acm) ' ' ' ] platypus and 
[Cys(Acm)A6, AI 1• A20,BI9][HB 1 OD] platypus insulin by molecular mass analysis where the 
mass values were measured to be 6153 and 6131 daltons respectively. 
4.2.1.3.6 Iodine oxidation of both native and mutant 
[C (A )A6 Al I A20 B19] 1 . li . . d ys cm ' · · p atypus 1nsu n to give nauve an mutant 
platypus insulins 
50 mg (8 µmole) of [Cys(Acm)A6, AI 1, A2o, B19] platypus and 15 mg (2.4 µmole) 
[Cys(Acm)A6, AI 1· A2o, B19][HB 1OD] platypus insulins respectively were dissolved in 
1.5 mL and 3 mL H20, after which glacial acetic acid (10.5 mL and 21 mL respectively) 
and 2 M HCl (60 and 120 µL respectively) were added. A solution of iodine, 13 mM, in 
glacial acetic acid ( 18 mL and 36 mL respectively), was added dropwise to these 
solutions with continual shaking at 45 °C, and continued for 60 minutes with the native 
and 90 minutes with the mutant. The oxidation reaction was terminated by the addition of 
0.25 ML-ascorbic acid (6 mL and 12 mL respectively). The acetic acid was evaporated 
off in a vacuum centrifuge, the Speed-Vac concentrator (Savant Instruments Inc., 
Hicksville, NY, U.S.A), until the volumes were 1 mL and 8 mL respectively. To these 
concentrated solutions a further addition of 0.25 M L-ascorbic acid ( 1 mL and 3.6 mL 
respectively) was made to ensure the reduction of all the iodine. These reaction mixtures 
were diluted with 18 mL and 15 mL, respectively, of 100 mM H3P04 /20 mM 
Triethylamine/5O mM NaC104 at pH 3.0 buffer containing 20% CH3CN. The diluted 
samples were in tum applied to a preparative RP-HPLC column and purified using 
method V for native platypus and VI for the mutant platypus insulin (Table 4.1 and 2). In 
both cases essentially two major peaks were eluted, the smaller, at 31 % CH3CN (33% in 
the case of the mutant) and the larger at 40% CH3CN (Figure 4.9 and Figure 4.10). The 
31 % or 33% CH3CN peaks containing respectively the native and HB 1OD mutant 
platypus insulins. These were lyophilised and desalted in tum on a preparative RP-HPLC 
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column using method IV for the native sample and III for the mutant sample (Table 4.1 
and 2). They eluted as a single symmetrical Gaussian peak that contained the specific 
insulin. These were confirmed by molecular mass analysis. (Found 5865; expected 
5865 daltons for native platypus insulin and found 5844; expected 5843 daltons for the 
mutant.) 
4.2.2 Characterisation of the synthesis products 
4.2.2.1 Mass analysis of peptides 
Mass analysis of peptides was performed using a matrix-assisted laser desorption 
ionisation time of flight mass spectrometer (MALDI-TOF-MS) with a maximum 
, power > 180 µJ. (It is a linear time of flight spectrometer that uses an ultraviolet 
~'. nitrogen laser. The laser beam is approximately 150-400 µm2 in size and power is 
continually variable by means of a diaphragm.) Positive molecular ions were detected in 
linear mode, with excitation at 330 nm when the sample was mixed with 
a-cyano-4-hydroxycinnamic acid matrix in 40% CH3CN and crystallised on a target. 
A sufficient amount (a speck on the tip of a spatula) of each peptide (lyophilised) to 
give a definable signal in the MALDI-TOF-MS was dissolved in 40% CH3CN/H20 
(concentration in the pico molar range). The following calibration compounds were 
used as either internal or external references: GramicidinS (Sigma), FW 1141.5; 
(M + H)+ 1142.5 and bovine insulin (Sigma), FW 5733.5; (M + H)+ 5734.5; 
(M + 2H)2+ 2867 .75 daltons. Calibration compounds or unknown peptides were 
prepared together or separately for internal or external calibration by mixing 1-2 µL 
peptide solution(s) with about 10 µL of saturated matrix solution. The mixtures (3.5 µL) 
were crystallised on a stainless steel mass spectrometer target before loading onto the 
magnetic probe of the mass spectrometer. Mass spectra were obtained, calibrated with 
either the internal or external calibration compounds and the mass of the unknown 
noted. 
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4.2.2.2 Biological characterisation of synthetic insulins 
Insulin stimulated lipogenesis was measured by the method of Moody et al. (Moody et 
al., 1974) as the incorporation of [3-3H]D-glucose into toluene-extractable lipids of rat 
epididymal fat cells. The [3-3H]D-glucose was obtained from Amersham (Amersham 
International pie, Buckinghamshire, England) and the specific activity of the batch was 
73 .5 mCi/mg. 
Isolation of Adipocytes 
Adipocytes were isolated from epididymal fat pads of 2 male Sprague-Dawley rats 
(weight approximately 150 g) fed ad libitum. Fat pads were digested by gentle agitation 
of sliced tissues for 45 minutes in a Krebs-Ringer-Bicarbonate buffer containing 
IO mM HEPES, 1.5 mg/mL collagenase A, 0.55 mM glucose and 35 mg/mL bovine 
serum albumin (fatty acid free, fraction V, from Sigma) at pH 7 .4. The cell suspension 
was then passed through a nylon mesh (200 micron) and washed 3 times with 
Krebs-Ringer-Bicarbonate-HEPES (KRBH) buffer pH 7.4 containing 1.5% bovine serum 
albumin (BSA) with the last wash containing 3% BSA at room temperature. The cell 
suspension was diluted for use in the assay with KRBH buffer pH7 .4 and the 
concentration (mg dry-weight cells/ mL) determined by weighing a blotted aliquot of cell 
suspension on filter paper after drying in a desiccator. 
[3-
3
HJD-glucose incorporation into cellular lipids 
Cell suspensions (0.5 mL, corresponding to 10-20 mg dry-weight cells) (Joshi et al., 
1990) and varying concentrations of insulin ( 10 µL ) were pre incubated in 5 ml 
polyethylene vials for 15 minutes at 37 °c in KRBH pH 7.4 buffer containing 3% BSA. 
The gas phase was 95% 0 2; 5% CO2 . [3-
3H]D-glucose ( 10 µL) was then added (final 
concentration 1.0 µCi/mL) and incubation continued in the presence of 95% 0 2; 5% CO2 
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for 60 minutes. The reaction was stopped by the addition of 4 mL of toluene-based liquid 
scintillant Econofluor (Du Pont Australia Ltd, Sydney, Australia) suitable for 
radioactivity measurements in non-aqueous solutions, thus extracting the newly formed 
3H-lipid without interference from water-soluble [3-3H]D-glucose. Counting was in a 
Packard Tri-Carb 460. A standardised dose response curve of porcine insulin (Sigma) 
was constructed with the same cells. Duplicate experiments were performed and the data 
points for each indicated concentration represent the mean of duplicate determinations 
(Figures 4.16 and 4.17). Stimulation, expressed as percent of maximum, was plotted as a 
function of insulin concentration and data points were fitted to the sigmoidal equation of 
the program GraphPadPRISM with a non-linear regression algorithm and ED50 (the 
log[Dose] when response =50%) values for all the insulins calculated with this program 
(GraphPad Software, San Diego, CA, U.S.A). The relative potency on a molar basis for 
the synthetic insulins were calculated as fallows: 
Relative % Activity = ED50 (Porcine Insulin)/ED50 (Synthetic Insulin) x 100 
(Equation 4.1) 
4.2.2.3 Biophysical characterisation of synthetic insulins 
Circular dichroism spectra of synthetic insulins 
The secondary structure of the synthetic insulins were investigated using circular 
dichroism (CD). CD spectra were recorded with a Jobin-Yvon Mark V dichrograph 
calibrated with (+)-10-camphorsulfonic acid. The buffer used was 1.0 mM HCl pH 3.2. 
All insulin concentrations were determined photometrically (Varian Techtron 634) using 
the molar extinction coefficient, £276=6200 M-1 cm-1, at 276 nm (Frank and Veros, 1968). 
All spectra were recorded at room temperature. Far-UV CD spectra were scanned from 
185 nm to 250 nm, using a cell with a pathlength of 0.05 cm and the concentration of 
porcine, synthetic platypus and HB 1 OD platypus insulins were 25, 24 and 50 µM 
respectively. All spectra were smoothed before subtraction of the appropriate solvent 
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blanks. The CD data (in differential dichroic absorption, ilE (M-1 cm-1)) were converted 
to mean residue ellipticity ([S]MRW) using a mean residue weight (MR) of 112 for both 
native and mutant platypus insulin according to the following formula: 
[0]MRW = (0°)(MR)/1O[C](L) 4.2 
where 0° is the observed rotation in millidegrees, MR is the mean residual weight in 
daltons, C is the protein concentration in mg/mL, L is the cell path length in centimetres, 
and [0]MRW is mean residue ellipticity and has the units of deg cm2/dmole (Adler et al., 
1973). The converted data was then plotted as [0] MRW versus wavelength (run) and the 
[0Ji0gl[0]223 ratios were calculated with the GraphPadPRISM program. (For more details 
about this program see Chapter 5). 
4.3 Results 
4.3.1 Total chemical synthesis of platypus and HB 1 OD platypus insulin 
4.3.1.1 Solid-phase synthesis of the peptide chains 
The peptide chains, [Cys(Acm)A6, All , A20] A-chain; [Cys(Acm)819] native and 
[Cys(Acm)819][HB 10D] B-chains, were synthesised by the solid -phase method using the 
Fmoc a-amino group protecting strategy (Chang and Meienhofer, 1978; Fields and 
Noble, 1990). The final weights of the peptides ( on the resin) for the A-chain, native 
B-chain and mutant B-chain were 69 mg, 92 mg and 83 mg respectively and the % yields 
calculated from the theoretical yields of resin-peptide 75.3, 72.6 and 68.8% respectively 
(Table 4.3). After cleavage of the peptides from the resin the A-chain was partially 
purified on a preparative RP-HPLC column (Figure 4.2) and the native and mutant 
B-chains in tum on a Sephadex G 10 column followed by a preparative RP-HPLC column 
(Figures 4.3 and 4). The total weight yields for the A-chain and the native and mutant 
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Figure 4.2 
Preparative RP-HPLC of the resin-cleaved [Cys(Acm)A6, All , A20J A-chain of 
platypus insulin (arrow) on a Dynamax-300A pore column at 24 mUmin. 
Purification method I (Table 4.1 and 2) was followed. The A-chain eluted at 
approximately 28% CH3CN. 
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Figure 4.3 
Preparative RP-HPLC of [Cys(Acm)819] B-chain of platypus insulin (arrow). 
Purification method II (Table 4.1 and 2) was followed. The B-chain eluted at 
approximately 45% CH3CN. 
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Figure 4.4 
Preparative RP-HPLC of 
[Cys(Acm)
819
][HB 1 OD] B-chain of platypus insulin (arrow). Purification 
method III (Table 4.1 and 2) was followed. The B-chain eluted at approximately 
38% CH3CN. 
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B-chains were approximately 50 mg, 65 mg and 45 mg respectively. Some weight 
determinations are only approximations based on the summation of the peak areas 
(RP-HPLC chromatograms) of all the runs of the relevant peptide (See superscript d) , 
Table 4.3). A reduced yield was obtained with the mutant B-chain, as judged from the 
chromatogram (Figure 4.4) which displayed many minor and two major peaks of which 
only one of the latter contain the correct peptide as ascertained by mass analysis. This 
background of impurity found with the automated peptide synthesis of the mutant 
B-chain is probably contaminant peptides with incorrect sequences; the result of 
accidental double additions due to the double couple strategy employed. 
4.3.1.2 S-2-pyridinesulfenylation of the B-chains 
The success of the S-2-pyridinesulfenylation of the native [Cys(Acm)B 19] B-chain can be 
judged from the chromatographic profile shown in Figure 4.5, where it is seen that the 
[Cys(Acm)B 19, Cys(S-Pyr)87] B-chain eluted essentially as a single peak. The yield 
obtained with this peptide by this method was in the order of 90% (Table 4.3), a yield 
which is in good agreement with that obtained for other similar peptides (Nagata et al., 
1992). 
The S-2-pyridinesulfenylation of the [Cys(Acm)B 19][HB 10D] B-chain was more 
problematic since the peptide(s) were significantly less soluble in the reaction mixture. 
The chromatogram of the partial purification showed two peaks with the lesser front 
peak containing the correct synthesis product [Cys(Acm)819 , Cys(S-Pyr)B7][HB 10D] 
B-chain (Figure 4.6) as shown by mass analysis. The peptide(s) in the second peak, 
probably some are isomers and truncated peptides, were also S-2-pyridinesulfenylated as 
ascertained by the Ellman method (Ellman, 1959). The presence of contaminants resulted 
in a low yield of the correct peptide. Total weight yields are shown in Table 4.3. 
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Table 4.3a: Approximate total weight and percentage yields of each step of the synthetic process. 
Synthetic Platypus Insulin 
[Cys(Acm)A6, All, A2o] A-chain (on resin) (Resin-peptide • peptide) 
[Cys(Acm) A6, All , A2o] A-chain (Cleavage from resin • RP HPLC) 
[Cys(Acm)B 19] B-chain (on resin) (Resin-peptide • peptide) 
[Cys(Acm)B 19] B-chain (Gl0 • RP HPLC) 
[Cys(Acm)B 19, Cys(S-Pyr)B7] B-chain 
(S-2-pyridinesulfenylation • RP HPLC) 
[Cys(Acm)A6, All , A2o, B19] Insulin (CysA7-CysB7 • RP HPLC) 
Insulin (Iodine oxidation • RP HPLC) 
Wt (mg) Start 
69 a) 
ND 
92 a) 
75 b) 
65 d) 
44 (B-chain) 
31 (A-chain) c) 
50 d) 
Wt (mg) Final 
ND 
50 d) 
ND 
65 d) 
60 d) 
50 d) 
3.5 d) 
% Yield 
72 
87 (70) d) 
92 
67 
7 .0 d) (8 t) 
Table 4.3b: Approximate total weight and percentage yields of each step of the synthetic process. 
Synthetic HB 1 OD Platypus Insulin 
[Cys(Acm)A6, All, A2o] A-chain (Cleavage resin • RP HPLC) 
[Cys(Acm)B 19] B-chain (on resin) (Resin-peptide • peptide) 
[Cys(Acm)B 19] B-chain (GlO • RP HPLC) 
Bl9 B7 . [Cys(Acm) , Cys(S-Pyr) ] B-cham 
(2-S-pyridinesulfenylation • RP HPLC) 
[Cys(Acm)A6,A11,A20· B19] Ins (Cys A7-Cys B7 • RP HPLC) 
Insulin (Iodine oxidation • RP HPLC) 
Wt (mg) Start 
ND 
83 a) 
70 b) 
45 d) 
10 (B-chain) 
14 (A-chain) c) 
15 d) 
Wt (mg) Final 
50 
ND 
45 d) 
20 d) 
15 d) 
1.Q d) 
% Yield 
60 
44 
63 
6.7 d) (10) e) 
Figure 4.5 
Preparative RP-HPLC of [Cys(Acm)
819
, Cys(S-Pyr)87] B-chain of platypus 
insulin (arrow). Purification method II (Table 4.1 and 2) was followed. The B-
chain eluted at approximately 40% CH3CN. 
017 S£ 0£ 
I I 
0 I-
0 z-•-----
' ' 
' ' I 
' I 0 £-
' I 
' ' I 
' ' I 
0 .,_ ' 
' ' 
' ' I 
' ' 0 s-
' ' 
0 
' 
_, 
' 
,, 
' 
,, 
' 
,, 
', ,- ' 
,, 
9-' ,, ------
OL 
sz I 
,- _, 
,, 
(u flU) aw l.L 
oz I 
' ~ 
i, 
,, ,, 
,, ,, 
,, ,, 
,, 
t 
SI I 
I 
,, ,, 
_, 
01 s I 
~ ~ 
-
, ----- •• _, 
,, 
-,, ,, 
---- _, ., ,, ~, 
-- ,-
-
~ 
Figure 4.6 
Preparative RP-HPLC of [Cys(Acm)B 19 , Cys(S-Pyr)B7][HB10D] B-chain of 
platypus insulin (arrow). Purification method III (Table 4.1 and 2) was followed. 
The B-chain eluted at approximately 39% CH3CN. 
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4.3.1.3 Fonnation of the disulphide linked CysA 7-CysB7 dimer 
In order to obtain exclusively the heterodimer, the first disulfide bond fonnation between 
Cys A7 and Cys B7 was performed according to the method of Ruiz-Gayo et al. (Ruiz-
Gayo et al., 1988). First the native and mutant B-chains were subjected separately to 
S-2-pyridinesulfenylation at the unprotected Cys B7 (see above) and then coupled to the 
A-chain in 1.0 and 1.4 molar equivalents respectively to form the first disulfide bond 
. A6 All A20 B19 . CysA 7-CysB7 to yield [Cys(Acm) · · · ] native platypus and 
[Cys(Acm)A6, All , A2o, 819][HB 10D] platypus insulin. The first disulfide bond, 
CysA7-CysB7 coupling of both native and mutant A-B chains were performed in the 
buffers recommended by Nagata et al. (Nagata et al., 1992) but in 40% CH3CN to 
enhance the solubility of the peptides. The S-pyridinesulfenylated native B-chain 
especially, at the concentrations used, needed extensive sonication to facilitate 
dissolution. The addition of acetonitrile in this reaction mixture did not seem to adversely 
influence the coupling reaction as was evident in the final results of the synthesis. The 
chromatographic profiles of the purification of the [Cys(Acm)A6, All, A2o, 819] native 
platypus and [Cys(Acm)A6, All, A2o, 819] [HB 1 OD] platypus insulins are shown in 
Figures 4.7 and 4.8, and the weight yields were approximately 50 mg (67% yield) and 
15 mg (63%) respectively (Table 4.3). 
4.3.1.4 Subsequent disulfide bond fonnation between Cys A20-Cys B 19 and 
Cys A6-Cys A 11 
The remaining disulfide bonds were fanned by oxidative cleavage with iodine oxidation 
at 45 °C, a method developed by Kamber et al. (Kamber et al., 1980) in the same buffer, 
95% aqueous acetic acid containing HCl, that was used for the synthesis of bombyxin 
(Nagata et al., 1992). The reaction time of this oxidation reaction was optimised for the 
native and mutant platypus insulins and improved results were obtained by increasing the 
duration to 60 minutes and 90 minutes respectively (compared to 30 minutes used for the 
synthesis of bombyxin II). 
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Figure 4.7 
Preparative RP-HPLC of 
[Cys(Acm)A6, All , A2o, B 19] platypus insulin (arrow). Purification method II (Table 
4.1 and 2) was followed. The AB-chain eluted at approximately 39% CH3CN. 
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Figure 4.8 
Preparative RP-HPLC of 
[Cys(Acm)A6, Al 1• A2o, 819][HB 10D] platypus insulin (arrow). Purification method 
III (Table 4.1 and 2) was followed. The AB-chain eluted at approximately 370/( 
CH3CN. 
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4.3.1.5 Purification of synthesised native and mutant insulins 
The oxidation reaction gave 2 major peaks on the preparative RP-HPLC for both the 
native platypus (Figure 4.9) and HB 10D platypus insulins (Figure 4.10). The first peak, 
eluted on a linear 28-33% (native insulin) and a 29-34% (mutant insulin) CH3CN 
gradient in a buffer designed to separate insulins in general (Shoelson et al., 1983 ), was 
identified as insulin by mass analysis. The second major peak ( outside the gradient) gave 
multiple peaks on its mass spectrum. These were not further investigated. The identity of 
the native and mutant insulins were further indicated by the fact that mammalian insulins, 
namely bovine, human and pig, elute in the buffer and gradient (28-34% CH3CN) used 
(data not shown). No other peaks of significance were eluted in this gradient. 
4.3.1.6 Desalting of the native and mutant platypus insulin 
The native and mutant platypus insulins in turn were desalted by preparative RP-HPLC 
and separated out as a single Gaussian peak (Figures 4.11 and 12). The total mass yields 
for the native and mutant insulins, based on the mass yields of the corresponding 
[Cys(Acm)819, Cys(S-Pyr)87] B-chains were approximately 3.5 mg (8%) and 1 mg (10%) 
respectively (Table 4.3). 
4.3.1. 7 Purity of the synthetic insulin samples 
The purity of the synthetic insulins were verified by analytical RP-HPLC, mass analysis 
and high performance capillary electrophoresis (HPCE). 
On an analytical RP-HPLC column (conditions similar to that used in Figures 4.9 and 
4.10) the synthetic insulins had retention times similar to those of mammalian insulins, 
(bovine, porcine and human) and the peaks were single Gaussian peaks with no apparent 
contamination in the samples (not shown). 
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Figure 4.9 
Preparative RP-HPLC of platypus insulin (arrow). Purification method V (Table 
4.1 and 2) was followed. The insulin eluted at approximately 31 % CH3CN. 
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Figure 4.10 
Preparative RP-HPLC of [HB 1 OD] platypus insulin (arrow). Purification 
method V (Table 4.1 and 2) was followed. The insulin eluted at approximately 
33% CH3CN. 
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Figure 4.11 
Preparative RP-HPLC of platypus insulin (arrow). Purification method IV 
(Table 4.1 and 2) was followed. The insulin eluted at approximately 35% 
CH3CN. T_his is the desalting step. 
Ot S£ 0£ SI OI 0 I I 
I I I I I 
oo·o 
0 10·0 I-
i,.. 
-----, ----· ,, 
' . 
' ,, ' , 
zo·o 0 
£0·0 
0 
to·o 
' ,, 
' 
, 
' 
,, i,.. 
z-' ,, 
' 
,, 
' 
, 
' 
,, , 
' 
,, 
' ,, ... 
' ,, 
' 
, 
£-' ,, 
' 
,, 
' 
,, 
' 
, 
I ,, 
' ~' - • 
0 
so·o 
0 
' 
,, 
' 
,, 
1t,-' , 
' 
, 
' 
,, 
' 
,, 
' 
,, 
- , ' ,, 
' 
, 
' 
,, 
1S-' 
, ,, 
' ,, 
' ,, 
' - ' ,, 
' 
,, 
' ,, , 
' , 19-' ,, _____ .,,, 
i,.. 
90·0 
0 
Lo·o 
t OL so·o 
Figure 4.12 
Preparative RP-HPLC of [HBIOD] platypus insulin (arrow). Purification 
method IV (Table 4.1 and 2) was followed. The insulin eluted at approximately 
35% CH3CN. This is the desalting step. 
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Mass analysis of the synthetic insulin samples showed similar results, where only the two 
peaks as known with pure bovine insulin were obtained. These were (M+H)+ 5865; 
5844 daltons and (M+2H)2+ 2936; 2922 daltons respectively for synthetic native and 
mutant platypus insulins. The MALDI mass spectrum of the synthetic platypus insulin is 
shown in Figure 4.13. No contaminant peptides peaks were present and the sample was 
judged to be pure. The calibration compounds GramicidinS and bovine insulin were used 
as external references (Section 4.2.2). 
Analysis of the HPCE chromatograms of the synthetic insulins showed only single peaks 
(not shown). 
4.3. l .8 Yields of the products of synthesis. 
The approximate total weight and percentage yields of each step of the synthesis process 
are shown in Table 4.3. Not all the products of previous steps were used for subsequent 
steps. Superscripts are; 
ND Not determined. 
a) Dry weight accurately determined. 
b) Weight based on the peak area, determined at 280 nm, of peptide 
(B-chain) eluted from a G 10 Sephadex column. 
c) The concentrations of the A-chain and B-chain solutions were 
accurately determined by means of amino-acid analysis. 
d) The total weight determinations are only approximations based on 
the peak areas (related to concentrations in b) of the relevant 
RP-HPLC chromatograms. 
e) Overall yield from based on the corresponding 
B19 B7 . [Cys(Acm) , Cys(S-Pyr) ] B-chain. 
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Figure 4.13 
MALDI mass spectrum of the synthetic native platypus insulin. The calibration 
com pounds GramicidinS and bovine insulin were used as external references. 
The peaks are platypus insulin (M + H)+ 5865 and (M + 2H)2+ 2936 daltons 
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The relative yields of the native platypus insulin were 7% d) (based on 
[Cys(Acm)A6, Al 1' A2o, B19] native platypus insulin) and 8% e) (based on the 
[Cys(Acm)B 19, Cys(S-Pyr)B7] B-chain) while the relative yields of the mutant platypus 
insulin were 6.7% d) (based on [Cys(Acm)A6, All, A2o, B19] mutant platypus insulin) and 10 
) B 19 B7 · % e (based on the [Cys(Acm) , Cys(S-Pyr) ] mutant B-chain). 
4.3.1.9 Mass analysis of peptides 
All peaks of the chromatograms shown in Figures 4.2-12 were subjected to mass analysis 
for identification of the synthesis products. The results of the mass analysis of the 
appropriate chromatogram peaks are displayed in Table 4.4. and were within + 1-5 mass 
units of the calculated mass (in brackets). The MALDI mass spectra of the synthetic 
native and mutant platypus insulin are shown in Figures 4.14 and 4.15. The calibration 
compounds GramicidinS and bovine insulin were used as internal references (Section 
4.2.2). 
Mass analysis for th~ synthetic native and mutant platypus insulins produced the expected 
mass values (within+ of 2 mass units) of 5865 and 5843 daltons respectively. These 
values are in agreement with their primary amino-acid sequences. 
Mass analyses of some of the smaller chromatographic peaks of Figures 4.9 and 10 
(excluding the peaks that contain the positively identified synthetic insulins) yielded 
masses similar to the synthetic insulins. These are possibly insulin isomers formed during 
the iodine oxidation reaction, but the recovery yields were insufficient to warrant further 
characterisation. 
4.3.2 Biological activity of synthetic native and mutant platypus insulins 
The biological activity of porcine insulin was compared with platypus and HB 1 OD 
platypus insulin. The biological activity was plotted as % [3-3H]D-glucose incorporation 
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Figure 4.14 
MALDI mass spectrum of the synthetic native platypus insulin. The calibration 
compounds GramicidinS and bovine insulin were used as internal references. 
The peaks are: GramicidinS (M + H)+ 1139 daltons; bovine insulin (M + H)+ 
5737 and (M + 2H)2+ 2868 daltons; platypus insulin (M + H)+ 5864 and 
(M + 2H)2+ daltons. (See Table 4.4 for calculated mass values.) 
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Figure 4.15 
MALDI mass spectrum of the synthetic mutant HB 10D platypus insulin. The 
calibration compounds GramicidinS and bovine insulin were used as internal 
references. The peaks are: GramicidinS (M + H)+ 1143 daltons; bovine insulin 
(M + H)+ 5734 and (M + 2H)2+ 2868 daltons; HB 1 OD platypus insulin 
(M + H)+ 5847 and (M + 2H)2+ 2926 daltons. (See Table 4.4 for calculated 
mass values.) 
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Table 4.4: MALDI-TOF mass analysis (m/z) of peptides in daltons eluted from RP-HPLC columns. 
The calculated mass values are in brackets. 
Platypus Insulin HB 1 OD Platypus Insulin 
[Cys(Acm)A6, All, A2o] A-chain 2598 + 2 (2598) 2598 + 2 (2598) 
[Cys(Acm)819] B-chain 3557 + 5 (3557) 3535 + 3 (3535) 
B19 B7 . [Cys(Acm) ,Cys(S-Pyr) ] B-cham 3667 + 2 (3667) 3645 + 5 (3645) 
[Cys(Acm)A6, A11 , A20, B19] Insulin 6153 + 1 (6153) 6131 + 1 (6131) 
Insulin 5865 + 2 (5865) 5843 + 4 (5843) 
1·· 
into rat adipocytes versus log insulin concentration (Figures 4.16 and 17). The 
GraphPadPRISM program was used to calculate ED50• These values for porcine, 
platypus and HB 10D platypus insulin were 5.23 x 10 -10; 5.47 x 10 -10 and 2.56 x 10 -lO M 
respectively. The relative potency on a molar basis for native and HB lOD platypus insulin 
were 96 and 200% respectively. 
4.3.3 Biophysical characterisation of synthetic native and mutant platypus insulins 
Circular dichroism spectra of synthetic native and mutant platypus insulin 
A comparison of the CD spectra (far UV) of porcine, platypus and HBlOD platypus 
insulin at pH 3.2 are shown in Figure 4.18. It is clear that the features of the CD spectra 
of the two synthetic insulins are similar to that of porcine insulin in the same solution. It 
may thus be concluded that the final synthetic products are both correctly folded insulins. 
Enhanced concentration and association of insulin produce CD-spectral effects that have 
been observed in the CD spectra of the mutant platypus insulin, notably a decrease in the 
[0l20gl[0l223 ratio (Packer and Biswas, 1980); in fact the features are very similar to that 
of human insulin at pH 7.8 in the presence of zinc (Wollmer et al., 1994). The 
[0]z0g/[0l223 ratios for porcine, platypus and HB 1 OD platypus insulin are shown in (Table 
4.5). 
Table 4.5: CD data of porcine and synthetic insulins in 1.0 mM HCl, pH 3.2 
Platypus insulin 
HB 1 OD platypus insulin 
Porcine insulin 
Concentration (µM) 
24 
50 
25 
81 
[0120/[01223 
1.53 
1.21 
1.48 
Figure 4.16 
A comparison of the stimulation of lipogenesis (expressed as percent of the 
maximum) in isolated rat adipocytes by platypus and porcine insulin. Broken line 
( o) is porcine, solid line ( •) platypus insulin. 
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Figure 4.17 
A comparison of the stimulation of lipogenesis (expressed as percent of the 
maximum) in isolated rat adipocytes by HBIOD platypus and porcine insulin. 
Broken line ( o) is porcine, solid line ( • ) HB 1 OD platypus insulin. 
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Figure 4.18 
A comparison of the far UV CD spectra of porcine (-----), platypus ( -- ) and 
HB 10D platypus insulins (- - -) at 25, 24 and 50 µM respectively in 0.001 M 
HCl, pH 3.2. 
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4.4 Discussion 
Combination of the A- and B-chains 
In this synthesis the decision was to effect 2-S-pyridinesulfenylation of the B-chain rather 
than the A-chain as used by Nagata et al. in their synthesis of bombyxin-II (Nagata et al., 
1992). This was because multiple peptide peaks were observed in the mass spectra of the 
native B-chain derivative (and subsequently the mutant) eluted in the chromatographic 
step (Figures 4.3 and 4.4 ), leading to the conclusion that large amounts of contaminant 
peptides (produced during the automated peptide synthesis) might have been present. It 
was hoped that by 2-S-pyridinesulfenylation of the B-chain that its chromatographic 
properties (behaviour) might be altered in such a way that it could be separated from 
most of the contaminants; thus serving as a partial purification step. This strategy was to 
a certain extent justified but also, as a consequence of this these 2-S-pyridinesulfenylated 
B-chains in both cases were insoluble in the aqueous buffers prescribed. 
In order to facilitate the solubilization of the peptides, in particular the 
2-S-pyridinesulfenylated B-chains, the reaction of the combination of the A- and B-chains 
in the synthesis of both the synthetic insulins was carried out in the prescribed aqueous 
buffers (Nagata et al., 1992) adding acetonitrile (total of 40% ). The use of acetonitrile 
for this solubilization proved most successful because the fonnation reaction of the 
CysA 7-CysB 7 disulfide bond produced good yields of the desired product, provided care 
was taken in combining the A-chain and B-chain in the correct molar ratio by weight 
(equal for the native and 1.4 molar amounts for the mutant chains). 
In the fonnation of multiple inter- and intra-molecular disulfide bonds, the order of 
fonnation of disulfide bonds is an important factor. The strategy where the disulfide bond 
CysA7-CysB7 was fonned first, instead of the CysB 19-CysA20, was chosen because of 
the higher yield of the correct product over the incorrect disulfide linkages that were 
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obtained by Nagata et al. (Nagata et al., 1992) in their synthesis of bombyxin-II. It has 
been assumed that no recognisable exchange of the disulfide linkages occurred during the 
iodine oxidation and that all the synthesis products should retain the disulfide bond 
CysA7-CysB7. The correct mode of disulfide linkages of natural insulins is as follows: 
CysA7-CysB7; CysA6-CysAl 1 and CysA20-CysB19 (Figure 4.1). Other products that 
could have different modes of disulfide linkages from the natural insulin will be 
CysA 7-CysB7; CysA6-CysA20 and CysAl 1-CysB 19 (isomer 1) as well as 
CysA7-CysB7; CysAll-CysA20 and CysA6-CysB19 (isomer 2). 
Iodine oxidation 
In the work here iodine oxidation was carried out in the presence of HCl despite there 
being no Trp in the peptides studied. This step was however, included for two reasons. In 
the first instance it was used because it was known to yield successful results and also it 
was reported by Nagata et al. (Nagata et al., 1992) that during iodine oxidation 
considerable side reactions occurred that lowered the yield of this reaction. If some of 
these side reactions were unrelated to the presence of Trp then the use of HCl would 
prevent these happening so its use was adopted as a precautionary measure since it was 
not the intention here to study side reactions caused by iodine oxidation. From the yields 
obtained here, however, which are in agreement to those obtained by Maruyama et al. 
(Maruyama et al., 1992) in their synthesis of bombyxin-IV without the addition of HCl, 
the use of HCl might not have been necessary (see below). 
Relative yields of native and mutant platypus insulin 
The percentage yields of native and mutant platypus insulin, based on the quantities of 
the corresponding [Cys(Acm)819, Cys(S-Pyr)87] B-chain, were 8% and 10% respectively. 
These do not compare very favourably with the 32% yield obtained by Nagata et al. 
(Nagata et al., 1992) for the synthesis of the bombyxin-lI, a brain secretory peptide of 
the silkworm Bombyx mori whose amino-acid sequence shows considerable homology 
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with the vertebrate insulin family peptides (Nagata et al., 1992 and references therein). 
The high loss or low percentage yield was mainly caused by the 12 oxidation step (Section 
4.2.1.3.6 and Table 4.3) but was balanced by the high purity of both products, which 
were homogenous according to several high performance analytical methods (mass 
spectrometry, high performance capillary electrophoresis, analytical RP-HPLC and 
sedimentation equilibrium analysis). 
The yields with the insulin products here, however, are in general agreement with those 
of others using chemical synthesis (Brandenburg, 1990). Taking into account the fact that 
in chemical synthesis chemical bonding is not directed by a template, the yields obtained 
would seem to compare favourably with those of insulin produced by DNA recombinant 
technology; which were in the order of 11-52% for a series of insulin analogues 
(Markussen et al., 1988). Purity of the final product is, however, of paramount 
importance and in this work the purity was greater than 99% and this compares well with 
that obtained by the mentioned workers. An important advantage of this chemical 
method over DNA recombinant technology is that insulin analogues containing non-
proteinogenic amino-acids can be synthesised (Brandenburg, 1990). 
Characterisation of synthetic insulins: CD spectra and biological activity 
The CD spectra of the final synthetic products (native and mutant platypus insulins) show 
typical features of a correctly folded insulin, and it can be reasonable assumed that they 
are indeed insulins. The CD spectrum of the synthetic mutant insulin at pH 3.2 shows 
spectral effects that are typical of insulin in a conformational state that it adopts in the 
presence of Zn2+ or at high concentrations where it is in a state of enhanced self-
association (Packer and Biswas, 1980; Wollmer et al., 1994; Goldman and Carpenter, 
1974). This observation has not been investigated further but it is tempting to suggest 
that the reason for the possible enhanced self-association in an acid environment is due to 
the B 10 Asp. The latter resulting in a reduction of net charge when compared to the 
protonated His that it replaced, and thus may contribute to an increase in hydrophobic 
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self-interaction. (Hydrophobic self-interaction being the main force driving the 
association process (Jeffrey and Coates, 1966; Baker et al., 1988). 
The success of the chemical synthesis of both the native and mutant platypus insulins are 
measured by the in vitro biological activity test. Synthesised native platypus insulin has 
virtually the same potency as human (porcine ) insulin. In agreement with HB 10D human 
insulin, which in activity tests in vitro has a potency of 200% (Schwartz et al., 1987), 
that of HB 1 OD platypus insulin is of the same order. 
Conclusion: Verification, yields and homogeneity 
The conclusion that the final synthetic products are indeed the native and mutant platypus 
insulins is supported by the results of the biological activity measurements, the features of 
the circular dichroism spectra, very similar retention times on a RP-HPLC gradient 
developed to separate insulins (Shoelson et al., 1983), mass analysis and sedimentation 
equilibrium analysis (Chapter 5). 
Possible disulfide bond isomers (incorrect disulfide linkage products) of the synthetic 
insulins which could be expected to be obtained due to the strategies of semi-
regioselective disulfide bond formation were not identified and characterised. 
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Chapters 
The Self-association Pattern of Zinc-free Bovine, 
Synthetic Platypus and HBlOD Platypus Insulin: 
A Sedimentation Equilibrium study. 
5. 1 Sedimentation analysis 
In an ultracentrifuge parameters of the molecules under investigation can be related to 
their behaviour in a gravitational field. These parameters include molecular weight, 
shape and density of the molecule. Solvents influence this behaviour and their effects 
must be accounted for as the molecules (solute) are in solution. 
The general ultracentrifugation equation or Lamm equation (Bowen, 1970) describes 
the effects of sedimentation, diffusion and angular velocity on the concentration 
changes and thus behaviour of solute with time. In this equation the centrifugal cell 
dimensions and the fact that the centrifugal field is not homogeneous but increases 
linearly with r, the distance from the axis of rotation, are taken into account. The 
solute movement can be divided into two processes namely sedimentation towards 
the bottom of the cell and diffusion in the opposite direction. 
The flow equation describes the movement of material across a plane at r as follows; 
dm ( 2 de) -==0rh csw r-D-
dt dr 
5.1 
Where dm is the net movement of the material, r the distance from the axis of 
rotation, c the concentration of the solute, s the sedimentation coefficient, co the 
angular velocity of the rotor and D the diffusion coefficient. 0rh relates to the 
dimensions of the centrifugal cell where 0 is the sector angle, and h the solution 
thickness. 
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If sedimentation and diffusion are assumed to be independent of concentration the 
Lamm equation can be derived from the flow equation; 
-=D -+-- -sco r-+2e de { d 
2 
e 1 de} 2 { de } 
dt dr 2 r dr dr 
5.2 
Symbols as before (Bowen, 1970). 
Expressions involving the molecular weight of the solute can be formulated from 
equations 5.1 and 5.2. In the Beckman Optima XL-A analytical ultracentrifuge the 
total concentration at any point in the cell can be measured by absorption optics. 
From these data molecular weights of solute in the native state as they exist in 
solution can be calculated directly. There are two main approaches for the 
determination of molecular weight by sedimentation techniques namely, the 
sedimentation velocity method where a sufficiently high gravitational field is applied 
to cause the sedimentation of a molecule that can be directly measured, and the 
sedimentation equilibrium method. The latter is the method of choice, especially for 
self-associating proteins, and was used exclusively in the work to be described. 
5.1.1 Sedimentation equilibrium 
In sedimentation equilibrium a protein solution in a cell is inserted into a rotor and 
spun at a constant angular velocity, co (radian/second), and constant temperature, T 
(absolute), until the resulting distribution of total concentration of solute, e (g/L), 
versus radial distance from the ax.is of rotation, r, becomes invariant with time. In 
other words centrifugation is carried on for an appropriate period of time at low 
speed until a steady state is reached where the processes of sedimentation and 
diffusion are in equilibrium. No net movement of the material occurs, dm I dt = 0 and 
the flow equation, 5.1, becomes 
s de I dr -
D eco 2r 
5.3 
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Equation 5 .3 applies at the equilibrium state no matter hows and D may depend on 
concentration (Bowen, 1970; Archibald, 1963) and can be substituted into the very 
well known Svedberg equation (Bowen, 1970; Svedberg and Pedersen, 1940) 
RTs 
M= D(l-vp) 5.4 
to give the equation for the determination of molecular weights by the method of 
sedimentation equilibrium 
ln(dc ) M(l- vp)m 2 
__ r -- --
dr2 - 2RT 5.5 
where Mis the solute molecular weight (g/mol), cr is the concentration of the solute 
(g/mL) at the radial distance r from the axis of rotation, co the angular velocity of the 
rotor (radians/second), p the density of the solution, v the partial specific volume of 
the solute, T the absolute temperature, and R the gas constant. 
The sedimentation flow is proportional to m2-r , and r increases towards the cell 
bottom. There is thus a greater sedimenting tendency at the bottom of the cell, and in 
consequence a greater balancing tendency for diffusion in the opposite direction. 
Since diffusion is driven by the gradient of chemical potential (which depends on the 
concentration gradient) it follows that the concentration gradient increases towards 
the cell bottom. In other words the centrifugal field increases towards the bottom of 
the cell (Williams et al., 1958). 
A plot of ln cr versus r2 will yield a straight line with a slope proportional to M for a 
single ideal solute. When multiple species are present, or for an associating system, 
the measured molecular weight shows an increase from the meniscus towards the cell 
bottom and also upward curvature. The slope of the ln cr versus r2 plot is then 
proportional to the average molecular weight; an average based on the proportion by 
weight of the various species present known as the weight-average molecular weight 
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M w • Thus for a non linear In cr versus r2 plot, tangents to the curve yield a weight-
average molecular weight for the mixture of species present at each radial position 
(Aune, 1978; Kim et al., 1977; Teller, 1973). The weight-average molecular weight is 
defined as 
M = "'LMici 
w u . 
I 
5.6 
Non-ideality arising from the finite size of macromolecules and the charge they carry 
tends to reduce apparent molecular weight. In the presence of non-ideality, the 
concentration distribution at equilibrium leads to the apparent weight-average 
molecular weight, Mw,app .The plot must be assessed very carefully as upward 
curvature can be partially obscured by non-ideality, as the latter tends to cause 
downward curvature (Aune, 1978). 
Overlaying plots of data from samples of different starting concentrations and angular 
speeds will provide information about the presence of more than one species in the 
cell. Results from sedimentation equilibrium experiments have thus the ability to 
detect polydisperse and self-associating systems and determine the monomer 
molecular weight and stoichiometry. The effects of non-ideality can be taken into 
account (Albright and Williams, 1967; Harding, 1985; Munk and Halbrook, 1976; 
Soucek and Adams, 1976). 
Sedimentation equilibrium of a single solute species 
It must be pointed out that equation 5.5, although simple, does not satisfy detailed 
analysis nor have thermodynamic theory and consideration of non-ideality been taken 
into account. In fact, many assumptions have been made to derive equation 5.5. In 
the following section some general principles of thermodynamics will be employed to 
deduce equations which are very similar in form to the above but are modified to 
contain various terms such as activity coefficients. In a later section (5.1.4) the 
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consideration of non-ideality effects with the increase in total concentration of the 
solute in the treatment of experimental results will be discussed. 
At equilibrium the total potential is constant at each point in the cell, in other words 
the variation with radial distance of the centrifugal potential 'Vi, tending to cause 
sedimentation, is exactly balanced by the variation with radial distance of the chemical 
potential, µi tending to cause back-diffusion. 
The mathematical equation of sedimentation equilibrium at constant temperature is as 
follows 
do/ i - dµi = 0 
dr dr 
(Fujita, 1962) 5.7 
The tenn do/; I dr may be fonnulated as Mir co2- dr where Mi is the molecular weight 
of the species i and the second tenn dµ/dr is obtained from the partial differentiation 
of µi = µi0 + RT In ai where µ;° is the standard chemical potential per mole and ai the 
thennodynamic activity of the species i. Thus the basic sedimentation equilibrium 
equations can be formulated assuming constant pressure applies as follows 
dlna .(r) Mico 2 (1-uip) 
I ------
dr2 - 2RT 5.8 
which may be integrated utilising the reasonable assumption that the buoyancy term 
(1-uip) is constant with respect to radial distance, and hence to pressure variation 
to give 
ai (r) = ai (rF) exp{q> i Mi (r 2 - r;)} 
n'\ , = co
2
(1-uip) 
't' I RT 
5.9 
5.9a 
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where rand r Fare two radial distances between the meniscus, rm and the base of the 
solution column rb. It has been assumed that the species i is a non-electrolyte or at 
least a electroneutral component as defined by Casassa and Eisenberg (Casassa and 
Eisenberg, 1964). For a single non-associating solute 
a. = y .c. and c = ~ c. 
I I I L.J I 5.9b 
Where ci is the weight concentration of species i and Yi is the activity coefficient on 
the same concentration scale. 
Sedimentation equilibrium of a single solute species which self-associates to form an 
equilibrium mixture of states of different molecular weights 
For each state equation 5.8 satisfies the conditions of sedimentation equilibrium as 
well as the condition that chemical equilibrium is maintained at each point in the cell 
(Nichol and Ogston, 1965). This can be illustrated by fonnulating the following ratio 
for a monomer-dimer system based on equation 5.9. 
a
2
(r) _ a 2 (rp)exp{<t> 2 2M1(r
2 -r;)} 
a: (r) - a: (rp) exp{2<t> 1 M 1 (r
2 
- r})} 
5.10 
when ~2 = <t> 1, the partial specific volume of monomer and dimer, are identical and 
there is no volume change upon reaction. The exponential term in equation 5.10 
cancels and the dimerization constant is identical at each point in the cell. Even when 
a volume change accompanies dimerization equation 5.9 is still valid as the correct 
dependence of the equilibrium constant on pressure can be predicted, consequent on 
changing radial distance (Howlett et al., 1970). 
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5.1.2 The omega analysis 
Milthorpe et al. (Milthorpe et al., 1975) developed the theoretical background for the 
omega analysis where sedimentation equilibrium results obtained with polymerising 
systems can be analysed directly and therefore the errors inherent in differentiation 
and integration steps avoided. This analysis pennits the evaluation of the 
thennodynamic parameter a1 , the activity of the monomer, in equilibrium with a 
series of polymeric species, as a function of total weight concentration c. The omega 
function (Q) provides a means of fitting reaction models to sedimentation equilibrium 
data obtained with polymerising systems. The method is capable of detecting possible 
volume changes inherent on polymer fonnation, of treating systems where activity 
coefficients of solute species are functions of total concentration and of describing the 
system in tenns of relevant equilibrium constants (Milthorpe et al., 1975). 
Omega function versus protein concentration curves can be extrapolated to yield the 
indefinite dilution value, n° , whereby the thermodynamic activity of the self-
associating monomer can be determined at a reference point in the centrifuge cell. 
The activity of the monomer at the reference point can subsequently be used to 
calculate the activity of the monomer as a function of the total solute concentration 
(Milthorpe et al., 1975). The activity of the monomer for a particular set of reaction 
conditions is a function only of the total solute concentration and can be used for the 
estimation of relevant equilibrium constants describing polymerising systems 
belonging to a particular model. For a thermodynamically ideal system, the equations 
required to fit the experimental data are those expressing the relations between m1, 
the molar concentration of monomer (M1 must be known), and c , the total 
concentration of the protein. The activity of the monomer, a1, a thermodynamic 
parameter, as a function of total concentration of the solute, c , can also be used to 
evaluate non-ideality effects. (see later) 
The experimentally obtained plot of c versus r may be analysed to yield the activity 
of the monomer a1 as a function of total weight concentration c (Milthorpe et al., 
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1975). This is achieved by defining an experimentally determinable dimensionless 
function n (r) as : 
Q(r) = C(r) exp(<!> t M1 (r} - r2)] 
c(rF) 
ti\ - ( 1 - u 1 p )ro 2 
't' 1 - RT 
5.11 
u 1 is the partial specific volume of the effective monomer, p the solution density, oi2 
the angular velocity, R, the universal gas constant and T the absolute temperature of 
the sedimentation equilibrium experiment. M 1 is the effective-monomer molecular 
weight, c(r) and c(rF) the total protein concentrations at radial positions rand rF 
between or at rm and r h' the meniscus and base of the cell, respectively. 
Provided M1 and u 1 are known and any reference radial distance, rF, is chosen to lie 
between or_ at rm and rb, a plot construct of n ( r) versus c(r) from experimental 
results can be obtained (in the case of the Beckmann Optima XL-A from absorption 
optical measurements) across the entire distribution. Raw data sets are measurements 
of c (r ) versus radial distance r. 
By definition Q(r) = 1 at c (rF) 
Rewriting equation 5.10 
Q(r) = al (rF )c(r) 
a1(r)c(rF) 
5.1 la 
5.12 
Equation 5.12 makes it possible to evaluate a 1 (r) as a function of c(r) , as described 
below, without differentiation of experimental results that can introduce error. The 
value of c (rF) used to compute Q( r) may be selected as any value in the observed 
total concentration range. 
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As c(r) • 0, a 1 (r) • c(r) since the activity coefficient tends to unity and in 
addition c (r) • c1 (r) since dilution favours dissociation. A plot of n ( r) versus 
c(r) can be extrapolated to infinite dilution to yield a value for n°. 
Jim Q(r) = no = al (rF) 
c( r ) • O C (rF) 
5.13 
Since the selected value of c(rF) is known, the monomer activity, a 1 (rF) can be 
calculated. The value of a 1 (rF) is then used to determine the monomer activity, 
a 1 (r), at any radial position and hence at any measured concentration. Equation 5.9 
can be written in terms of a 1 (r) as follows 
a 1 (r) = a 1 (rF) exp[~ 1 M 1 (r; - r 2 )] 5.14 
allowing a 1 to be calculated as a function of r . 
A plot of a 1 (r) versus c(r) can now be constructed and fitted with various reaction 
models. The values of the reaction model parameters can be determined by 
simultaneous solution of the reaction model equations using the data from a number 
of arbitrarily chosen points (Milthorpe et al., 1975). Alternatively the entire data set 
could be used for the fitting procedure using non-linear regression. 
Combination of equation 5.12 and 5.13 simplifies the analysis and the significance of 
this extrapolated value can thus be appreciated 
noc(r) 
a1(r)= Q(r) 5.15 
A plot of Q(r) versus c(r) provides the value of n° which can then be used to 
construct a plot of a 1 (r) versus c(r) using equation 5.14. 
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By conducting several experiments with varying initial concentrations and/or angular 
velocities several n(r) versus c (r) plots can be constructed, extrapolated to 
indefinite dilution and the value of n° determined. To assist in the required 
extrapolation it is desirable to include an experiment which is of the meniscus 
depletion design so that the lowest measurable c(r) can be included in the analysis 
(Milthorpe et al., 1975). The method permits correlation of results obtained in 
different experiments conducted over a reasonable range of concentrations. Provided 
chemical equilibrium has been reached and samples are homogeneous, coincident 
plots of n(r) versus c(r) can then be obtained in their common total concentration 
range for different experiments by selecting a c(rF) common to all (Milthorpe et al., 
1975). This is a very sensitive test for determining the presence of polymerising 
systems. The extrapolated value of n° obtained for all experiments are the same since 
the weight-fraction of monomer is a function of the variable c (r) and the equilibrium 
constants are pressure independent. It follows that n° of this coincident plot can be 
used to calculate the activity of the monomer at the reference concentration and 
hence values of a 1 (r) are available for the entire concentration range encompassed 
by all experiments using equation 5.15. Different reference points within the 
concentration distribution will provide the same result. 
The advantage of this method is that the thermodynamic activity of the monomer a 1 , 
as a function of total weight concentration c , is obtained rather than an apparent 
quantity which defines non-ideality effects in a less explicit way. For a single non-
associating solute the omega analysis directly yields the concentration dependence of 
the activity coefficient, yi , since ai = yi ci (Jeffrey et al., 1977). (See section on 
non-ideality effects). 
Extrapolation of the omega function 
The accuracy of the analysis described above is highly dependent on the accuracy 
with which the n(r) versus c (r) curve can be extrapolated to zero concentration. 
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The extrapolation of an omega function curve to infinite dilution for a nearly ideal, 
weakly self-associating solute is relatively straightforward because there is little or no 
curvature in the omega function near zero concentration. This is demonstrated by the 
fact that when a small reference concentration is chosen, the intercept has a value 
close to its maximum possible value of 1. In this way if an error is made in the 
extrapolation, the percentage error is likely to be small and therefore the error in 
ai (r F) and other monomer activities will be small (Morris and Ralston, 1985). 
As the strength of the self-association increases extrapolation becomes more difficult. 
For mild-associations the omega function curve becomes steeper at low concentrations 
and the curvature in this region becomes more difficult to determine. Even if a small 
reference concentration is chosen, the intercept value will be substantially smaller than 
1.0. In these cases, a small error in the extrapolation will result in a large percentage 
error in the intercept value and hence the monomer activity values. This percentage 
error will tend to increase as the strength of the self-association increases. Therefore 
for mild and strong self-associating systems there is a possibility of rejecting the 
correct self-associating model because of an error made in extrapolating the omega 
function curve to zero concentration. 
In principle the extrapolation and its associated problems can be avoided entirely by 
fitting the omega function directly to a reaction model equation, since the omega 
function, like the activity function, is dependent only on the total solute concentration 
and can be written in terms of the self-association parameters (Morris and Ralston, 
1985). 
5.1.3 Associating systems at low total solute concentrations 
Over a range of low c the system may be considered, to a good approximation, as 
thermodynamically ideal (all Yi - 1). In this region therefore the omega analysis 
yields directly corresponding values of m 1 ( m1 = a1 I M w) and c , appropriate for use 
in self-associating model equations (see later). The results obtained in this way can be 
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used to explore the nature of the association pattern, using the available theory, and 
to obtain first estimates of relevant equilibrium constants. 
The sedimentation equilibrium equation 
d lnai (r) _ Mico 2 (1-uj p) 
dr 2 2RT 
5.8 
can be rewritten assuming that all y i = 1; <t> j = <t> and using equation 5. 9 
<t> j = <t> = (1 - up )co 2 
RT 
as 
d In cj (r) = q>Mi 
d(r 2 ) 
It follows that 
d Inc(r) = q>M w 
d(r 2 ) 
5.16 
5.17 
The slope of the tangent to a plot of ln c versus r2 obtained from the sedimentation 
equilibrium experiments yield, with the knowledge of <t> , the weight-average 
molecular weight of the system at the corresponding value of c . The monomer 
molecular weight, M 1 , can be obtained as it is equal to M w at c • 0. An increase in 
M w with increasing c can give the first insight into the nature of the association. 
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5.1.4 Associating systems at high values of total solute concentrations c : 
non-ideality effects 
Over a range of high c solute concentrations thermodynamic non-ideality must be 
included in all calculations where c is present in the equation. This thermodynamic 
non-ideality correction is demonstrated in the following equation 
ln y. = ~ a .. m. 
I L.J I) I 5.18 
j 
where each of the subscripts i, j is allowed to span the set of monomeric and 
polymeric species independently. Only the first term of the expansion has been 
retained because a relatively low total concentration have been considered. This 
approximation is applicable to experiments with insulin due to its low solubility in 
aqueous solutions (up to approximately 4 mg/mL). 
The aiJ may be calculated by using the expression (Wills et al., 1980) 
41tN(r. + r . )
3 z.z. (1 + xr. + xr .) 
I J I J I J M-
a;j = 3 + 2/(l+xr;Xl+xri)- /Ui 5.19 
where the first term represents the co-volume contribution, based on spherical 
geometry; r; and r1 being radii of the impenetrable spheres used to approximate 
protein molecules; the second term gives the charge-charge interactions, born by the 
spheres in terms of their net charge Z; and ZJ' the ionic strength, I and the Debye 
inverse-screening length x; and the third term expresses the molar volume of species j. 
The required Stokes radii and electrostatic charges for the different insulin species 
were described in detail previously (Mark et al., 1987). 
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5.2 Review of the self-association of zinc-free insulin 
5.2.1 The indefinite duoisodesmic (IDI) model of self-association 
No marked volume change accompanies the self-association of insulin especially in 
the low concentration range (Howlett et al., 1970). Thus equation 5.5 and its 
differentiated form are applicable to the sedimentation equilibrium distribution of all 
insulin species which self-associate to fonn an equilibrium mixture of different 
molecular weights. 
The pattern of self-association of zinc-free bovine insulin has been extensively studied 
by a wide variety of techniques including nuclear magnetic resonance (NMR) 
(Bradbury et al., 1981; Kadima et al., 1992), circular dichroism (CD) (Goldman and 
Carpenter, 1974), sedimentation velocity (Jeffrey et al., 1976), sedimentation 
equilibrium (Jeffrey et al., 1976) and light scattering (Kadima et al., 1993). 
Mark et al. (Mark et al., 1987) have undertaken an extensive study of the self-
association pattern of zinc-free bovine insulin in solution over a wide range of 
experimental conditions of pH, ionic strength and temperature. Sedimentation 
equilibrium was chosen as the method of study as precise information can be obtained 
on the dependence of both weight-average molecular weight and of concentration of 
the monomer m1 on total protein concentration. Mark et al. (Mark et al., 1987) based 
their model on interactions observed in the crystal between subunits where insulin 
acts as a bi-functional monomer having two distinct non-identical interfaces both 
capable of self-interaction. Experimental data from sedimentation equilibrium 
experiments were fitted to the proposed model of self-association described by a 
mathematical equation in terms of the dependence of weight-average molecular 
weight and monomer concentration on total protein concentration (Nichol et al., 
1984). By relating pH, temperature and ionic strength dependence of the association 
constants with properties of various amino-acid residues on the surface of the insulin 
monomer, each constant has been tentatively assigned to a particular reaction domain. 
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The inclusion of terms allowing for thermodynamic non-ideality in the analysis made 
it the most comprehensive treatment of the insulin system available. 
The proposed model of Mark et al. (Mark et al., 1987), called indefinite 
duoisodesmic (IDI), can be described as the indefinite self-association of a bivalent 
insulin monomer along the monomer-monomer and dimer-dimer interfaces governed 
by two binding constants KA and KB respectively. The two initial pathways of 
dimerization are followed by the indefinite addition of monomer under the control of 
the same two equilibrium constants. 
The monomer possesses two independent non-identical self-association sites 
designated a (monomer-monomer interface) and p (dimer-dimer interface), both 
capable of self-interaction. This account for two different sets of interactions between 
monomers in the crystallographically determined zinc hexamer structure. These are 
defined as interactions about two 2-fold axis, OP and OQ, respectively (Baker et al., 
1988; Bundell et al., 1972). 
Two types of dimers are formed, one involved in an a-a interaction, leaving the two 
P sites exposed and governed by an association constant KA; the other involving P-P 
interaction, leaving two a sites exposed and governed by an association constant KB. 
Linear chain growth proceeds by successive addition of monomer so that all 
polymers, both odd and even numbered, coexist in equilibrium. Each of these 
polymers possesses alternating a-a and P-P bonds with even numbered polymers 
having either two a-sites or two P-sites exposed and odd numbered polymers having 
an a-site at one end and P-site at the other. The authors postulated it is likely that 
given the relative magnitudes of KA and KB that they referred to the interactions about 
OP and OQ respectively. In other words the interactions about the OP interface 
(represented by KA and also referred to as the monomer-monomer interface) appears 
to be stronger than the interactions about the OQ interface (represented by KB and 
also referred to as the dimer-dimer interface). 
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The conclusion made by the authors (Mark et al., 1987) was that the a-a interactions 
may be identified with the OP interactions and the P-P interactions most certainly 
exist in solution. Thus it is possible to describe the solution behaviour of zinc-free 
insulin in terms of a single association pattern at neutral pH and 25 °C. In general the 
solution will contain an equilibrium mixture of all polymeric forms of insulin of which 
the composition depends on the total concentration and the values of KA and KB for a 
specific environment. The hexamer is merely one of these species and has no 
particular significance. 
The mathematical equation developed by Nichol et al. (Nichol et al., 1984) describing 
this model taking both KA and KB into consideration and distinguishing between the 
non-identical self-association domains is as follows 
c = M111ti[(1+2KA11ti)(1+2Ka11ti)] 
1-4K K m_2 A B .. '1 
5.20 
where M 1 is the molecular weight of the monomer, m1 its concentration on the molar 
scale and c is the total protein concentration in g/L. Thus the above mathematical 
equation describes the composition of a solution consisting of an infinite array of odd-
and even numbered polymeric species. The weight-fraction of each species can be 
calculated as a function of total insulin concentration (see later, equation 5.17). 
Mark et al. (Mark et al., 1987) developed an expression describing the dependence of 
"reduced" weight-average molecular weight (M w I M 1) on total concentration c. 
MW - p --- 5.21 
Ml Q 
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where 
P= I6K~K~mt +I6KAK8 (KA +K8 )"1{ +24KAK8 rrti
2 +4(KA +K8 )f1ti +1 
Q = (1-4KA K 8 rrti
2 )(1 + 2KArrti )(1 + 2K8 ~) 
When KA = KB i.e. the association sites are equivalent, the above equation reduces to 
the same fonn as the equation for an indefinitely self-associating system governed by 
a single equilibrium constant, K1 (isodesmic) (Tang et al., 1977). 
M w - I+ K1rrti ; Kl~ < 1 
Ml - 1- K1rrti 
with 
2KA +2KB = Kl 
5.22 
Equations 5.14 and 5.15 describe a smooth monotonically increasing dependence of 
Mw I M 1 on c . 
5.2.2 Weight-fractions of species 
Mark et al. (Mark et al., 1987) formulated an expression in tenns of the weight-
fraction of species as a function of total concentration for the IDI model. The weight-
fraction of the insulin species present in solution under the relevant conditions as a 
function of total insulin concentration can be calculated provided KA and KB are 
known. 
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The weight-fraction, </Ji, of each species, i being given by: 
</Ji = ci = iXim;-1 (1- 4KAKBm12 )2 
c (1 + 2KAm1)(1 + 2KBm1) 
where 
xi = (4KAKB)u-1)12 
X = (K + K )(4K K )Ci-l)/2 i A B A B 
i odd 
z even 
5.23 
5.23a 
5.23b 
The complex distribution of species within the insulin system in solution can be 
represented graphically. A distinction can be made between the weight-fraction of the 
two types of dimer a and ~ and tetramer a and ~- It stresses the importance of the 
odd-numbered species, the dominant species by weight in bovine insulin under these 
particular conditions. The possible presence of odd-numbered species other than 
monomer have been taken into account. 
Thermodynamic non-ideality effects are assessed basically in terms of co-volume and 
charge-charge interaction effects. Non-ideality effects in the present system are not 
large due to the relatively small size of insulin, the small net charge borne by it and 
the low concentration range (0- 4 mg/rnL) that was examined. Insulin is insoluble at 
higher concentrations in these solution conditions. 
5.2.3 Comparison of IDI with other proposed models 
Mark et al. (Mark et al., 1987) formulated a model based on interactions observed in 
the crystal between subunits and showed that it could be satisfactorily applied to 
describe insulin's self-association over all sets of experimental conditions. 
The question that inevitably arises is whether more than one model can be found that 
fits all conditions and, if so, what might be the consequences for instance for the 
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pharmacological applications of insulin in a concentration range where the self-
association is likely to be significant. Mark and Jeffrey (Mark and Jeffrey, 1990) 
addressed this problem in a subsequent paper where they have made similar 
systematic attempts to fit all of the available data with other reasonable models. 
Mark and Jeffrey (Mark and Jeffrey, 1990) applied data fitting procedures both with 
and without correction for non-ideality to experimentally measured concentration 
distributions of zinc-free insulin obtained over a wide range of experimental 
conditions (pH 2, 7, and 10, ionic strengths 0.05 and 0.1, T = 25 °C and 37 °C) using 
four different models of self-association patterns based on known physico-chemical 
properties of insulin in solution and patterns already in the literature. All the models 
have in common the inclusion of the monomer, known to be present in solution from 
earlier studies (Jeffrey, 1974; Jeffrey and Coates, 1966b), and the other species, the 
dimer and the hexamer, known to be stable (Blundell et al., 1972). 
The four models considered are the following: 
(i) Indefinite isodesmic self-association of monomers (IIM). 
(ii) An initial dimerisation, followed by indefinite isodesmic self-association of 
dimers (IID). 
(iii) Two initial pathways of dimerisation followed by the indefinite addition of 
monomer under the control of the same two equilibrium constants (IDI). 
(iv) Dimerisation, followed by hexamerization, and then indefinite isodesmic 
self-association of hexamers (IIH). 
The IID model (ii) (Jeffrey et al., 1976) describes the self-association of insulin at 
pH 7; The IDI model (iii), described in equation 5.20, is the pattern based on 
interaction in the crystal that has already been used (Mark et al., 1987) to fit results 
over a wide range of experimental conditions, mentioned above, and discussed 
extensively in a paper by Mark et al. (Mark et al., 1987), and the IIH model (iv) by 
Pekar and Frank (Pekar and Frank, 1972) to fit the results obtained with zinc-free pig 
insulin at pH 7. The IIM model (i) (not published before) was included in this analysis 
as being the simplest one that could be formulated if account is taken of measured 
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molecular masses ranging from less than that of the insulin dimer to greater than that 
of the hexamer. 
Values for the association constants and their uncertainties for all 4 models, fitted by 
both the ideal and non-ideal procedures, were calculated. In almost all instances the 
constants evaluated, when ideality was assumed, were well within the limits of 
uncertainty characteristic of the non-ideal computations. This suggests that there was 
little to gain in the relatively low concentration range considered here by the non-
ideality correction (Mark and Jeffrey, 1990). 
Comparing the standard deviations for the models and conditions it was found that 
IID, IDI and IIH were all acceptable models for all the experimental conditions if the 
fits including non-ideality were discounted. The model IDI that was originally 
proposed for these conditions (Mark et al., 1987) was the only one that was 
satisfactory when non-ideality corrections were included in the analysis. Model 11M 
failed badly at pH 2 and was therefore excluded by the authors. They could, however, 
not justifiably exclude either of the other models. 
The 4 models have been compared at three total insulin concentrations of practical 
importance, namely "physiological", 3ng/mL (0.5 nM); "pharmacological" , 3 mg/mL 
(0.5 mM); and "physico-chemical", 30 mg/mL (5mM). The calculated values of the 
association constants were used to compute the concentrations and mass fractions of 
any desired insulin species as a function of total insulin concentration for all of the 
models and all of the conditions. The calculations were performed using the constants 
obtained at pH 7, / = 0.1 and 25 °C, the conditions closest to those appropriate to the 
three total concentrations chosen. 
The conclusions arrived at were as follows: 
(i) At serum concentrations (" physiological ") the distribution is independent 
of the model, essentially all of the protein is monomeric. 
(ii) At any of the three concentrations the fraction of monomer is almost 
independent of the model as indeed is the fraction of the dimer. 
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(iii) At the pharmacological concentration regardless of the model, the fraction of 
monomer, the active species, is very low, being less than 10%. 
(iv) At the concentration required for the studies by NMR spectroscopy 
of the solution structure of insulin (" physico-chemical "), the fraction of 
monomer, the molecule of interest here, is extremely low whatever model is 
considered. 
(v) All models show that at concentrations well above the serum level, insulin 
solutions contain a very complex set of polymers of different sizes, 
dominated by species hexameric or bigger. 
The above findings were independent of the model chosen to represent the self-
association, and may be taken to reflect real properties of insulin at different 
concentrations. 
In an attempt to make monomeric insulins at pharmacological concentrations 
(0.6 mM) which have largely preserved their biological activity, single amino-acid 
substitutions have been introduced in mainly the monomer-monomer interface of the 
honnone (Brange et al., 1988). The term, "association state", has been used to 
monitor changes in self-association characteristic of these modified insulins. 
Association state is defined as a number which for a thermodynamically ideal 
solution, at a given concentration, is equal to the ratio of the number-average 
molecular mass, Mn , to the molecular mass of the monomer. (The number-average 
was chosen because only osmotic pressure measurements were available to these 
workers to estimate molecular weight changes). 
- IM M - ,.n. n- I 
I2n. 
I 
5.24 
where Mn is the number -average molecular mass and ni the number of moles. For a 
homogeneous solute, the ratio of M w to M is 1.0. The greater the degree of 
heterogeneity the greater the ratio of M w I Mn . 
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An expression for the number-average molecular mass in terms of the IDI model of 
the self-association pattern of insulin can be derived as follows 
C [ 1 - ( 4 KA KB ) ~ 2 ] 
M =------
n 111i[I+(KA +Ka)~] 
5.25 
The fractions of any desired polymeric species at any specified pair of values of Mn. 
Mn and c can thus be calculated. The process can be applied to especially modified 
insulins and for comparison to give insight into their particular association state. 
In the IDI model equation the interaction at the monomer-monomer interface is 
represented by KA and the interaction at the dimer-dimer interface by KB (Equation 
5.23). Mark and Jeffrey (Mark and Jeffrey, 1990) determined by calculation the KA 
values for these modified insulins by determining what changed value of KA 
corresponds to the paired values of Mn and c measured by osmometry by using the 
IDI model equation and leaving KB values unaltered. This assumption was reasonable 
because the amino-acid residues in the dimer-dimer interface, represented by KB in the 
IDI model, were unmodified in zinc-free insulin at pH 7. The fractions of any 
polymers at any total insulin concentration desired were then calculated using 
equation 5.23. The "association state", calculated when KA is given the value that it 
has in unmodified zinc-free insulin at c = 0.2 mM, is 3.1, in exact agreement with 
that measured by osmometry (Brange et al., 1988). This agreement confirms that 
model IDI provides a valid description of insulin self-association 
The conclusion that emerges from studying these results refered to above (Brange et 
al., 1988), is that the modified insulins of about normal activity are not likely to ~e 
more than 35 % monomeric under the reported conditions. In fact there are more 
dimers than monomer at each concentration for all the values of KA. The apparently 
paradoxical increase in the fraction of dimer as KA is weakened reflects the formation 
of dimer at the expense of higher species via the P-P interaction in this model. The 
calculated fractions show that the amino-acid substitutions have resulted in a doubling 
or trebling of the amount of monomeric insulin at each concentration, consistent with 
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the reported two to three times better absorption and with changes detected 
quantitatively in circular dichroism spectra. 
It emerges from the calculations that the theoretical lower limit (when KA= 0) for the 
association state for the concentration range studied here is 1.5. If one could confirm 
that model IDI is indeed the correct description of self-association, these results 
would imply that the only way an insulin with a higher proportion of monomer could 
be produced is to modify appropriate residues in the ~-P interaction region. 
Thus the IDI model is the favoured model, both on the grounds that it is most 
consistent with the available infonnation from structural studies and that it is the best 
fit to the experimental data. 
It must be noted that some of the values of the association state estimated by 
osmometry with these modified insulins are slightly lower than the theoretical lower 
limit of 1.5. The operation of thermodynamic non-ideality depresses these values, 
especially due to the introduction of extra charged side chains into the insulin 
molecule as was the case (Brange et al., 1988). In addition, conformational changes 
induced by modification of the native molecule could also affect the P-P interaction, 
thereby lowering the KB . Even without using a specific model as a basis for 
calculation, the values of the association state imply a relatively low level of monomer 
at the concentrations used. 
The analysis emphasises that it is important to employ a model for the self-association 
process that defines the composition of the solution under a given set of conditions in 
a way that reflects as closely as possible the real state of affairs. Rationally designed 
attempts to stop the self-association would be more productive if it were known that 
a second route of dimerization, as in model IDI, is actually utilised. 
In conclusion it is highly desirable to define as precisely as possible the types and 
proportions of insulin species present in solutions of the protein. To be able to define 
uniquely the self-association pattern, experimental approaches that distinguish 
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quantitatively between different pathways of polymer formation must be devised. It is 
also desirable to concomitantly, also experimentally, remove as many as possible of 
the assumptions that make thermodynamic non-ideality corrections ambiguous. This 
information is important in the design of strategies to suppress insulin polymerisation 
completely while retaining full activity in the modified monomer. 
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5.3 Materials and methods 
Glassware that had been in contact with the insulin samples was treated with 
0.1 mM EDT A for 24 hours to remove contaminating divalent cations followed by 
thorough rinsing in HPLC grade distilled water. Protein and peptide concentrations 
were detennined spectrophotometrically using a Varian series 634 
spectrophotometer. All dialysis was performed at 4 °C using Spectrapor No 3 
membrane tubing (Mw cutoff 3,500 daltons). The tubing was thoroughly rinsed with 
HPLC grade distilled water. Solutions were dialysed against a minimum of 100 
volumes of buffer for at least 24 hours with the buffer being changed at least twice. 
Experimental solutions were allowed to equilibrate for at least 10 hours after the final 
buffer change before ultracentrifugation. 
Three insulin preparations were used in these self-association studies. These were 
bovine insulin, totally chemically synthesised platypus insulin and totally chemically 
synthesised HB l OD platypus insulin. 
5.3.1 Bovine insulin preparation 
Bovine insulin (Sigma) was purified before use in a PrePak Waters RCM Base 
preparative Reverse Phase (RP) HPLC column as follows: Crystalline bovine insulin 
(approximately IO mg) was dissolved in 
100 mM H3PO/20 mM Triethylamine/50 mM NaC1O4 pH 3.0 buffer containing 
20% CH3CN. This solution was injected on to a preparative RP-HPLC column and 
purification method V (Table 4.1, Chapter 4) was followed. Bovine insulin eluted in a 
major peak at 31 % CH3CN on the linear gradient and was lyophilised. The 
lyophilisate was dissolved in 10% CH3CN plus 0.09% aqueous TF A , total volume 
10 mL, and desalted on the preparative RP-HPLC column using method IV 
(Table 4.1, Chapter 4 ). Bovine insulin as a single symmetrical Gaussian peak. The 
identity of the insulin was confirmed by molecular mass analysis (5734 daltons) using 
a matrix-assisted laser desorption ionisation (MALDI) time-of-flight mass 
spectrometery. This lyophilised product was used in all the experiments. 
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5.3.2 Sedimentation equilibrium studies 
Only samples judged to be homogeneous by HPLC, mass analysis and high 
performance capillary electrophoresis were used in the experiments. The composition 
of the buffer employed in all the sedimentation equilibrium studies was as follows: 
20 mM Tris, 18 mM HCl, 79 mM NaCl, 1 mM EDTA, pH 7.0, 
ionic strength, /, 0.1 M. The concentrations of the insulins in solution were 
determined spectrophotometrically at 276 nm employing an extinction coefficient of 
10.5 for a 1 % solution, 1 cm light path length (Frank and Veros, 1968). These were 
substantiated again when measured in a Beckman Optima XL-A using its optical 
system and a light path length of 1.2 cm during sedimentation equilibrium studies. 
Dilutions where necessary were performed with dialysate. 
Sedimentation equilibrium experiments were carried out in a Beckman Optima XL-A 
Analytical Ultracentrifuge (Beckman Instruments, Inc., Fullerton, Ca, U.S.A.) and 
final sedimentation ~quilibrium concentration distributions were obtained from scans 
at 280 nm using its absorbance optical system. Dialysed solution (100 µL) and 
dialysate (110 µL) were placed in the sample and solvent sector respectively of a 
double sector carbon filled epon centrepiece. Experiments were conducted at 
different speeds and initial concentrations as detailed later (Table 5.1). Baseline scans 
at 360 nm were subtracted to remove the effects of oil droplets on lenses and 
windows, as well as of optical imperfections in the windows and lenses. 
5.3.3 Analysis of sedimentation equilibrium data 
The computer program XLACALC/RALSTON/XLAMW , using the slope of the 
tangent to the plot of ln c versus r2 (equation 5.17), was employed to calculate the 
weight-average molecular weight, M w , as a function of total insulin concentration c 
after the baseline has been subtracted with the computer program 
XLACALC/RALSTON/XLABASE. The solution density p has been taken as 
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1.00 g/mL and it has been assumed that u , the partial specific volume of insulin, is 
the same for all insulin species namely 0.725 mL/g (Jeffrey, 1974; Jeffrey, 1986). 
Non-ideality effects were not taken into account in the calculations used in this thesis 
but M w was used rather than M w ,app for convenience in nomenclature. 
The program XLACALC/RALSTON/XLAMW was also employed to calculate 
omega values as a function of total concentration using equation 5.11. A reference 
concentration of c(rF) = 0.50 g/L was chosen for all omega analyses. The value of 
the reference concentration used to compute the omega plots may be selected as any 
value in the observed total concentration range (Milthorpe et al., 1975). 
For the "reduced" weight-average molecular weight ( M w I M1 ), versus c plots the 
monomer molecular weight M 1 values for bovine insulin, 5734 daltons; platypus 
insulin, 5865 and HB 10D platypus insulin, 5843 daltons, previously calculated with 
the PEPTIDESORT program from GCG (Chapter 3), were used in these calculations. 
All other equations referred to in this section and used for the calculations were 
installed in the application program GraphPadPRISM™ Version 1.0 from 
Graphpad Software Inc., San Diego, CA, U.S.A. The non linear regression algorithm 
of this application program was employed in the curve fitting procedures. 
5.4 Results 
5.4.1 The dependence of "reduced" weight-average molecular weight on total 
bovine, platypus and HB 1 OD platypus insulin concentration 
In the sedimentation equilibrium experiments conducted with zinc-free insulin, the 
ionic strength was fixed at 0.1 M and the temperature 25 °C to pennit the correlation 
of results over a range of total insulin concentration at 0-1.5 g/L. This correlation was 
achieved in several experiments (Table 5.1) by employing different loading 
concentrations and angular velocities. In this range of protein concentrations it is 
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Table 5.1: 
Insulin 
Bovine 
Platypus 
A summary of the experimental conditions applicable to 
sedimentation equilibrium experiments conducted with zinc-free 
insulin. Optical path length 1.2 cm and c0 starting 
concentration. 
Experimental 
run 
bin3al 
bin3a2 
bin3a3 
bin4a2 
bin4a3 
plin3al 
plin5al 
plin5a3 
plin6a3 
c0 (g/L) 
1.38 
0.50 
0.25 
0.50 
0.25 
0.37 
0.85 
0.86 
0.86 
Speed 
(rev/min) 
30K 
30K 
30K 
50K 
50K 
30K 
30K 
30K 
42K 
Time 
(hour) 
6 
6 
6 
12 
12 
6 
6 
6 
12 
HB 1 OD Platypus 
doala2 0.34 30K 6 
doala3 0.66 30K 6 
doa2a2 0.34 42K 12 
doa2a3 0.66 42K 12 
assumed that the samples obey the Beer-Lambert Law where absorbance and 
concentration are proportional. The zinc-free buffer employed in all cases was 
20 mM Tris, 18 mM HCl, 79 mM NaCl, 1 mM EDTA, pH 7.0, 
ionic strength, /, 0.1 M. 
The weight-average molecular weight M w and the omega values as a function of 
total concentration were calculated for the three insulins using the RALSTON 
computer program. An increase in M w with increasing total concentration can give 
the first insight into the nature of the association. 
Plots of M w I M 1 (the "reduced" weight-average molecular weight) as a function of 
total protein concentration c were constructed for all the insulins for all experiments 
listed in Table 5.1. All the results from all experiments for bovine insulin (Figure 5.1), 
regardless of the loading concentrations and angular velocity, were coincident. The 
same was found for the experiments with platypus (Figure 5.2) and HB 1 OD platypus 
insulins (Figure 5.3). This supports the observation that all the insulin samples were 
homogeneous. It is clear from the above plots for bovine and platypus insulin that the 
M w I M I increases with increasing total protein concentration, an indication of self-
association. The plots for HB 10D platypus insulin (Figure 5.3) also indicate 
self-association but to a lesser extent. In fact, this value does not increase above two 
at a total concentration of 0.5 g/L and higher. This is an indication that the major 
associated species of this analogue is dimer over the concentration range and 
conditions used. 
5.4.2 Omega Analysis. 
Omega values .Q (r) , as a function of total concentration c (r) , using equation 5.11 
were calculated for the three insulins using the RALSTON computer program. All 
data sets listed in Table 5.1, used for the calculation of M w as a function of total 
concentration using equation 5.17, were used in these calculations. Different 
113 
Figure 5.1 
The overall extent of association of zinc-free bovine insulin 
(pH 7 .0; / = 0.10 M; T = 25 °C) reflected in plots of the concentration 
dependence of the "reduced" weight-average molecular weight. The 
experimental data sets mbin3al (o) and mbin3a2 (•)(Table 5.1) are displayed. 
The KA and K8 values, shown in Table 5.2, were used to calculate the smooth 
monotonic dependence of M w I M1 on c using equation 5.21. This calculated 
solid curve is displayed superimposed on the experimental points. 
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Figure 5.2 
The overall extent of association of zinc-free chemically synthesised platypus 
insulin reflecteq in plots of the concentration dependence of the "reduced" 
weight-average molecular weight. The experimental data sets mplin5al ( •) and 
mplin3al (o) (Table 5.1) are displayed. The KA and K8 values, shown in Table 
5.2, were used to calculate the smooth monotonic dependence of M w I M 
1 
on 
c using equation 5.21. This calculated solid curve is displayed superimposed on 
the experimental points. 
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Figure 5.3 
The overall extent of association of zinc-free chemically synthesised HB 1 OD 
platypus insulin reflected in plots of the concentration dependence of the 
"reduced" weight-average molecular weight. The experimental data sets 
mdoala3 (•) and mdoa2a3 (o) (Table 5.1) are displayed. The KA and K8 values, 
shown in Table 5.2, were used to calculate the smooth monotonic dependence 
of M w I M1 on c using equation 5.21. This calculated solid curve is displayed 
superimposed on the experimental points. 
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reference concentrations within the concentration distribution of each insulin, namely 
0.4; 0.45; 0.5; 0.55 g/L respectively, were used in the omega analysis. 
Plots of n(r) versus c ( r), for each reference concentration, were constructed for the 
three insulins. For each specific reference concentration (0.4; 0.45; 0.5; 0.55 g/L), 
n(r) versus c(r) plots were coincident for a particular insulin. Thus over the common 
concentration range the data for all insulins showed acceptable overlap, indicating the 
attainment of both chemical and sedimentation equilibrium. This good overlap was 
achieved with different concentrations derived from the same preparations with the 
angular velocity, listed in Table 5 .1. This good overlap was not influenced with different 
preparations of chemically synthesised platypus insulin. Using the reference 
concentration c(r F) = 0.50 g/L for the omega analysis, the coincident plots of n(r) 
versus c(r) for a specific insulin are displayed in Figure 5.4 (bovine insulin); Figure 5.5 
(platypus insulin); Figure 5 .6 (HB 1 OD platypus insulin). 
The coincident plot of n(r) versus c(r) for bovine insulin at this reference concentration 
was extrapolated to determine the value of no at c = 0. It was difficult to accurately 
determine the value of no at c = 0, as the data covering the lowest c values seemed 
unreliable and were thus disregarded (Figure 5.4). Therefore a range of possible no at 
c = 0 values between 0.18 and 0.22 were tested and used in the fitting procedure. The 
value of no at c = 0 of 0.21 gave the best fit according to the R2 values obtained. It was 
thus decided to use this extrapolated value as a starting point for all three insulins in the 
calculation of a 1 as a function of total protein concentration, using equation 5 .14. There 
is clearly some uncertainty as to the correct extrapolated value no at c = 0 of 0.21 as can 
be seen in the omega plot of bovine insulin (Figure 5.4). 
By definition n(r) = 1 at c(r F) 5.1 la 
and constructs of Mw I M1 versus c curves via Eq. 6, using the association constants KA 
and K8 (derived from the omega analysis) return the origin of the curves at infinite 
dilution to unity (at infinite dilution Mw = M1 and M1 I M1 =l). Although slight errors in 
the extrapolation of the omega function would not necessarily be detected as shown by 
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Figure 5.4 
An illustrative plot of the omega-method used to analyse the sedimentation 
equilibrium results obtained with zinc-free bovine insulin. All the experimental 
data sets listed for bovine insulin in Table 5.2 were used in the analysis. The 
ordinate values were obtained using equation 5.11 utilising the common 
reference concentration of 0.5 g/L, while the abscissa values refer to the 
corresponding total concentrations for which omega values were determined. 
The extrapolation to given°= 0.21 is shown. 
a 
2.4 
2.3 
2.2 
2.1 
2.0 
1.9 
1.8 
1.7 
1.6 
1.5 
1.4 
1.3 
1.2 
1.1 
1.0 
0.9 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 'It no= 0.21 
0.1 I.'\ 
Figure 5.4 
• • • • .. -,,-
•• .. _.,, 
•• 
.. --•• •• •• ,· 
• • 
' 
' , 
: -• • 
• 
• 
0 .0 I I I I I I I I I I I I I I I I I 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 
c (mg/mL) 
Figure 5.5 
An illustrative plot of the omega-method used to analyse the sedimentation 
equilibrium results obtained with zinc-free chemically synthesised platypus 
insulin. All the experimental data sets listed for platypus insulin in Table 5.2 
were used in the analysis. The ordinate values were obtained using equation 5.11 
utilising the common reference concentration of 0.5 g/L, while the abscissa 
values refer to the corresponding total concentrations for which omega values 
were determined. 
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Figure 5.6 
An illustrative plot of the omega-method used to analyse the sedimentation 
equilibrium results obtained with zinc-free chemically synthesised HB 10D 
platypus insulin. All the experimental data sets listed for HB 10D platypus insulin 
in Table 5.2 were used in the analysis. The ordinate values were obtained using 
equation 5.11 utilising the common reference concentration of 0.5 g/L, while the 
abscissa values refer to the corresponding total concentrations for which omega 
values were determined. 
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Morris and Ralston (1985), it was found that the chosen no value of 0.21 (reference 
concentration 0.5 g/L) gave the best fit of the experimental data to the IDI model equation 
for all three insulins. 
Since the system may be considered to a good approximation as being 
thermodynamically ideal in this low concentration range (the activity coefficient Yi being 
close to unity), corresponding values of m 1 (m 1 = a 11 M1 ), and c were calculated from the 
aJ(r) versus c (r) curve. Estimates of KA and KB values, shown in Table 5.2, were 
obtained by fitting the experimental points of m 1 and its corresponding c values, using 
the non linear regression method, to the equation 5.20 (Nichol et al., 1984) that describes 
the self-association of zinc-free insulin (IDI model). These experimental points, (aJ(r) 
with the corresponding c (r) values), together with the fitted curves (solid lines) that 
extrapolated smoothly to the origin as required, are shown for all three insulins in Figures 
5.7-5.9. 
Table 5.2 Results of the fitting process with errors (95% confidence 
levels) for KA and KB values. 
Insulin KA(M-1) KB(M-1) 
-Bovine Insulin 25000 + 1200 8000 + 400 
Platypus insulin 47000 + 1200 3400 + 100 
HB 1 OD Platypus Insulin 103,900 + 600 69 + 9 
R2 
0.997 
0.996 
0.998 
The results of the fitting procedure converged and two consecutive iterations changed the 
sum-of-squares by less than 0.01 %. A graph of the residuals (the distance of a point 
from the curve) in all cases showed that the deviation of the experimental data points 
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Figure 5.7 
A plot of the thermodynamic activity of monomer, a1 versus the total weight 
concentration from the sedimentation equilibrium experiments conducted with 
zinc-free bovine insulin. Equation 5.15 was used to calculate the experimental 
points from the plot shown in Figure 5.4. The solid line shows the final result of 
the fitting procedure of experimental m1 values with non-linear regression to 
equation 5.20 (describing the IDI model of self-association) and a1 values were 
back calculated with m1 = a/M1 • The solid curve was calculated using equation 
5.20 with estimates values KA = 25000 M-1 and KB = 8000 M-1 and shows the 
final result of the curve fitting procedure used to obtain these estimates. 
r 
! 
0.150 Figure 5.7 
0 
0.125 
~ 
~ 
~ 
~ 
... ~[l 
!Jl 
0.100 ~ 
...--. 
,-J 
s 
ell 0.075 
s ...._, -~ 
0.050 
: 
0.025 
0.000 I I I I I I I I I I I I I I I I I 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 
-
c (mg/mL) 
Figure 5.8 
A plot of the thermodynamic activity of monomer, a1 versus the total weight 
concentration from the sedimentation equilibrium experiments conducted with 
zinc-free chemically synthesised platypus. Equation 5.15 was used to calculate 
the experimental points from the plot shown in Figure 5.4. The solid line shows 
the final result of the fitting procedure of experimental m1 values with non-linear 
regression to equation 5.20 (describing the IDI model of self-association) and a1 
values were back calculated with m1 = a/M1 . The solid curve was calculated 
using equation 5.20 with estimates values KA = 47000 M- 1 and KB = 3400 M-1 
and shows the final result of the curve fitting procedure used to obtain these 
estimates. 
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Figure 5.9 
A plot of the thermodynamic activity of monomer, a1 versus the total weight 
concentration from the sedimentation equilibrium experiments conducted with 
zinc-free chemically synthesised HB 1 OD platypus. Equation 5.15 was used to 
calculate the experimental points from the plot shown in Figure 5.4. The solid 
line shows the final result of the fitting procedure of experimental m1 values with 
non-linear regression to equation 5.20 (describing the IOI model of self-
association) and a1 values were back calculated with m1 = a/M1 . The solid 
curve was calculated using equation 5.20 with estimates values 
KA = 103,900 M-1 and K8 = 69 M-1 and shows the final result of the curve fitting 
procedure used to obtain these estimates. 
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from the the best fit curve were within experimental error. The R2 values, a measurement 
of goodness of fit, were all greater than 0.99 in all cases (Table 5.2); indicating excellent 
fits within experimental precision. 
The values of KA and KB shown in Table 5 .2 were used to calculate the smooth 
monotonic dependence of M w I M1 on c using equation 5 .21. These calculated solid 
curves for each insulin are displayed superimposed on the experimental points of the 
Mw I M1 with its corresponding c values in Figures 5.1 (bovine insulin); Figure 5.2 
(platypus insulin) and Figure 5.3 (HB 1 OD platypus insulin). With all three insulins the 
calculated curves fit the experimental results well. (Not all data sets are displayed). 
Figure 5 .10 shows a comparison of the overall extent of association of zinc-free bovine 
and platypus insulins at neutral pH as reflected in the experimental plots of the 
concentration dependence of the "reduced" weight-average molecular weight. When the 
calculated curves using equation 5 .21 are superimposed on the experimental results it is 
seen that the graph indicates some reduction in the extent of self-association of platypus 
insulin compared to bovine insulin in the same concentration range. 
Figure 5 .11 shows the same comparison for bovine and HB 1 OD platypus insulins. Here, 
there is no question of the dramatic reduction in the extent of self-association ( oligomeric 
state, approximately two) of the HB 1 OD platypus insulin compared to bovine insulin in 
the same concentration range. 
To put these results in perspective, they were plotted together in Figure 5.12 and 
compared with the values obtained for bovine insulin by Mark and Jeffrey (Mark and 
Jeffrey, 1990) whose KA and KB values were derived from analysis of results over a 
bigger concentration range, when using the model E ultracentrifuge and a different mode 
of analysis. 
Table 5.3 shows the comparison of published and present results of state of the 
association of different insulins. This demonstrates the variation in values when 
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Figure 5.10 
A comparison of the overall extent of association of zinc-free bovine insulin and 
chemically synthesised platypus insulin reflected in plots of the concentration 
dependence of the "reduced" weight-average molecular weight. The 
experimental data sets for bovine insulin mbin3al (o) and mbin3a2 (• ) and 
from platypus insulin mplin3al ( ~) and mplin5al ( _. ) (Table 5.1) are 
displayed. The ¾ and KB values, shown in Table 5.2, were used to calculate the 
smooth monotonic dependence of M w I M 1 on c using equation 5.21. The 
calculated solid curves of bovine and platypus insulin, indicated on the graph 
are displayed superimposed on the experimental points. 
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Figure 5.11 
A comparison of the overall extent of association of zinc-free bovine insulin and 
chemically synthesised HB 10D platypus insulin reflected in plots of the 
concentration dependence of the "reduced" weight-average molecular weight. 
The experi1nental data sets for bovine insulin m bin3al ( o) and m bin3a2 ( • ) and 
for HBlOD platypus insulin mdoala3 (• ) and mdoa2a3 ( 0) (Table 5.1) are 
displayed respectively. The¾ and KB values, shown in Table 5.2, were used to 
calculate the smooth monotonic dependence of M w I M 1 on c using equation 
5.21. The calculated solid curves of bovine and platypus insulin, indicated on the 
graph, are displayed superimposed on the experimental points. 
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Figure 5.12 
A comparison of the overall extent of association of zinc-free bovine, chemically 
synthesised platypus and HB 1 OD platypus insulin and bovine insulin from work 
by Mark et al. (Mark et al., 1987) as reflected in plots of the concentration 
dependence of the "reduced" weight-average molecular weight. The 
experimental data sets for platypus insulin mplin5al (o) and 3al (0) 
(Table 5.1) are displayed. The ¾ and KB values, shown in Table 5.2 for the 
three insulins in this study, and values obtained by Market al. (Mark et al., 
1987) for bovine insulin were used to calculate the smooth monotonic 
dependence of M w I M 1 on c using equation 5.21. The calculated solid curves 
of the three insulins and of the bovine insulin in this study (AEM Bovine Insulin) 
(Mark et al., 1987) shown on the graph, are displayed superimposed on the 
experimental points of platypus insulin. 
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Table 5.3: The comparison of the state of association M w I M1 at three 
different total concentrations (1 g/L, 2 g/L and 3.6 g/L) of the 
different insulins in solution, neutral pH and zinc-free. 
Published and own values were used. 
Insulin 
Insulin(human) 
Insulin(bovine) 
Insulin (Bovine) 
Insulin (Porcine) 
Insulin (Platypus) 
Insulin (Bovine) 
Insulin(HB 1 OD Platypus) 
Insulin(HBlOD Human) 
a) (Brems et al. , 1992) 
b) (Mark et al., 1987) 
c) (Holladay et al., 1977) 
ct) (Pekar and Frank, 1972) 
e) Nourse, this thesis. 
t) (Weiss et al., 1991) 
Cone (g/L) 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
3.6 
MW I Ml Reference 
4.5 a) 
5.5 
5 b) 
7 
4.2 c) 
5 
3.5 d) 
5 
3.5 e) 
4.9-5.1 
4.5 e) 
6.5 
2 e) 
2.1 
2 f) 
I 
different methods of sedimentation equilibrium data collection are used. The solution 
conditions also vary slightly. The significance of these results is discussed later. 
5.4.3 Evaluation of the weight-fractions of all species up to and including hexamer 
of bovine, platypus, and HB 1 OD platypus insulin as a function of total 
concentration. 
· According to the IDI model of self-association of insulin in the concentration range 
,I; 0-2g/L (0 - 0.33 mM) in a zinc-free neutral pH solution, bovine insulin (and human 
insulin) exists as a complex distribution of monomers, dimers, trimers, tetramers, 
pentamers, hexamers and higher order polymers. This relative distribution is 
dependent on the total concentration of insulin and can be analysed in terms of the 
weight-fraction of a particular species as a function of total concentration. 
The values for weight-fractions of all species up to and including hexamer (i = 6) 
~ present in solutions of zinc-free insulin (pH 7 .O; I= 0.1 M; T = 25 °C) as a function of 
total concentration were calculated, using equation 5.23, and are displayed 
~! graphically in Figures 5.13 - 5.15. Values for KA and KB used in the calculations are 
from Table 5.2. 
The graphs of both bovine insulin (Figure 5.13) and platypus insulin (Figure 5.14) 
illustrate the presence of monomers, a- and P-dimers, trimers, a- and P-tetramers, 
pentamers and hexamers in the specified concentration range, albeit in different 
amounts as related by the difference in KA and KB values. From the weight 
distribution of all species of HB 1 OD platypus insulin as a function of total 
concentration (Figure 5.15), it can be noted that under the conditions examined and in 
the concentration range of O - 2 g/L, only monomers, P-dimers and P-tetramers (in 
very small amounts) exists in solution. 
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Figure 5.13 
The weight-fractions ($i) of all species up to and including (i = 6) present in a 
solution of zinc-free bovine insulin as a function of total concentration is 
shown. The values for the weight-fractions were calculated using equation 5.23 
assuming values for KA and K8 from Table 5.2. The lines labelled a-dimer and 
a-tetramer refer to the species of dimer and tetramer with two exposed a-faces 
whereas the lines labelled P-dimer and ~-tetramer refer to the species of dimer 
and tetramer with two exposed P-faces. 
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Figure 5.14 
The weight-fractions (~i) of all species up to and including (i = 6) present in a 
solution of zinc-free chemically synthesised platypus insulin as a function of 
total concentration is shown. The values for the weight-fractions were 
calculated using equation 5.23 assuming values for KA and K8 from Table 5.2. 
The lines labelled a-dimer and a-tetramer refer to the species of dimer and 
tetramer with two exposed a-faces whereas the lines labelled ~-dimer and~-
tetramer refer to the species of dimer and tetramer with two exposed ~-faces. 
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Figure 5.15 
The weight-fractions (~i) of all species up to and including (i = 6) present in a 
solution of zinc-free chemically synthesised HB 10D platypus insulin as a 
function of total concentration is shown. The values for the weight-fractions 
were calculated using equation 5.23 assuming values for KA and KB from Table 
5.2. The lines labelled P-dimer and P-tetramer refer to the species of dimer and 
tetramer with two exposed P-faces. (No other oligomers than those depicted 
were present at significant weight-fractions in the concentration range shown). 
No a-dimer, trimers, a-tetramers, pentamers and hexamers than those depicted 
were present at significant weight-fractions in the concentration range shown. 
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5.4.4 Comparison of the weight-fractions of monomers and oligomers of the three 
insulins 
The concentration range 0-2 g/L of insulin samples was used in the analysis because 
the changes in weight-fractions of the different polymeric (oligomeric) species are 
most significant in this range. Figure 5.16 displays the weight-fractions of the 
monomer and dimer of bovine, platypus, and HB 1 OD platypus insulin as a function of 
total concentration in a zinc-free solution (pH 7.0; I= O. l; T = 25 °C). Dimer 
fractions are expressed as total weight-fractions of a- and P-dimers. The latter will be 
discussed in a next section. There is little difference between the weight-fractions of 
the monomers of the various insulins at any given concentration. It is clearly 
illustrated from this graph, based on the KA and KB values for each insulin, that the 
weight-fraction of dimers of HB 1 OD platypus insulin is far greater in magnitude than 
bovine and platypus insulins. At a total concentration of 0.5 g/L and greater, the 
weight-fraction value for dimer is 0.8, i.e. 80% of all species by weight. The 
consequence of this is a reduction in the number of monomers available for 
association ·interactions to fonn other polymeric species and is the quantitative 
reflection of the dramatic reduction in M w I M 1 of HB lOD platypus insulin compared 
with bovine insulin observed in the primary data (Figure 5.11). This supports 
observations of others that a similar HB 1 OD human insulin exists mainly as dimers 
under similar solution conditions (Brange et al., 1988; Weiss et al., 1991). In the case 
of platypus insulin KA is higher and KB lower than bovine insulin and this difference 
leads to a greater weight-fraction of dimers with a concomitant reduction of other 
species for platypus insulin. This shows up in the slightly reduced M w I M 1 versus c 
dependence of platypus insulin compared to bovine insulin depicted in Figure 5.10. 
Figure 5.17 displays the weight-fractions of the a- and P-dimer of bovine, platypus, 
and the P-dimer of HB 1 OD platypus insulin as a function of total concentration. The 
a-dimer refers to the species of dimer with two exposed a faces whereas the 
~-dimer refers to the species of dimer with two exposed p faces. The HB 1 OD dimer 
exists exclusively as a P-dimer in this concentration range. Compared to other 
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Figure 5.16 
A comparison of the weight-fractions ( <?i) of monomers and dimers in solutions of 
zinc-free bovine, chemically synthesised platypus and HB 10D platypus insulins as a 
function of total concentration. The values for the weight-fractions were calculated 
using equation 5.23 assuming values for KA and KB from Table 5.2. The lines labelled 
dimer include both a- and P-dimers. Plin = platypus and Bin = bovine. 
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Figure 5.17 
A comparison of the weight-fractions (~i) of a- and ~-dimers in solutions of 
zinc-free free bovine, chemically synthesised platypus and HB 1 OD platypus 
insulins as a function of total concentration. The values for the weight-fractions 
were calculated using equation 5.23 assuming values for KA and K8 from Table 
5.2. The lines labelled a-dimer refer to the species of dimer with two exposed 
a-faces whereas the lines labelled P-dimer refer to the species of dimer with 
two exposed P-faces. Plin = platypus and Bin = bovine. 
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insulins, the KA value is huge (indicating a strong a-a interaction) and the KB value 
very low, an indication that the P-P interaction has been virtually destroyed. 
Comparing the weight-fractions of the a- and ~-dimers of bovine and platypus insulin 
it can be seen as expected that the ~-dimers are the dominant dimer in solution in 
these conditions, with the weight-fraction of P-dimers of platypus insulin being higher 
than that in bovine insulin. 
It can be seen in Figure 5.18 that there is very little difference of weight-fractions of 
hexamers between bovine insulin and platypus insulin in contrast to the dimers. As 
expected there are no HB 1 OD hexamers. These figures are a graphic demonstration of 
how the relative values of KA and KB for a particular insulin can determine the identity 
and relative amount of a specific polymeric (oligomeric) species at a specific total 
concentration. 
Weight-fractions can be calculated in the same way for trimers, tetramers, pentamers 
and so on but such calculations merely reinforce the trends already illustrated. That is, 
that the fractions of species above dimer are lower for platypus insulin than for bovine 
insulin and that virtually no aggregated species above dimer exist for HB 10D platypus 
insulin. 
5.5 Discussion 
5.5.1 Omega Analysis 
Sedimentation equilibrium was used successfully to obtain the values of 
thermodynamic parameters of the self-association of different insulins at chemical 
equilibrium. In this regard omega analysis was used to obtain the thermodynamic 
parameter a1, the activity of the monomer, in equilibrium with a series of polymeric 
species, as a function of total weight concentration c . 
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Figure 5.18 
A comparison of the weight-fractions ($i) of dimers solutions of zinc-free 
bovine, chemically synthesised platypus and HB 1 OD platypus insulins as a 
function of total concentration. The values for the weight-fractions were 
calculated using equation 5.23 assuming values for KA and K8 from Table 5.2. 
The lines labelled dimer include both a- and P-dimers. Plin = platypus and 
Bin = bovine. 
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The coincidence of the omega plots 
The overlap of omega function curves (Figure 5.1-3) for the different insulins shows 
that chemical equilibrium had been achieved and in all cases no significant 
concentration of solute was present that did not participate in the self-association. 
When different concentration reference points for the omega analysis within the 
concentration distribution for all insulins were selected, the same overlap was 
observed in all instances. 
The extrapolation of the omega function 
Insulin is a mildly self-associating solute in the environment studied and the 
extrapolation of the omega function to indefinite dilution to yield the correct no value 
has been difficult. Morris and Ralston (Morris and Ralston, 1985) have shown that 
the activity curve, used in the omega analysis, would pass through the origin 
regardless of the error in extrapolation. This is because by definition n(r) is equal 
to 1 at the reference concentration ( equation 5 .11 a) which means that a construct of a 
Mw I M1 versus c curve via equation 5.21, using association constants derived from 
the omega analysis, will pass through the point (0,1) as c• O, Mw• M 1. In other 
words Mw I M1 equals unity at infinite dilution. 
Although slight errors in the extrapolation of the omega function would not 
necessarily be detected, it was found however, that the chosen no value of 0.21 
(reference concentration 0.5 g/L) gave the best fit of the experimental data to the IDI 
model equation for all three insulins. The coincident omega function plot (Figure 5.4) 
of bovine insulin, had data points available in the low concentration region and could 
be extrapolated most accurately to obtain the no value and was therefore used as a 
starting point for the analysis of all three insulins. Sufficient sedimentation 
equilibrium data points in the low concentration region of the coincident omega 
function plots were not so readily available for platypus and HB 1 OD platypus 
insulins. Subsequent analysis, where the value of no was varied and the fitting criteria 
applied, also showed that this was the best value that could be found for these two 
insulins. 
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The choice of the reference concentration 
The value of c(rF), the reference concentration value, chosen to compute Q (r) values 
as a function of c(r) may be selected as any value in the observed total concentration 
range. Irrespective of a possible error in the choice of the reference concentration, a good 
extrapolation to indefinite dilution of the omega function curve (omega Q (r) versus 
c ( r)) will yield the correct value of the reference monomer activity at the appropriate 
radial position r (Morris and Ralston, 1985; Milthorpe et al., 1975). In this study 
different reference concentrations, within the concentration distribution of each insulin, 
were used in the omega analysis and subsequent fitting procedure of the experimental 
data as described in the preceding sections. The results of this analysis for each reference 
concentration were compared for the different insulins respectively and found to give 
similar results in terms of calculated association constants (not shown). 
Thermodynamic non-ideality effects 
The effects of non-ideality in the present system are not large due to the relatively small 
size of, and net charge borne by, the insulin protein and because a restricted range of 
total concentration (0-1.5 g/L) was examined. At higher concentrations, however, the 
system can exhibit non-ideality (from excessive crowding or charge effects) and can 
obscure the existence of higher association states. It should be noted that the 
determination of the thermodynamic activity of monomer is independent of any 
assumption concerning the nature of the self-association pattern. There is, however, 
nothing to gain in the low concentration range considered here by the non-ideality 
correction; a decision based on the results of Mark et al. (Mark et al., 1987) when taking 
non-ideality effects into account over a wide concentration range 0.01 - 3.3 g/L for the 
calculation of the KA and Ks found that the values obtained differ little from those 
obtained neglecting non-ideality. 
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The allowance for non-ideality assumes greater significance in experimental 
environments where charge-charge interactions are increased in magnitude. The 
results (Mark et al., 1987) have shown that in the environment under discussion the 
values of the activity coefficients Yi differ very little from unity, even for higher 
polymeric species. 
5.5.2 The fitting of the m1 versus c, data to the IDI model 
Fitting the experimental data to a mathematical equation describing the IDI model of 
self-association of insulin was excellent as was interpreted from the results of the non 
linear regression analysis, namely R2 values, standard errors and 95% confidence 
intervals. A visual inspection of the fitted curve and experimental data (Figures 5.7-9) 
for all the different insulins support the goodness of fit parameters in all cases. 
It was found that HB 10D platypus insulin is dimeric in a zinc-free neutral pH 
environment and is similar to HBl0D human insulin (Weiss et al., 1991). The 
successful fitting of the sedimentation equilibrium data of this dimeric insulin 
analogue, HB 10D platypus insulin, to the IDI model of insulin self-association 
demonstrates the extensive applicability of this model. In addition, the association 
constants derived for this dimeric insulin analogue make biological sense in terms of 
what is known about the structure of insulin (Baker et al., 1988). 
It can be concluded that the IDI model for the self-association of insulin is supported 
by data in the present study for a specified solution environment (zinc-free, neutral 
pH, / = 0.1, T = 25 °C) and that previously obtained by others. 
The association constants KA and KB 
For all insulins the association constants KA and KB calculated from the omega 
analysis and returned in the ( M w I M1) versus c solid line curve, using equation 
5.21, are in good agreement with the experimental data points (Figure 5.1-3) by 
visual inspection. 
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The KA derived for bovine insulin in this study, 25000 M-1 , compares well with the 
value, 27400 M- 1 , obtained by Mark and Jeffrey (Mark and Jeffrey, 1990) in their 
sedimentation equilibrium study (ideal treatment) under identical solution conditions. 
The value for K8 , 8000 M-1 , in this study is, however, slightly lower than the value 
of 11800 M-1 , derived by Mark and Jeffrey (Mark and Jeffrey, 1990). This may be 
due to thermodynamic non-ideality effects as they used a much wider concentration 
range (0.1 - 3.3 g/L), using the Rayleigh interference optical system than was used in 
the present study (0-1.5 g/L). This overall good agreement in two completely 
independent studies adds confidence in the results of the analysis of the platypus 
insulin samples and is also a good indication of the global error in the association 
constants resulting from this kind of analysis. It should be noted that neutral pH 
insulin does not dissolve beyond 4 g/L (Mark et al., 1987). 
5.5.3 The dependence of "reduced" weight-average molecular weight on total 
insulin concentration : The overall extent of the self-association of zinc-free 
insulin 
The overall extent of the self-association of bovine, platypus and HB 1 OD platypus 
insulin differ markedly as illustrated in Figures 5.7-5.9 respectively and is governed by 
the relative values of association KA and K8 . In all instances self-association is 
present as is illustrated by the dependence of "reduced" weight-average molecular 
weight ( M w I M 1) of insulin on the total concentration. Even HB 1 OD platypus 
insulin self-associates, although its highest association state is two in these solution 
conditions. In the following section the extent and the role the association constants 
play in the self-association process of all the insulins will be discussed. 
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Comparison of the self-association pattern of bovine and platypus insulin 
From the comparison of the overall extent of association of zinc-free bovine and 
platypus insulins at neutral pH as reflected in plots of the concentration dependence 
of the "reduced" weight-average molecular weight ( M w I M1) versus c 
(Figure 5.10), it can be reasonably concluded that the extent of the self-association of 
platypus insulin is clearly less than that for bovine insulin. This reduction in self-
association is not very large but it is considered to be just significant in the light of the 
estimation of the magnitude of the errors as assessed from the comparison of the two 
studies of bovine insulin referred to above. Assuming experimental conditions are 
identical and sample preparations homogeneous the difference in the extent of self-
association can be attributed to the different amino-acid residues in the interaction 
regions (monomer-monomer interface and dimer-dimer interface) of monomeric 
insulin. The biological activity of the two insulins has been found to be identical 
(Chapter 4). The amino-acid residue changes, A5 Gln• Glu and B25 Phe• Tyr, in the 
receptor interaction region are not expected to change the self-association behaviour 
of insulin (Baker et al., 1988). 
The KA value of platypus insulin (47000 M-1) is nearly two fold higher in magnitude 
than that of bovine insulin (25000 M-1 ). The changes in amino-acid residues from 
bovine insulin to platypus insulin in the monomer-monomer interface ( a-a interaction 
region or OP interaction region in the crystal) are B25 Phe• Tyr and B27 Thr• Ile 
respectively. Comparing the properties of the residues (Table 3.1, Chapter 3) and 
according to previous studies the B25 Phe• Tyr is not expected to have an effect on 
the extent of monomer-monomer interaction in this region or its receptor binding 
capabilities. The B27 Thr• Ile substitution, however, introduces a more hydrophobic 
amino-acid residue in the monomer-monomer interface ( a-a interaction region) and 
has the potential to increase the extent of this self-association as hydrophobic 
interactions are considered to be the dominant force that govern this interaction as 
shown by (Jeffrey and Coates, 1966a; Baker et al., 1988). Mark et al. (Mark et al., 
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1987) in their sedimentation equilibrium studies of the self-association of bovine 
insulin over a wide pH range and at different ionic strengths and temperatures at 
pH 7.0, have found that the value of KA (which in all experimental environments is 
greater than KB) increases with increased temperature and increasing ionic strength; 
both characteristics of interactions which are predominantly hydrophobic in nature 
(Kauzmann, 1959). The relative small dependence of KA on pH (in comparison to KB) 
at fixed ionic strength and temperature is consistent with the above finding for the 
nature of the a-a interaction region (Mark et al., 1987). 
The KB value, representing the dimer-dimer interface (P-P interaction region or 
OQ interaction region in the crystal) according to the IDI model, of platypus insulin 
(3400 M-1) is more than two-fold smaller in magnitude than that of bovine insulin 
(8000 M-1 ). The changes in amino-acid residues from bovine to platypus insulin in the 
dimer-dimer interface are B2 Val• Pro and Al3 Leu• Met. When comparing the 
properties of the residues (Table 3.1, Chapter 3) it is seen that neither substitution 
would be expected to alter the overall hydrophobic nature of this region. The 
substitution of B2 Val• Pro, however, has the potential of having an effect on the 
spatial arrangement of residues in its region as Pro is known to be a breaker of 
secondary structure (Fasman, 1989) (Chapter 3). These properties of Pro in the B2 
position in platypus insulin could have an influence on the overall local arrangement 
of the amino-acid side chains in the dimer-dimer interface and thus translate into a 
reduced P-P interaction that is reflected in the sedimentation equilibrium experiments 
on the self-association of platypus insulin. 
In addition, the hydrophobicity (the value of free energies of transfer) calculated in 
kcal mole -1 for Pro is slightly lower than that for Val (Fasman, 1989). The 
A13 Leu• Met substitution introduces a sulfur containing amino-acid, slightly less 
hydrophobic than Leu (Fasman, 1989), into this region which in tum could effect the 
spatial arrangement of its neighbouring residues. Although the sulphur may have 
some H-bonding capability, the major role of methionine is to provide a very flexible 
hydrophobic side chain (Fasman, 1989). It was indeed found, when using molecular 
modelling (Chapter 3), that the spatial arrangement of residues Al 7, A13 and A14 in 
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the dimer-dimer interface is very different in platypus insulin. It is possible that this 
observation could translate into a change (reduction) in the extent of the 
self-interaction in the dimer-dimer interaction region and which indeed was found. 
Comparison of the self-association pattern of bovine and HB I OD platypus insulin 
X-ray analysis of mammalian insulins suggests that the B 10 His residue is important 
for the formation of zinc hexamers (Baker et al., 1988). This residue also participates 
in the hexamer contact (so called dimer-dimer interface) of non-zinc hexamers and 
thus forms part of the residues involved in the ~-~ interaction of insulin 
(OQ interaction in the crystal structure). It must be pointed out however, that it is by 
no means certain that the groups involved in the OQ interaction in the crystal (Baker 
et al., 1988) are necessarily the same ones involved in the associated states of zinc-
free insulin in free solution (Mark et al., 1987). Weiss et al. (Weiss et al., 1991) with 
their 2D NMR studies on a monomeric DKP human insulin in solution, also list 
B 10 His as involved in the dimer-dimer interface. 
Studies of HB 1 OD human insulin were originally motivated by the identification of 
Asp B 10 proinsulin in association with diabetes mellitus and hyperproinsulinemia in 
man (Gruppuso et al., 1984; Chan et al., 1987). The mutation apparently impairs the 
regulated pathway of proinsulin processing, storage and release (Carroll et al., 1988; 
Gross et al., 1989). The corresponding HB 1 OD human insulin analogue was 
synthesised and shown to exhibit enhanced bioactivity and receptor binding affinity 
(Schwartz et al., 1987). Its self-association was explored by the methods of 
osmometry (Brange et al., 1988) and sedimentation equilibrium (Weiss et al., 1991) 
and found to be dimeric in the solution conditions and in the concentration range 
studied. The latter concluded from their 2D NMR studies on this analogue that it is 
structurally conservative, in other words no significant structural changes occur upon 
the substitution at the B 10 position. 
Hagfish insulin (HB 10D) together with insulins from guinea pig (HB ION); coypu 
(HB 1 OQ), degu (HB 1 ON) and casiragua (HB 1 OQ) that have a substitution in the B 10 
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position do not form stable zinc hexamers (Burke et al., 1984). In addition, these 
insulins are found to be much less active than the B 10 His mammalian insulins which 
do form stable zinc hexamers (Emdin et al., 1980; Peterson et al., 1975). In contrast 
HB 1 OD human insulin which also do not form stable zinc hexamers has a high 
biological activity. The difference in activity is evidently due to the difference in the 
background sequence. The nature of the B 10 residue position has been explored with 
the chemical synthesis of BlO Asn, BIO Leu and BlO Lys human insulins (Burke et 
al., 1984 ). The data obtained in this particular study indicated that the steric character 
rather than the polarity of the amino-acid in this position is important for high 
biological activity. This view tends to agree with the finding that the BIO Asp human 
insulin analogue exhibits a potency of 2 to 4 times that of the natural hormone in an in 
vitro lipogenesis assay with rat fat cells (Schwartz et al., 1987). Unfortunately it is 
however a characteristic of insulin that changes in the activity measured in vitro are 
often not reflected in in vivo assays (Bristow, 1993). B 10 Asp human insulin, despite 
having a two to three fold increase in both receptor-binding and in vitro bioactivity, is 
- equipotent with human insulin in vivo (Bristow, 1993). 
In this study it was undertaken to synthesise a HB 1 OD platypus insulin analogue by a 
totally chemical means. The analogue displayed increased biological activity in vivo 
and the expected reduction in the extent of self-association in a zinc-free neutral pH 
solution environment. This is in contrast to a similar HB 1 OD human insulin analogue 
which does not show this increase in biological activity in vivo (Bristow, 1993). 
The HB 10D platypus insulin analogue also shows a dramatic reduction in the self-
association as demonstrated in Figure 5.9; a self-association state which does not 
increase beyond two. A similar finding for the state of association of 
HBlOD human insulin (a similar analogue) was found under similar solution 
conditions (Weiss et al., 1991) and the conclusion was made that this analogue is 
dimeric at 0.6 mM. No detailed analyses were however undertaken. The same result 
was also evident from osmometry studies with this analogue in similar conditions 
(Brange et al., 1988). To confuse matters it has even been suggested that it is 
monomeric at pharmacological concentrations (Bristow, 1993). The approach in the 
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work presented here was to analyse the self-association pattern in a zinc-free neutral 
pH solution, fitting sedimentation equilibrium data to a model of self-association and 
calculating the association constants. This has not been attempted before for an 
insulin with an Aspartic acid in the B 10 position. 
Although the background sequences between human and platypus insulins are 
different, it can reasonably be assumed that this does not contribute in a major way to 
the reduction of self-association as the difference in the extent of the self-association 
of bovine and platypus is not very marked. In the HB 1 OD platypus insulin one amino-
acid residue change in the dimer-dimer interface has been introduced that presumably 
destroys the P-P interaction under these conditions. This hypothesis can be supported 
by analysing the self-association pattern of this analogue. 
The KA value (103,900 M-1) that represents the a-a interaction region (monomer-
monomer interface) according to the IDI model of HB lOD platypus insulin, is just 
over four times higher in magnitude than that of bovine insulin (25000 M-1). In 
contrast, the KB value (69 M-1 ), that represents the P-P interaction region 
( dimer-dimer interface) according to the IDI model, of HB 1 OD platypus insulin, is 
effectively zero (bovine insulin 8000 M-1 ). H can concluded that this huge reduction in 
KB value virtually abolishes the P-P interaction involving the dimer-dimer interface. 
The increase in the KA value for HB 1 OD platypus insulin could be explained as 
follows. It is possible that with the abolishment of the P-P interaction, and thus 
removing of this previously (in the native sequence insulins) competing self-
association event , that the availability for association via the a a interaction region 
increases. In other words the a - a interaction is stronger in the absence of a 
competing P-P interaction. These quantitative findings demonstrate nicely that 
analysis of the self-association pattern employing sedimentation equilibrium and the 
omega method allows meaningful correlations to be made between changes at the 
molecular level and their subsequent expression at the structural and biological 
activity level. 
128 
11: 
Comparison with published results of state of association 
Table 5.3 demonstrates the variation in the state of association ( M w I M1 ) that can be 
found when different methods, sometimes over various concentration ranges, for 
collection of sedimentation equilibrium data in similar solution environments. The 
difference in the association state between platypus and bovine insulin only came to 
light when the latter insulin is used as a standard against which the state of association 
of other insulins are measured under the exact conditions. This difference, in the light 
of these data, must however be interpreted with caution. It can be concluded that the 
state of association of platypus insulin does not deviate significantly from that found 
for the other mammalian insulins. Since the state of association of platypus insulin is 
not dramatically different from other mammalian insulins, it validates the success of 
the use of chemical synthesis (this thesis). The same conclusion regarding the success 
of chemical synthesis can be made for HB 1 OD platypus insulin. The association state 
of this analogue in this study was found to be similar to that for HBlOD human 
insulin. 
5.5.4 Weight-fractions as a function of total concentration 
In the following discussion it will be assumed that the IDI model for the self-
association of insulin applies. The rationale for utilising this model has been given in 
the theory section of this chapter. As noted already, the sedimentation data acquired 
and analysed in this study for all insulins also supports the validity of this model of 
self-association. Thus, variations of the association constants can be explained in 
terms of the known properties of amino-acid residues in the postulated interaction 
regions (self-association and receptor binding regions). 
Figures 5.13-5.15 clearly demonstrate, in tenns of weight-fractions, the complex 
distribution of species within each of the three insulins under study in a zinc-free 
solution (pH 7 .O; / = 0.1 M ; T = 25 °C) as well as the effect of the relative difference 
in KA and K8 values for the different insulins. 
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Despite the significant difference between the KA and KB values of the different 
insulins, the weight-fractions of the monomers including HB lOD platypus insulin, do 
not differ significantly, even in the higher concentration range (Figure 5.16). This is 
reflected in the experimental finding that the extrapolated n° values of all three 
insulins at a reference concentration of 0.5 g/L are identical within experimental error. 
Bovine, platypus and HB 1 OD platypus insulins are overwhelmingly monomeric at 
these low concentrations as is shown graphically in Figure 5.16. This can be expected 
since in humans the plasma insulin concentration range is 0.7 - 3 ng/mL (Fajans et al., 
1972) and in vitro binding and biological activity studies in cells maximum stimulation 
occurs at 10 ng/mL (Marsh et al., 1984). Insulin solutions containing 10 ng/mL of 
insulin would comprise 99.987% monomer by weight using equation 5.23. Apart 
from the existence of zinc hexamer crystals in the p granules of the pancreas (Baker 
et al., 1988), in a biological context no function for the self-association of insulin has 
been found in vivo (Jeffrey et al., 1976; DeMeyts et al., 1976). 
The magnitude of the KA value describes the strength of the a-a interaction along the 
monomer-monomer interface of both monomers in the P- dimer. The constant KB 
defines the strength of the P-P interaction to produce a-dimers. Figure 5.18 illustrates 
the comparison of the weight-fractions of a- and p dimers of bovine and platypus 
insulin and P-dimers of HB 1 OD platypus insulin. The magnitude of the KA value of 
these insulins decrease as follows; HB 1 OD platypus insulin > platypus insulin > and 
bovine insulin (Table 5.2) and is reflected in the concurrent decrease in the weight-
fraction of their P-dimers in the same order with the highest weight- fraction being 
that of HB 1 OD platypus insulin. The weight-fraction of P-dimer of HB 1 OD platypus 
insulin is approximately 0.8 (80% by weight) at concentrations 0.4 g/L and higher. In 
contrast, bovine- and platypus insulin under the above solution conditions consist of 
an array of different oligomers and polymers. 
A similar trend is noticed with the weight-fractions of the a-dimers of these insulins. 
With a decrease in the magnitude of the KB value there is a decrease in the weight-
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fraction of the a-dimer with the existence of a-dimers in a solution of HB 1 OD 
platypus insulin negligible, showing that the P-P interaction is virtually wiped out. 
Likewise the lower K8 value for platypus than bovine insulin is reflected by the lower 
weight-fraction of the a-dimer of platypus insulin. Comparing the different insulins, 
the difference in strength of the a-a interaction of the P-dimer and P-P interaction of 
the a-dimer manifest itself also in the difference of the weight-fractions of the other 
species, trimers, a- and P-tetramers, pentamers and hexamers. These are all slightly 
lower for platypus than for bovine insulin in the direction predicted by the modelling 
exercises (Chapter 3). The really significant result is of course found in HBlOD 
platypus insulin. There are effectively no oligomeric species present in this 
synthesised, fully active mutant platypus insulin except P-dimers. 
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5.6 Future work 
The production of a therapeutic insulin which is more user friendly is still being pursued. 
The reason for this is that there are still problems associated with the exogenous 
administration of insulin. Specific physico-chemical and biological properties have been 
identified as desirable, for example a fully active insulin that exhibits reduced self-
association in solution at the concentration administered and at physiological pH 
(Chapter 1). Directions to take in the design of these therapeutic insulins may be 
indicated and become apparent from ongoing research. Some of these indications which 
have become apparent to this author are outlined below. 
The success of the total chemical synthesis of the native and mutant platypus insulins 
(this thesis) sets the stage for the synthesis of mutant insulins containing non-
proteinogenic amino-acids. It is hoped that by doing this it might be possible to abolish or 
reduce self-association by substituting residues involved in this self-association. An 
insulin with desirable properties could thus be obtained that would improve insulin 
therapy (Chapter 1). A13 Met is unique in platypus and B2 Pro is only found in insulins 
from reptiles and fishes (Chapter 3 ). The importance of these positions in the insulin 
molecule is that they are involved in dimer-dimer interaction (Chapter 3) and are thought 
to be responsible for the reduced self-association that was observed for platypus insulin 
(this thesis). Thus to investigate the effect of substituting non-proteinogenic amino-acid 
residues with specific properties in positions A13 and B2 on self-association, mutant 
A- and B-chains MA13Nle, MA13Mso and PB2Nma were chemically synthesised by the 
author. These will be combined with their respective native A- and B-chains to form the 
mutants insulins based on the platypus insulin sequence. 
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The residue properties of the following non-proteinogenic amino-acids were chosen: 
• Nle (Mutant MA13Nle; A13 Met replaced by a nor-leucine). 
Compared to Met (the residue in platypus insulin in this position) Nle is 
less hydrophobic. Both have similar side-chain lengths. Also Met is 
involved in a specific interaction with the aromatic rings of the tyrosine on 
either side of the Met side-chain as observed in the molecular model of 
platypus insulin (Chapter 3).The effect of disrupting that specific 
interaction on receptor binding and self-association can be investigated. 
Also compared to Val (the residue in human insulin) Nle has a longer 
side-chain length by one carbon. Sterle properties on self-association and 
receptor binding can be investigated. 
• Mso (Mutant MA13Mso; A 13 Met replaced by a Met-sulfoxide). 
Compared to Met (the residue in platypus insulin in this position), Mso is 
more polar and the effect of a more polar residue (similar properties and 
size) on receptor binding and self-association can be investigated. 
• Nma (Mutant PB2Nma; B2 Pro replace by N-methyl alanine). 
Compared to Pro (the residue in platypus insulin in this position), Nma is 
similar in size and polarity but does not have the steric restrictive 
characteristic of Pro that is known to be a breaker of regular secondary 
structure (Fasman, 1989). Also Pro is occasionally found to be the second 
residue in N-terminal capping boxes of helices (Harper and Rose, 1993). 
B 1-8 in insulin is nonnally in the extended ~-conformation in insulin and a 
Pro in the B2 position may give this a more helical character. (This was 
observed in the molecular model of platypus insulin, not shown). The self-
association properties of this mutant can be investigated. 
The residue at position A13 in insulin is implicated in modulating the binding to its 
receptor (Schaffer, 1994) and platypus insulin has an unique Met in that position. 
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Therefore receptor binding studies need to be perfonned on the synthetic native and 
mutant platypus insulins presented in this study as well as those proposed above since the 
different amino-acids in the receptor binding region might be significant in influencing a 
change in binding with its receptor. 
Insulin has both metabolic and growth-promoting activities. These growth-promotion 
activities have been shown to include rapid effects on gene transcription (Messina, 1990). 
The hystricomorph (guinea pig, porcupine, coypu and casiragua) insulins and insulin-like 
growth factors display relatively higher potencies for growth promotion effects than most 
mammalian insulins. Platypus insulin shares residues in the receptor binding region with 
some of these hystricomorph insulins and insulin-like growth factors (Rinderknecht and 
Humbel, 1978) that display high potencies for growth promotion effects (King and Kahn, 
1981; Blundell, 1972). These residues are A5 Glu and B25 Tyr. The residue B 10 Asp in 
the mutant platypus insulin sequence with similar properties than the corresponding 
residue in some of the hystricomorph insulins and insulin-like growth factors (B 10 Glu) 
may also contribute to growth. Another is A8 Lys in the mutant and native platypus 
insulin sequence. His in this A8 position in chicken insulin is thought to contribute to its 
high potency for growth (King and Kahn, 1981). Lys and His are both basic amino acids 
in contrast to most mammalian insulins with Thr in that position. (All the amino-acid 
sequences were found in the SWISSPROT amino-acid sequence database (Chapter 3). 
It is of interest that the marsupial kangaroo insulin also has a basic amino-acid Asn in that 
position (Treacy et al., 1989). Thus in the light of some residues of the mutant and native 
platypus sequence that are implicated in higher potencies for growth than most 
mammalian insulins this activity should be tested. 
Structural information of these insulin mutants from nuclear magnetic resonance (NMR) 
experiments as well as from X-ray crystallography may also contribute to a better 
understanding of the self-association properties and biological activity of insulin. 
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It is noted that an increase in temperature resulted in an increase of the KA value and a 
decrease of the K8 value when analysing the self-association pattern of bovine insulin as 
obtained using sedimentation equilibrium and the IDI model of self-association (Mark et 
al., 1987). This is a demonstration that temperature has an influence on the self-
association pattern of bovine insulin. It would be interesting to investigate the influence 
of temperature on the self-association behaviour of platypus insulin since platypus has a 
body temperature of only 32 °C. Since its insulin functions at lower temperatures, the 
self-association pattern of platypus insulin might be significantly different from the 
patterns of other mammalian insulins. From such a study some desirable properties may 
come to light that may be used in the design of therapeutic insulins. 
The ideal therapeutic insulin would be one that can be taken orally avoiding the 
discomfort of application by injection and the problems associated with the latter 
(Chapter 1). (Also nasal application of insulin as an alternative to injection has been 
associated with problems.) Such an insulin must not be degraded by the proteolytic 
enzymes in the digestive system, be absorbed into the circulation and must not be 
immunogenic. If this is possible it is envisaged that it can best be accomplished by the 
total chemical synthesis of insulin and substituting natural amino-acids in the sequence 
with non-proteinogenic amino-acids which have all the specific desirable properties and 
which also block proteolytic degradation. 
It is a hope of this author to be able to extend the work already started and even work in 
a project with the goal of producing the ideal therapeutic insulin. 
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Short Communication 
Platypus Insulin: Indications from the Amino Acid Sequence of 
Significant Differences in Structure from Porcine Insulin 
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Insulin from a monotreme, the platypus (Ornithorhyn-
chu~ anatinus), was isolated and the amino acid se-
quence determined. It differs from pig insulin at eleven 
amino acid sites, mainly on the surface of the 
monomer. Substitutions relative to pig insulin occur in 
the monomer-monomer interface, the dimer-dimer in-
terface and the receptor binding region. The residues 
AS Glu, A8 Lys and A13 Met have not been reported be-
fore in any insulin. Multiple sequence comparison 
studies reveal a relatively close relationship with the 
nearest group of relatives to the platypus, the mam-
mals. The relationship of the platypus sequence to rep-
tilian insulin sequences {and amphibian and avian in-
sulin sequences in this case) is sufficiently close to 
support the observation that platypus has retained 
some ancient reptilian characteristics over the course 
of evolution. Model building the platypus insulin se-
quence on the structure of porcine insulin indicates 
that there may be some interesting differences. 
Key words: Amino acid sequence/ Insulin structure/ 
Molecular modelling/ Platypus/ Sequence comparison. 
The platypus (Ornithorhynchus anatinus) is the only extant 
species of the family Ornithorhynchidae belonging to the 
order Monotremata, the egg laying mammals. It is an an-
cient highly specialised animal well adapted to its am-
phibious existence in the waterways of eastern Australia 
(Grant, 1989). Its biological features indicate that it is more 
closely related to marsupial and placental mammals than 
to any group of reptiles, despite retaining several ancestral 
reptilian characteristics over the course of evolution 
(Grant, 1989; Griffiths, 1988). 
Mammalian insulin, under physiological conditions of 
pH and at concentrations required for exogenous admin-
istration, strongly self-associates in solution to form a 
complex mixture of polymeric species (Blundell et al., 
1972; Jeffrey et al., 1976). As insulin is biologically active in 
its monomeric form, attempts have been made to keep in-
sulin in this highly desirable state (Brange et al., 1988). 
Numerous strategies have been employed in efforts to try 
and achieve this, mainly on insulins from human, pig and 
cow, without much success. These are addition (Bringer et 
al., 1981) and removal (Jeffrey, 1986) of substances to insu-
lin solutions and replacement or modification of strategi-
cally chosen amino-acids (Brange et al., 1988;Weiss et al., 
1991 ). Investigation of the composition, structure, biologi-
cal activity and self-association of insulin from more exo-
tic species, like the platypus, increases the possibility of 
identifying an insulin with desirable properties by exploit-
ing natural variation. 
The uniqueness of platypus insulin presents this oppor-
tunity to study the structure-function relationship because 
it differs from that of human at eleven amino-acid sites, 
three of which exhibit residues that have not been ob-
served in other organisms. It also differs from pig and 
human insulin at its self-associating surfaces (monomer-
monomer and dimer-dimer interfaces) by 4 residues, offer-
ing the possibility of a change in association properties, 
and at its receptor binding surface by 2 residues, offering 
the possibility of a change in biological activity. 
On the basis of the complete platypus insulin amino-
acid sequence, a three dimensional structure was model-
led on the X-ray crystal structure of porcine insulin. These 
studies form part of a program with the aim of evaluating 
insulins and insulin derivatives, both new and previously 
reported, with the desired characteristics. 
A Chain 
I S lO IS 20 
GI VEECCKGVCS MYQLENYCN 
Q TS I L 
B Chain 
I S 10 IS 20 2S 30 
FPNQHLCGSHLVEALYLVCGEKGFYYI PRM 
V R F T KA 
Fig. 1 Amino Acid Sequence of Insulin from Platypus Or-
nithorhynchus anatinus. 
The residues of porcine insulin at sites where they differ are 
shown below. Peptide sequences were determined using the 
Applied Biosystems Model 477, a pulsed liquid phase sequencer 
with on-line Model 120A PTH-Analyser modified for nanomole 
sensitivity. Methods used were as described previously (Treacy et 
al., 1989). The molecular mass of platypus insulin, calculated as 
5865 daltons, has been confirmed with the matrix-assisted laser 
desorption ionisation (MALDI) time-of-flight mass spectrometer. 
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Table1 A Comparison of the Amino Acid Sequence of Platypus and Porcine Insulin. 
Only platypus amino acid subst1tut1ons relative to porcine insulin are presented. 
Residue Amino acid Side chain properties Structural domaina.b Typea.b 
Porcine Platypus Porcine Platypus 
A5 Gin Glu polar acidic a-helix , receptor binding conserved 
AS Thr Lys polar basic a-helix variable 
A9 Ser Gly polar surface residue variable 
A10 lie Val non polar non polar extended B conformation variable 
A13 Leu Met non polar non polar, S a-helix, dimer-dimer interface variable 
B2 Val Pro non polar non polar dimer-dimer interface variable 
B22 Arg Lys basic basic Bbend conserved 
B25 Phe Tyr aromatic aromatic monomer-monomer interface, conserved 
receptor binding region 
B27 Thr lie polar non polar monomer-monomer interface variable 
B29 Lys Arg basic basic extended B chain variable 
B30 Ala Met polar non polar, S extended B chain variable 
a Baker et al. , 1988. 
b Shoelson et al., 1992. 
Table 2 Comparison of Platypus Insulin with Insulin Sequences 
from other Organisms. 
Only platypus insulin residues different from porcine insulin are 
shown. Sequence library used was the SWISS-PROT database. 
Organisms that share residues with 
platypus insulin 
Platypus insulin 
Rattle snake, cantor, electric ray, dogfish , 
degu, copyu , casiragua 
Elephant, goat, porcupine, sheep, horse, 
guinea pig 
Elephant, goat, porcupine, sheep, cat , 
camel, bovine 
Rattle snake, cantor, electric ray, dogfish , 
ratfish, elephantfish 
Electric ray, dogfish, salmon, alligator 
Guinea pig 
Rattle snake, cantor 
Sponge 
a Residues not observed in other organisms. 
residues 
--
A58 
A88 
A138 
B25b 
A9c 
A10c 
B2c 
B22c 
B27c 
s29c 
830c 
b Residues conserved, but observed in other organisms. 
c Residues variable and shared with other organisms. 
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Platypus pancreatic tissue was obtained from 9 animals 
which had been deep frozen at death. The extraction of in-
sulin from the pancreases was carried out in the cold ac-
cording to the method of Treacy et al. (1989). The precipi-
tate did not separate cleanly from the liquid but rather as a 
dark coloured oily-looki11g liquid between the yellow pre-
cipitate and the other layer. Platypus insulin was obtained 
from this 'oily supernatant'. Reverse phase HPLC was em-
ployed to purify the insulin. Elution was in 0.09 % aqueous 
trifluoroacetic acid using a linear gradient from 8 % to 
SO% acetonitrile in 20 minutes. 
The amino-acid sequence of platypus insulin, shown in 
Figure 1, differs from that of human and pig insulin at ele-
ven residues. Most of these, summarised in Table 1, repre-
sent relatively conservative substitutions in regions that 
have been observed as varying from highly conserved to 
variable. Three, AS Glu, A8 Lys and A 13 Met have not been 
observed in other organisms (Table 2). Most substitutions 
occur on the surface, or at least partial surface, in regions 
of important receptor binding and aggregation of the 
molecule. The amino acid sequence reveals strict conser-
vation of the residues known to be involved in maintaining 
the three dimensional structure (Baker et al., 1988). These 
include the thirteen invariant residues (the six half-cystine 
residues, A6, A7, A11, A20, B7, B19, glycine residues at B8 
and B23, leucine residues at A16, B6, B11 , and B1S and 
B12 Val) as well as the invariant group of surface residues 
believed to be involved in receptor binding and expression 
of biological activity (A 1 Gly, A 19 Tyr and A21 Asn) (Baker et 
al., 1988). Some of the conservative sites A2 lie, A3 Val , 
B24 Phe and B26 Phe to be found on the surface of the 
molecule are present in the platypus insulin structure. AS , 
B22 and B2S, that are grouped with the latter, are conser-
vative changes of AS Gln~ Glu , B22 Arg~ Lys and B2S 
Phe~ Tyr in platypus insulin. 
There are three distinct surfaces on the insulin mole-
cule, namely the monomer-monomer interface (A21, B8, 
B9, B12, B16, B20, B21 and B23-B28), the dimer-dimer 
interface (A13, A14 , A17, B1, B2, B4, B10, B13, B14, and 
B17-20) that constitute the protein-protein interactive 
surfaces and the receptor binding surface (A 1, AS , A 19, 
A21 , B12 , B16, B23, B24 and B2S) (Baker et al. , 1988; 
Shoelson et al. , 1992). Platypus insulin has substitutions 
at all three interactive surfaces, namely B2S Phe~ Tyr 
and B27 Thr~ lle (monomer-monomer interface); A13 
Leu~ Met and B2 Val~ Pro (dimer-dimer interface) and AS 
Gln~ Glu and B2S Phe~ Tyr (receptor binding region). 
Self-associating forces that lead to dimerisation of insu-
lin (Baker et al., 1988; Shoelson et al. , 1992) are predomin-
antly non-polar, reinforced by hydrogen bonding (Baker et 
al., 1988; Packer and Biswas, 1981 ). Thus B2S and B27 lie, 
the residues different in platypus and part of monomer-
monomer interface, considered conservative changes, 
fulfil these criteria. All other residues that form part of this 
surface, including B28 Pro, the latter especially important 
for high affinity self association (Brems et al., 1992), are un-
changed in platypus insulin. It can be concluded then that 
it is highly likely that the platypus insulin will form dimers 
and as B5 His and B 10 His are conserved, hexamerization 
can be expected in the presence of zinc (Bentley et al., 
1976; Blundell et al., 1972). 
A model for insulin binding to the receptor was recently 
proposed (Schaffer, 1994) where the involvement of A 13 
and B17 in a putative second receptor binding site were 
discussed. Platypus insulin has a Met in position A 13, 
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Fig.2 Dendogram Displaying the Clustering Relationships of 
the Primary Sequence of Platypus Insulin with Insulins from Other 
Organisms Using the PILEUP Program, Genetics Computer 
Group (GCG) Sequence Analysis Software Package Version 7.1 
(Devereux et al., 1984). 
PILEUP is an extension of GAP (GCG) where a multiple sequence 
alignment (Feng and Doolittle, 1987), is created from a group of re-
lated sequences using progressive pairwise alignment. Platypus 
insulin was given the name plin. Names of insulins from different 
organisms are SWISS-PROT designations and their sequences 
and their respective references are stored in the SWISS-PROT 
database. Own clustering nomenclature was used. 
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which has not been seen in other organisms. B25 Tyr, also 
part of the receptor binding region and different from pig 
insulin, is Phe in most organ isms. The aromatic ring seems 
to be important for biological activity (Nakagawa andTager, 
1986). It has been shown that substitution atA8Thrfor Arg 
or His (positively charged residues) provides strong stabi-
lisation of the A-chain NHrterminal a-helix and lead to en-
hanced biological activity (Kaarsholm et al., 1993). Sub-
stitutions at A5 Gln~Glu (receptor binding region and 
charged) and AB Thr~Lys (positively charged residue) of 
platypus insulin introduce possible charge interactions in 
this region. The A5 Glu and B25 Tyr substitutions are 
known from the IGF-1 molecule (Rinderknecht and Hum-
bel, 1978) and in combination with substitutions inA8,A13 
and B22, indicate that binding properties to the insulin 
and IGF-1 receptors would be interesting to investigate. 
Receptor interaction and biological activity may be af-
fected by the above substitutions and the structural con-
sequences need direct investigation. 
Pairwise comparisons of platypus insulin sequences 
with insulin sequences from other organisms were per-
formed using the GAP sequence comparison algorithm of 
Needleman and Wunch (Needleman and Wunch, 1970). 
This is presented in Table 3 in order of decreasing percent 
identity with the platypus insulin sequence. 
The insulin sequences from different organisms were 
subjected to multiple sequence alignment on the basis of 
pairwise similarity. The vertical branch distance of the den-
dogram are proportional to the similarity between se-
quences (Devereux et al., 1984). In the resultant dendo-
gram the insulin sequences cluster into 4 main branches 
(Figure 2). 
The first two branches consist of the amphibian insulin 
sequence (cluster 1) and mammalian insulin sequence 
(cluster 2). These two together form cluster 3. The mam-
malian insulin sequences (cluster 2) can be roughly di-
vided into subcluster 2.1, the mouse and rat insulin se-
quences and subcluster 2.2, which contain the very simi-
lar sequences of porcine, bovine, human, elephant etc. It 
can be pointed out that the marsupial insulin sequence 
(Oidelphis marsupials virginiana identical to kangaroo 
Macropus giganteus) (Treacy et al., 1989) and the low po-
tency insulins of Aotus trivirgatus (Seino et al., 1987), Hys-
trix cristata (King and Kahn, 1981) and Chinchilla bre-
vicaudata (Horuk et al., 1979) are outside subclusters 2.1 
and 2.2 which indicate that they are more distantly related. 
The third branch is represented by the single platypus in-
sulin sequence which participates in a clustering relation-
ship with the amphibian and mammalian insulin se-
quences (cluster 3) to form cluster 4. The final branch con-
sist of reptilian and avian insulin sequences (cluster 5) that 
clusters with cluster 4 to form cluster 6. (Multiple se-
quence alignment with fish and other hystricomorph ro-
dent insulin sequences are not shown.) 
On taxonomic grounds it is believed that the mono-
tremes are the last survivors of a group of early mammals 
that evolved independently of the creatures that gave rise 
to today's marsupials and other mammals (Grant, 1989; 
150 A. Nourse et al. 
Table 3 Pairwise Comparison of Platypus Insulin with Insulin Sequences from Other Organisms in Order of Decreasing Percent Identity. 
SWISS-PROT 
Nomenclature 
Plina 
lns_Elema 
lns_Caphi 
lns_Sheep 
lns_Horse 
lns_Camdr 
lns_Bovin 
lns_Balph 
lns_Macfa 
lns_Canfa 
lns_Pig 
lns_Human 
lns_Rabit 
lns_Felca 
lns_Balbo 
lns_Anapl 
lns_Croat 
lns_Ansan 
lns_Chick 
lns_Crilo 
lns_Hyscr 
lns_Lepsp 
lns_Zoadh 
lns_Acoca 
lns_Didma 
lns2_Rat 
lns2_Mouse 
lns_Allmi 
Organ isms 
Ornithorhynchus anatinus 
(platypus) 
Elephas maximus 
(Indian elephant) 
Capra hircus 
(goat) 
Ovisarie 
(sheep) 
Equus cabal/us 
(horse) 
Came/us dromedarius 
(Arabian camel) 
Bos taurus 
(bovine) 
Ba/aenoptera physalus 
(fin back whale) 
Macaca fascicularis 
(monkey) 
Canis familiaris 
(dog) 
Susscrofa 
(pig) 
Homo sapiens 
(man) 
Oryctolagus cuniculus 
(rabbit) 
Fe/is catus 
(cat) 
Balaenoptera borealis 
(sei whale) 
Anas plathyrhynchos 
(duck) 
Crotalus atrox 
(rattlesnake) 
Anser anser anser(goose) 
Gallus gal/us (chicken) 
Cricetulus longicaudatus 
(Chinese hamster) 
Hystrix cristata (porcupine) 
Lepisosteus spatula (alligator) 
Zaocys dhumnades ( cantor) 
Acomys cahirinus 
(Egyptian spiny mouse) 
Didelphis marsupials virginiana 
(opossum) 
Rattus norvegicus 2 (rat) 
Mus muscu/us 2 (mouse) 
Alligator mississippiensis 
a Name assigned for platypus insulin. 
% Identity 
100 
82.353 
82.353 
82.353 
80.392 
80.392 
80.392 
78.431 
78.431 
78.431 
78.431 
78.431 
78.431 
78.431 
78.431 
76.471 
76.471 
76.471 
76.471 
76.471 
76.471 
74.510 
74.510 
74.510 
74.510 
74.510 
74.510 
74.000 
SWISS-PROT 
Nomenclature 
lns_Geocy 
lns2_Xenla 
lns1_Mouse 
lns1_Rat 
lns_Squac 
lns1_Xenla 
lns_Aottr 
lns_Torma 
lns_Chibr 
lns_Oncgo 
lns_Loppi 
lns_Cypca 
lns_Oncke 
lns_Myosc 
Ins_ Thuth 
lns_Plafe 
lns_Petma 
lns_Calmi 
lns_Hydco 
lns1_Batsp 
lns_Gadca 
lns2_Batsp 
lns_Katpe 
lns_Myxgl 
lns_Octde 
lns_Cavpo 
lns_Myoco 
lns_Progu 
Organisms % Identity 
Geod,a cydonium (sponge) 7 4.000 
Xenopus laevis2 72.549 
(African clawed frog) 
Mus musculus 1 (mouse) 72.549 
Rattus norvegicus 1 (rat) 72.549 
Squalus acanthias (spiny dogfish) 72.549 
Xenopus /aevis 1 70.588 
(African clawed frog) 
Aotus trivirgatus (night monkey) 70.588 
Torpedo marmorata (electric ray) 70.588 
Chinchilla brevicaudata 68.627 
(chinchilla) 
Onchorhynchus gorbuscha 68.000 
(salmon) 
Lophius piscatorius (goosefish) 67 .34 7 
Cyprinuscarpio(carp) 67.347 
Oncorhynchus keta 66.667 
(salmon) 
Myoxocephalus scorpius 66.000 
(sculpin) 
Thunnus thynnus 66.000 
2 (bluefin tuna) 
Platichthys flesus 66.000 
(flounderer) 
Petromyzon marinus 66.000 
(sea lamprey) 
Callorhynchus mi/ii 64. 706 
(elephantfish) 
Hydrolagus colliei 64. 706 
(spotted ratfish) 
Batrachoididae sp 64.000 
1 (toadfish) 
Gadus cal/arias 64.000 
(Baltic cod) 
Batrachoididae sp 63.265 
(toadfish) 
Katsuwonus pelamis 62.000 
(skipjack tuna) 
Myxine glutinosa 60. 784 
(Atlantic hagfish) 
Octodon degus 60.000 
(degu) 
Gavia parcel/us 58.824 
(guinea pig) 
Myocastorcoypus 54.000 
(coypu) 
Proechimys guairae 54.000 
(casiragua) 
Amino-acid sequence comparisons were performed using the Genetics Computer Group (GCG) Sequence Analysis Software Package 
Version 7.1 (Devereux et al., 1~84) that include the FASTA, GAP and SEQED programmes. The computationally fast algorithm FASTA, (Pear-
son and Lipman, 1988) that allows a homology search of one sequence against the entire SWISS-PROT amino acid sequence database 
was employed to search for insulin from different organisms with amino acid sequences related to the amino acid sequence of platypus 
insulin. Scores between platypus insulin amino acid sequence and each of the database entries were calculated and presented in order 
of decreasing best scores with the highest scores corresponding to the strongest relationship. The best 55 scores (all the insulin amino 
acid sequences) were subjected to a more sensitive sequence comparison program, GAP (Needleman and Wunch, 1970). The GAP pro-
gram that covers the complete sequence, maximises the number of matches and minimises the number of gaps. Data entries, where the 
amino acid sequences included the signal and C chain , had been edited out with SEQED for the GAP alignments. 
Griffiths, 1988). The PILEUP dendogram, displaying inter-
relationships of insulin sequences from different animals 
(Figure 2) reflects this theory. Although the platypus insulin 
sequence is not part of subcluster 2.2 that contains the 
similar sequences of human, porcine, and elephant etc. 
and from which some rodent and marsupial insulin se-
quences are excluded, its closest relationship appears to 
be with the mammalian insulin sequence as a single 
member of a more distantly related branch (cluster 2 of 
Figure 2 and highest percent identity, Table 3). Its relation-
ship with reptilian insulin sequences (and amphibian and 
avian insulin sequences in this case) is sufficiently close to 
support the observation that platypus has retained some 
ancient reptilian characteristics over the course of evolu-
tion (Grant, 1989; Griffiths, 1988). The insulin sequence of 
the other living member of the monotremes the echidna, 
two species 7achyglossus aculeatus and Zag loss us bruijnii 
(Grant, 1989; Griffiths, 1988) is still unknown. It would be 
expected that the sequence is similar (or identical) to that 
of platypus and thus should subcluster with it. In support 
of this proposal is the similar subclustering of the mouse 
and rat in subcluster 2.1 as well as the snakes in subcluster 
5.1 (own nomenclature). The results of the sequence com-
parison studies fits in with known taxonomic data used to 
classify and compile a hypothesis for the evolutionary re-
Porcine Insulin 
B25 
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lationship of platypus with these animals (Grant, 1989; 
Griffiths, 1988). 
In the computer modelling exercise of the platypus in-
sulin, monomer 2 (Chinese convention) was energy 
minimised and molecular dynamics for 100 ps of simula-
tion at 200 K have been performed in vacuo. Upon viewing 
the animation of the molecular dynamics simulation from 
1 to 100 ps it was noted that the structures changed very 
little between 35 ps to 100 ps. Movement of the B1 Phe oc-
cured but the arrangement of B1 Phe, A 13 Met and A 14 Tyr 
(see later) remained essentially the same. Transient struc-
tures written at 15 ps; 55 ps; 81 ps and 97 ps were chosen 
and each were energy minimised in vacuo. Structures 
minimised at 55 ps; 81 ps and 97 ps superimposed well 
and remained essentially the same. 
Comparison of the structure of the molecular model 
with that of pig insulin reveals it to be different. The A2-8 
a-helix seems more distorted and the B21-23 turn more 
irregular. The C-terminal B28-B30 end of the B-chain, 
which is known to be flexible, folds slightly back towards 
the main body of the monomer. A two-fold axis view reve-
als residues A 13, A 14, A 17, B1 and B2 (part of the dimer-
dimer interface) to be involved in a different spatial ar-
rangement from pig insulin (Figure 3). The non polar nature 
has been preserved in the two amino acids (A 13 Met and 
Platypus Insulin 
A13 
Fig.3 Space-Filling Diagrams of Modelled Platypus Insulin Monomer 2 and Porcine Insulin Monomer 2 Viewed in the Direction of the 
Local Two-Fold Axis. 
Receptor binding region (diagonal right to left line shading), monomer-monomer interface (diagonal left to right line shading), dimer-dimer 
interface (shaded), A13 (speckled); platypus insulin A5, B25, and B27 (vertical line shading). Platypus monomer insulin structure was 
modelled on the X-ray crystal structure of rhombohedral 2 Zn porcine insulin, monomer 2, entry 3 ins (Wlodawer et al., 1989) of the 
Brookhaven Protein Databank. The pig insulin monomer 2 structure was subjected to 250 iterations of steepest decent energy minimisa-
tion followed by 5000 iterations of conjugate gradient in vacuo and was used for modelling the structure of platypus monomer 2 insulin 
with the appropriate different residues. The platypus monomer 2 insulin has been subjected to 250 iterations of steepest descent energy 
minimisation followed by 5000 iterations of conjugate gradient energy minimisation in vacuo. Molecular dynamics of 100 ps of simulation 
at 200 K have subsequently been performed in vacuo. Analysis was performed using the transient structures written at intervals of 1 ps. 
Computrations for molecular dynamics were carried out using the Fujitsu VP of the Australian National University Supercomputer Facility. 
The number of iterations were 100000 with a time step of 1 fsec. A history file was written every 1000 steps. Transient structures written 
at 15 ps; 55 ps; 81 ps and 97 ps were chosen and each was energy minimised by using the conjugate gradient algorithm for 5000 steps in 
vacuo. In all cases the maximum derivative was below 0.001 kcal/mol-A. Both the energy minimisations and simulations were carried out 
using the program Discover Version 94.0 (May 1994) on a Silicon Graphics workstation as well as the analysis using the program Analysis, 
all generated by the computer program Insight II version 2.3.0 (December 1993). 
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82 Pro) of platypus insulin that differ from pig insulin in this 
interface. In the porcine insulin crystal there exists an A 14 
Tyr-81 Phe interaction in the dimer-dimer interface (Baker 
et al., 1988; Blundell et al. , 1972), although in 2D-NMR 
studies of insulin monomers in solution these residues 
seem to be flex ible and the interaction unlikely to be main-
tained in solution (Weiss et al., 1989). In the platypus insu-
lin model A 13 Met is sandwiched between A 14 and 81 and 
the B 1 Phe is pushed away from the body of the monomer 
(Figure 3). Such structural differences should be inter-
preted with caution, thus a possible altered dimer-dimer 
interaction and thus altered self-association properties of 
platypus insulin needs to be evaluated experimentally 
under solution conditions when sufficient material is avail-
able. 
Viewing the space filling models of both platypus and 
pig insulin, by looking directly at the receptor binding re-
gion, revealed no marked difference. As viewed from the 
two-fold axis pig insulin is mainly heart shaped while 
platypus insulin has a squarer structure. The invariant 
amino acids responsible for the stable core structure of in-
sulin (Baker et al., 1988) are identical in both species. 
In conclusion, platypus insulin's self-association be-
haviour under physiological conditions needs to be 
evaluated. The influence of the changes in amino acid 
composition on biological activity and receptor binding 
characteristics of platypus insulin also require experimen-
tal study. Platypus insulin possesses a unique evolutio-
nary-designed primary structure. The study of the ramifi-
cations of this, especially its molecular interactions and 
physico-chemical behaviour in its physiological environ-
ment, namely in solution, blood, and in contacts with re-
sidues of its receptor upon binding to elicit a biological re-
sponse, should contribute to our understanding of the 
structure-function relationship of insulin in general. The 
combination of knowledge gained from the resources of 
evolutionary designed and protein-engineered insulins 
will in turn contribute to a more informed insulin design 
and evaluation strategy in the quest for a monomeric, ac-
tive, stable and immunologically safe insulin for diabetes 
therapy. 
To date only sufficient platypus insulin for amino acid 
sequence determination has been isolated. Chemical pep-
tide synthesis, based on the known sequence, is currently 
under way to obtain sufficient material to conduct the 
studies referred to. 
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